Processing 00000000.tx.1: Simulated first-phase insulin release using Humulin or insulin analog HIM2 is associated with prolonged improvement in postprandial glycemia Catherine A. 

Phrase: "Simulated first-phase insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0030685:Release [Health Care Activity]
   804   C0391871:Release [Functional Concept]
   804   C0439180:% release [Quantitative Concept]
   804   C0680255:release [Health Care Activity]
   804   C1283071:Release [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1963578:Release [Therapeutic or Preventive Procedure]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Humulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020171:humulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C0020172:Humulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C3538423:Humulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "or"

Phrase: "insulin analog HIM2"

Phrase: "is"

Phrase: "associated with prolonged improvement"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0439590:Prolonged [Temporal Concept]
   770   C2986411:Improvement [Conceptual Entity]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in postprandial glycemia Catherine A."
Processing 00000000.tx.2: DiCostanzo,1 Mary Courtney Moore,1 Margaret Lautz,1 Melanie Scott,1 Ben Farmer,1 Carrie A. 

Phrase: "DiCostanzo,"

Phrase: "1 Mary Courtney Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0443030:moore [Intellectual Product]

Phrase: "1 Margaret Lautz,"

Phrase: "1 Melanie Scott,"

Phrase: "1 Ben Farmer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0221460:Farmer [Professional or Occupational Group]

Phrase: "1 Carrie A."
Processing 00000000.tx.3: Everett,1 J. 

Phrase: "Everett,"

Phrase: "1 J."
Processing 00000000.tx.4: Gordon Still,2 Alan Higgins,2 and Alan D. 

Phrase: "Gordon Still,"

Phrase: "2 Alan Higgins,"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "Alan D."
Processing 00000000.tx.5: Cherrington1 1Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee; 

Phrase: "Cherrington1 1Department of Molecular Physiology"

Phrase: "and"

Phrase: "Biophysics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005553:Biophysics [Biomedical Occupation or Discipline]

Phrase: "Vanderbilt University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Nashville,"

Phrase: "Tennessee"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039514:Tennessee [Geographic Area]

Phrase: ";"
Processing 00000000.tx.6: and 2Nobex Corporation, Research Triangle Park, North Carolina Submitted 10 December 2004 ; accepted in final form 9 February 2005  ABSTRACT TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  We examined the extent to which priming the liver with a pulse of Humulin or the insulin analog hexyl-insulin monoconjugate 2 (HIM2) reduces postprandial hyperglycemia. 

Phrase: "and"

Phrase: "2Nobex Corporation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corporation [Organization]

Phrase: "Research Triangle Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0562547:Park [Manufactured Object]
   827   C3160718:PARK [Disease or Syndrome]

Phrase: "North Carolina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028407:North Carolina [Geographic Area]
   861   C1709269:North [Spatial Concept]

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: "10 December 2004"

Phrase: ";"

Phrase: "accepted in final form 9 February 2005  ABSTRACT TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   753   C0035171:Research Design [Research Activity]
   736   C0000857:Abstract [Occupational Activity]
   736   C0035168:research [Research Activity]
   736   C0205088:Final [Temporal Concept]
   736   C0242481:Research [Research Activity]
   736   C0348078:Form [Qualitative Concept]
   736   C0376315:Form [Manufactured Object]
   736   C0600678:Abstract [Intellectual Product]
   736   C1272684:Accepted [Qualitative Concept]
   736   C1522492:Form [Functional Concept]
   736   C1546485:Final [Idea or Concept]
   736   C1548435:Accepted [Idea or Concept]
   736   C1552863:Abstract [Idea or Concept]
   736   C1704458:Top [Spatial Concept]
   736   C1707689:Design [Activity]
   736   C2983265:DESIGN [Intellectual Product]
   703 E C1548601:Accept [Idea or Concept]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the extent to which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "priming"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:Priming [Functional Concept]

Phrase: "the liver with a pulse of Humulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0023884:Liver [Body Part, Organ, or Organ Component]
   748   C0736268:LIVER [Body Part, Organ, or Organ Component]
   748   C1278929:Liver [Body Part, Organ, or Organ Component]
   748   C2346688:LIVER [Food]

Phrase: "or"

Phrase: "the insulin analog hexyl-insulin monoconjugate 2 (HIM2)"

Phrase: "reduces"

Phrase: "postprandial hyperglycemia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1855520:Hyperglycemia, Postprandial [Finding]
   861   C0020456:Hyperglycaemia [Disease or Syndrome]
Processing 00000000.tx.7: Somatostatin (0.5 gkg1min1) was given with basal intraportal insulin and glucagon for 4.5 h into three groups of 42-h-fasted conscious dogs. 

Phrase: "Somatostatin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037659:Somatostatin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1881011:Somatostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   916 E C0373723:somatostatins [Laboratory Procedure]

Phrase: "(0.5 gkg1min1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0444499:0/5 [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "given with basal intraportal insulin"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   797   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205112:Basal [Spatial Concept]
   760   C1442162:GIVEN [Conceptual Entity]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1550718:given [Idea or Concept]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C3244317:given [Intellectual Product]
   726 E C1947971:Give [Functional Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "glucagon for 4.5 h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   760   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "into three groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "of 42-h-fasted conscious dogs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0012984:Dogs [Mammal]
   804   C1280551:Dogs [Mammal]
Processing 00000000.tx.8: From 05 min, group 1 (BI, n = 6) received saline, group 2 (HI, n = 6) received a Humulin pulse (10 mUkg1min1), and group 3 (HIM2, n = 6) received a HIM2 pulse (10 mUkg1min1). 

Phrase: "From 05 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "group 1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441861:Group 1 [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "(BI,"

Phrase: "n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "received saline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036082:Saline [Substance]

Phrase: "group 2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441865:Group 2 [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "(HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "a Humulin pulse"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0232117:PULSE [Clinical Attribute]
   861   C0391850:Pulse [Physiologic Function]
   861   C1947910:Pulse [Phenomenon or Process]
   777 E C0034107:Pulses [Health Care Activity]

Phrase: "(10 mUkg1min1"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "group 3"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441869:Group 3 [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "(HIM2,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "a HIM2 pulse"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0232117:PULSE [Clinical Attribute]
   804   C0391850:Pulse [Physiologic Function]
   804   C1947910:Pulse [Phenomenon or Process]
   771   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   721 E C0034107:Pulses [Health Care Activity]

Phrase: "(10 mUkg1min1"

Phrase: ")."
Processing 00000000.tx.9: Duodenal glucose was infused (5.0 mgkg1min1) from 15 to 270 min. 

Phrase: "Duodenal glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "infused"

Phrase: "(5.0 mgkg1min1"

Phrase: ")"

Phrase: "from 15"

Phrase: "to 270 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.10: Arterial insulin in BI remained basal (6  1 U/ml) and peaked at 52  15 (HI) and 164  44 U/ml (HIM2) and returned to baseline by 30 and 60 min, respectively. 

Phrase: "Arterial insulin in BI"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "remained"

Phrase: "basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "(6  1 U/ml)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439340:U/ml [Quantitative Concept]
   861   C1880521:U/mL [Quantitative Concept]
   861   C2945590:U/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "peaked at 52  15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0444505:peaked [Quantitative Concept]

Phrase: "(HI)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "and"

Phrase: "164  44 U/ml (HIM2"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   793   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C1579433:Insulin [Pharmacologic Substance]
   737 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   710 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "returned to baseline"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   866   C0332156:Return to [Qualitative Concept]
           Return
   790   C0168634:baseline [Biomedical or Dental Material]
   790   C1442488:Baseline [Quantitative Concept]

Phrase: "by 30"

Phrase: "and"

Phrase: "60 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "respectively."
Processing 00000000.tx.11: Arterial plasma glucose plateaued at 265  20, 214  15, and 193  14 mg/dl in BI, HI, and HIM2. 

Phrase: "Arterial plasma glucose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0202042:Plasma glucose [Laboratory Procedure]
   901   C0455280:plasma glucose [Laboratory or Test Result]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "plateaued at 265  20,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2964353:Plateau [Quantitative Concept]

Phrase: "214  15,"

Phrase: "and"

Phrase: "193  14 mg/dl in BI,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0439269:mg dl [Quantitative Concept]
   783 E C3463848:dl mg [Quantitative Concept]
   753   C3642216:/dL [Quantitative Concept]

Phrase: "HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "and"

Phrase: "HIM2."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.12: Glucose absorption was similar in all groups. 

Phrase: "Glucose absorption"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0000854:Absorption [Natural Phenomenon or Process]
   861   C0220777:absorption [Functional Concept]
   861   C2347023:Absorption [Phenomenon or Process]
   861   C2347080:Absorption [Phenomenon or Process]
   861   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   861   C2825050:Absorption [Phenomenon or Process]

Phrase: "was"

Phrase: "similar in all groups."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.13: Significant net hepatic glucose uptake occurred at 85, 55, and 25 min in BI, HI, and HIM2, respectively. 

Phrase: "Significant net hepatic glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1159527:glucose uptake [Cell Function]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C0243144:Uptake [Physiologic Function]
   804   C0347980:% uptake [Quantitative Concept]

Phrase: "occurred at 85,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1709305:Occurred [Activity]
   756 E C2745955:OCCUR [Temporal Concept]

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "and"

Phrase: "25 min in BI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "and"

Phrase: "HIM2,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "respectively."
Processing 00000000.tx.14: Nonhepatic glucose clearance at 270 min differed among groups (BI, HI, HIM2): 0.62  0.11, 0.76  0.26, and 1.61  0.29 mlkg1min1 (P < 0.05). 

Phrase: "Nonhepatic glucose clearance at 270 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C3272933:Glucose Clearance [Laboratory Procedure]
   753   C0449297:Clearance [Qualitative Concept]
   753   C1382187:Clearance [Clinical Attribute]
   753   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "differed among groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0441833:Group [Idea or Concept]
   790   C0687744:group [Population Group]
   790   C1257890:Group [Population Group]
   790   C1552516:Group [Health Care Related Organization]
   790   C1552839:groups [Idea or Concept]
   790   C1705428:Group [Conceptual Entity]
   790   C1705429:Group [Population Group]

Phrase: "(BI,"

Phrase: "HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "HIM2"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: ":"

Phrase: "0.62  0.11,"

Phrase: "0.76  0.26,"

Phrase: "and"

Phrase: "1.61  0.29 mlkg1min1"

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.15: A brief (5-min) insulin pulse improved postprandial glycemia, stimulating hepatic glucose uptake and prolonging enhancement of nonhepatic glucose clearance. 

Phrase: "A brief"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282927:brief [Qualitative Concept]
  1000   C1879313:Brief [Temporal Concept]

Phrase: "(5-min) insulin pulse"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0232117:PULSE [Clinical Attribute]
   812   C0391850:Pulse [Physiologic Function]
   812   C1947910:Pulse [Phenomenon or Process]
   729 E C0034107:Pulses [Health Care Activity]

Phrase: "improved"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0184511:Improved [Qualitative Concept]
  1000   C0332272:Improved [Qualitative Concept]
  1000   C1561611:Improved [Intellectual Product]

Phrase: "postprandial glycemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005802:glycemia [Carbohydrate]

Phrase: "stimulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulating [Natural Phenomenon or Process]

Phrase: "hepatic glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1159527:glucose uptake [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "prolonging enhancement of nonhepatic glucose clearance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   753   C2349975:Enhancement [Activity]
Processing 00000000.tx.16: HIM2 was more effective than Humulin, perhaps because its lowered clearance caused higher levels at the liver and periphery and its biological activity was not reduced proportionally to its decreased clearance. hexyl-insulin monoconjugate 2; 

Phrase: "HIM2"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "more effective than Humulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280519:effective [Qualitative Concept]
   770   C1704419:Effective [Qualitative Concept]

Phrase: "perhaps"

Phrase: "because"

Phrase: "its lowered clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "higher levels at the liver"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "periphery"

Phrase: "and"

Phrase: "its biological activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0205177:Activity [Functional Concept]
   861   C0205460:biological [Qualitative Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "proportionally to its decreased clearance. hexyl-insulin monoconjugate 2"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   818   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0205216:Decreased [Quantitative Concept]
   742   C0392756:Decreased [Qualitative Concept]
   742   C0442797:decreased [Qualitative Concept]
   742   C0449297:Clearance [Qualitative Concept]
   742   C1382187:Clearance [Clinical Attribute]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C2825073:Clearance [Natural Phenomenon or Process]
   708 E C0547047:Decrease [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.17: insulin action SUBCUTANEOUSLY ADMINISTERED INSULIN is initially absorbed into the peripheral circulation of individuals with diabetes, resulting in fat and muscle being exposed to higher insulin levels than the liver. 

Phrase: "insulin action SUBCUTANEOUSLY ADMINISTERED INSULIN"

Phrase: "is"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "absorbed into the peripheral circulation of individuals"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0425710:Peripheral circulation [Finding]
   748   C0005775:Circulation [Physiologic Function]
   748   C0205100:Peripheral [Spatial Concept]
   748   C1516559:Circulation [Organism Function]
   714   C0027361:Individual [Population Group]
   714   C0237401:Individual [Human]

Phrase: "with diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "resulting in fat"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332294:Resulting in [Functional Concept]
   790   C0424612:FAT [Organism Attribute]
   790   C0678226:resulting [Functional Concept]
   756 E C1274040:Result [Functional Concept]
   756 E C1546471:Result [Idea or Concept]
   756 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "being"

Phrase: "exposed to higher insulin levels"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   806   C0202098:insulin levels [Laboratory Procedure]
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   806   C0428405:insulin levels [Laboratory or Test Result]
   790   C0020459:high insulin [Disease or Syndrome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0441889:Levels [Qualitative Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726   C0205250:High [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726   C1299351:High [Qualitative Concept]
   726 E C1547707:Level [Geographic Area]
   726   C2700149:HIGH [Intellectual Product]
   726 E C2946261:Level [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "than the liver."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.18: This peripheral hyperinsulinemia predisposes to hypoglycemia and is thought to be linked to weight gain and other metabolic abnormalities, which in turn lead to microvascular and macrovascular disease (15). 

Phrase: "This peripheral hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "predisposes to hypoglycemia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0020615:Hypoglycaemia [Disease or Syndrome]
   718 E C0020616:Hypoglycaemic [Pharmacologic Substance]

Phrase: "and"

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "linked to weight gain"
Meta Candidates (Total=17; Excluded=8; Pruned=0; Remaining=9)
   833   C0043094:Weight Gain [Finding]
   833   C2911647:Weight gain [Finding]
   791 E C0231246:weight gaining [Sign or Symptom]
   770   C0005910:weight [Organism Attribute]
   770   C0043100:Weight [Quantitative Concept]
   770   C1305866:weight [Diagnostic Procedure]
   770   C1517378:Gain [Quantitative Concept]
   770   C1705104:Weight [Idea or Concept]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]
   715 E C0205217:Increased [Quantitative Concept]
   715 E C0439661:Acquired [Temporal Concept]
   715 E C0442805:Increase [Functional Concept]
   715 E C0442808:Increasing [Functional Concept]
   715 E C1301820:Obtain [Functional Concept]
   715 E C1706701:Acquire [Activity]
   715 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "other metabolic abnormalities,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0000768:Abnormalities [Congenital Abnormality]
   861   C0000769:abnormalities [Functional Concept]
   827 E C1704258:Abnormality [Finding]
   777 E C0205161:Abnormal [Qualitative Concept]
   777 E C2347472:% Abnormal [Quantitative Concept]
   777 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "which in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "lead to microvascular"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0443258:Microvascular [Functional Concept]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "macrovascular disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.19: If insulin could be given orally, the normal portal vein/arterial insulin distribution would be restored. 

Phrase: "If"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "could"

Phrase: "be"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "orally,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442027:Orally [Spatial Concept]

Phrase: "the normal portal vein/arterial insulin distribution"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   895   C0028377:Normal Distribution [Quantitative Concept]
   895   C0332617:Normal distribution [Qualitative Concept]
   799   C0520511:distribution [Idea or Concept]
   799   C1704711:Distribution [Functional Concept]
   709   C0858301:normal insulin [Finding]

Phrase: "would"

Phrase: "be"

Phrase: "restored."
Processing 00000000.tx.20: It has been shown that agents capable of rapidly increasing the insulin concentration in response to a glucose challenge are good regulators of hepatic glucose metabolism and are more effective controllers of postprandial glucose concentrations than peripherally delivered insulin (3). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0450442:Agent [Chemical Viewed Functionally]
   966   C1254351:Agent [Pharmacologic Substance]
   966   C1521826:Agent [Intellectual Product]

Phrase: "capable of rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C2698977:Capability [Qualitative Concept]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the insulin concentration in response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "to a glucose challenge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0798503:Challenge [Clinical Attribute]
   861   C0805586:Challenge [Health Care Activity]
   861   C3274764:Challenge [Conceptual Entity]

Phrase: "are"

Phrase: "good regulators of hepatic glucose metabolism"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0182953:regulators [Medical Device]
   719 E C1704734:Regulator [Medical Device]
   719 E C1704735:Regulator [Conceptual Entity]

Phrase: "and"

Phrase: "are"

Phrase: "more effective controllers of postprandial glucose concentrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0180112:Controllers [Medical Device]

Phrase: "than peripherally delivered insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.21: An oral insulin would eliminate the disproportionately high peripheral insulin levels while still delivering adequate amounts of insulin to the liver, thereby potentially being useful as a new therapeutic agent. 

Phrase: "An oral insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "would"

Phrase: "eliminate"

Phrase: "the disproportionately high peripheral insulin levels"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   853   C0020459:high insulin [Disease or Syndrome]
   840   C0202098:insulin levels [Laboratory Procedure]
   840   C0428405:insulin levels [Laboratory or Test Result]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0441889:Levels [Qualitative Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "while"

Phrase: "still"

Phrase: "delivering"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
   966   C1705822:Deliver [Activity]
   966   C1874964:DELIVER [Pharmacologic Substance]

Phrase: "adequate amounts of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "to the liver,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "thereby potentially"

Phrase: "being"

Phrase: "useful as a new therapeutic agent."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0039795:therapeutic use [Therapeutic or Preventive Procedure]
   748   C1258064:Therapeutic Uses [Biologic Function]
Processing 00000000.tx.22: The release of insulin in response to a glucose challenge is biphasic in nature, with an early phase and a late phase. 

Phrase: "The release of insulin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to a glucose challenge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0798503:Challenge [Clinical Attribute]
   861   C0805586:Challenge [Health Care Activity]
   861   C3274764:Challenge [Conceptual Entity]

Phrase: "is"

Phrase: "biphasic in nature,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205184:Biphasic [Temporal Concept]

Phrase: "with an early phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "and"

Phrase: "a late phase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205087:Late [Temporal Concept]
   861   C0205390:Phase [Temporal Concept]
Processing 00000000.tx.23: The early phase consists of two parts: a cephalic phase and a first phase. 

Phrase: "The early phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "consists of two parts"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   802   C1292711:Part of [Spatial Concept]
   770   C0205448:Two [Quantitative Concept]
   770   C0332529:CONSIST [Qualitative Concept]
   770   C0449719:parts [Spatial Concept]
   770   C1709471:PARTS [Quantitative Concept]

Phrase: ":"

Phrase: "a cephalic phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "and"

Phrase: "a first phase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]
Processing 00000000.tx.24: The cephalic phase is rapid (2 min after a meal) yet very small, increasing arterial plasma insulin levels by only 5 U/ml. 

Phrase: "The cephalic phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "is"

Phrase: "rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "(2 min after a meal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0702093:/min [Temporal Concept]

Phrase: ")"

Phrase: "yet very small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0700321:Small [Quantitative Concept]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "arterial plasma insulin levels by only 5 U/ml."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   764   C0202098:insulin levels [Laboratory Procedure]
   764   C0428405:insulin levels [Laboratory or Test Result]
   764   C0857690:plasma insulin [Laboratory Procedure]
   756   C1276042:Plasma insulin level [Laboratory Procedure]
   745   C0456951:Level 5 [Qualitative Concept]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0032105:Plasma [Body Substance]
   742   C0441889:Levels [Qualitative Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.25: The more pronounced first phase occurs 510 min postprandially and is dependent on the amount of glucose present. 

Phrase: "The more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "pronounced"

Phrase: "first phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "510 min postprandially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "is"

Phrase: "dependent on the amount of glucose present."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]
Processing 00000000.tx.26: The liver responds quickly, such that the first-phase insulin pulse inhibits glucose production and/or causes an increase in hepatic glucose uptake in the presence of an oral glucose load (5). 

Phrase: "The liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "responds"

Phrase: "quickly,"

Phrase: "such"

Phrase: "that"

Phrase: "the first-phase insulin pulse"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0232117:PULSE [Clinical Attribute]
   812   C0391850:Pulse [Physiologic Function]
   812   C1947910:Pulse [Phenomenon or Process]
   729 E C0034107:Pulses [Health Care Activity]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "glucose production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "and/or"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in hepatic glucose uptake"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of an oral glucose load"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0442027:Oral [Spatial Concept]
   827   C1550025:Load [Idea or Concept]
   827   C1704782:Load [Manufactured Object]
   827   C1708715:Load [Activity]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.27: The way in which the liver responds to the first-phase insulin release during a glucose challenge has been shown to affect subsequent plasma glucose responses and thus is critical in maintaining normal glycemia (7, 10). 

Phrase: "The way in which"

Phrase: "the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "responds to the first-phase insulin release"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0030685:Release [Health Care Activity]
   748   C0205390:Phase [Temporal Concept]
   748   C0205435:First [Quantitative Concept]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1279901:First [Qualitative Concept]
   748   C1283071:Release [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "during a glucose challenge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0798503:Challenge [Clinical Attribute]
   861   C0805586:Challenge [Health Care Activity]
   861   C3274764:Challenge [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "subsequent plasma glucose responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0871261:responses [Organism Attribute]
   779 E C1704632:Response [Finding]
   779 E C1706817:Response [Intellectual Product]
   779 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "thus"

Phrase: "is"

Phrase: "critical in maintaining normal glycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511545:Critical [Qualitative Concept]

Phrase: "(7,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.28: The late phase of insulin release has a lower absolute peak but also plays a significant role in glucoregulation over the 23 h following a meal challenge. 

Phrase: "The late phase of insulin release"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205087:Late [Temporal Concept]
   753   C0205390:Phase [Temporal Concept]

Phrase: "has"

Phrase: "a lower absolute peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0444505:Peak [Quantitative Concept]

Phrase: "but"

Phrase: "also"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a significant role in glucoregulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "over the 23 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "a meal challenge."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0798503:Challenge [Clinical Attribute]
   861   C0805586:Challenge [Health Care Activity]
   861   C3274764:Challenge [Conceptual Entity]
Processing 00000000.tx.29: People with type 2 diabetes typically demonstrate a diminished or brief first-phase insulin release. 

Phrase: "People with type 2 diabetes typically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0027361:People [Population Group]

Phrase: "demonstrate"

Phrase: "a diminished"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:Diminished [Quantitative Concept]

Phrase: "or"

Phrase: "brief first-phase insulin release."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0030685:Release [Health Care Activity]
   804   C0391871:Release [Functional Concept]
   804   C0439180:% release [Quantitative Concept]
   804   C0680255:release [Health Care Activity]
   804   C1283071:Release [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1963578:Release [Therapeutic or Preventive Procedure]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.30: They often have an enhanced second-phase insulin release so as to compensate for this loss (7). 

Phrase: "They often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "have"

Phrase: "an enhanced second-phase insulin release so as to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0030685:Release [Health Care Activity]
   742   C0391871:Release [Functional Concept]
   742   C0439180:% release [Quantitative Concept]
   742   C0680255:release [Health Care Activity]
   742   C1283071:Release [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "compensate for this loss"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205432:compensate [Qualitative Concept]
   770   C1517945:Loss [Quantitative Concept]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.31: Loss of first-phase insulin release has many metabolic implications. 

Phrase: "Loss of first-phase insulin release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "has"

Phrase: "many metabolic implications."
Processing 00000000.tx.32: It is clear that it causes a significant impairment in the suppression of hepatic glucose production postprandially. 

Phrase: "It"

Phrase: "is"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that"

Phrase: "it"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a significant impairment in the suppression of hepatic glucose production postprandially."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0948807:Hepatic impairment [Disease or Syndrome]
   738   C0684336:Impairment [Pathologic Function]
Processing 00000000.tx.33: In a study carried out by Luzi and DeFronzo (18), abolition of the first-phase insulin secretion by somatostatin caused the liver to continually produce glucose despite the subject being both hyperglycemic and hyperinsulinemic. 

Phrase: "In a study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out by Luzi"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]

Phrase: "and"

Phrase: "DeFronzo"

Phrase: "(18"

Phrase: ")"

Phrase: ","

Phrase: "abolition of the first-phase insulin secretion"

Phrase: "by somatostatin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037659:Somatostatin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1881011:Somatostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   916 E C0373723:somatostatins [Laboratory Procedure]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "the liver to continually"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "produce"

Phrase: "glucose despite the subject"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "being"

Phrase: "both hyperglycemic"

Phrase: "and"

Phrase: "hyperinsulinemic."
Processing 00000000.tx.34: When first-phase insulin was replaced, there was a complete normalization of hepatic glucose production. 

Phrase: "When"

Phrase: "first-phase insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "replaced"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0559956:Replaced [Functional Concept]
  1000   C1299987:replaced [Functional Concept]
   966 E C1554078:Replace [Idea or Concept]

Phrase: ","

Phrase: "there"

Phrase: "was"

Phrase: "a complete normalization of hepatic glucose production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1882115:Normalization [Research Activity]
Processing 00000000.tx.35: Bruce et al. 

Phrase: "Bruce et al."
Processing 00000000.tx.36: (3) corrected a deficiency in early prandial insulin secretion using three different approaches in individuals with type 2 diabetes. 

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "corrected"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205202:Corrected [Qualitative Concept]
   966 E C2349182:Correct [Qualitative Concept]

Phrase: "a deficiency in early prandial insulin secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0011155:Deficiency [Functional Concept]
   748   C0162429:Deficiency [Disease or Syndrome]
   748   C1623416:deficiency [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "three different approaches in individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449445:Approaches [Spatial Concept]
   760   C1292724:Approaches [Functional Concept]

Phrase: "with type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.37: One group received insulin (1.8 U total) over the first 30 min to simulate first-phase insulin release following a glucose challenge. 

Phrase: "One group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(1.8 U total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439175:% total [Quantitative Concept]
   812   C0439810:Total [Qualitative Concept]

Phrase: ")"

Phrase: "over the first 30 min to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0456693:/30 min [Temporal Concept]
   861   C1442458:30 min [Temporal Concept]
   812   C0702093:/min [Temporal Concept]

Phrase: "simulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0284447:simulate [Biomedical or Dental Material]

Phrase: "first-phase insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1963578:Release [Therapeutic or Preventive Procedure]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "a glucose challenge."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0798503:Challenge [Clinical Attribute]
   861   C0805586:Challenge [Health Care Activity]
   861   C3274764:Challenge [Conceptual Entity]
Processing 00000000.tx.38: A second group received the same amount of exogenous insulin beginning 30 min after glucose challenge and continuing for 30 min, simulating second-phase insulin release. 

Phrase: "A second group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   964   C0680398:secondary group [Population Group]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "the same amount of exogenous insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "beginning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Beginning [Temporal Concept]

Phrase: "30 min after glucose challenge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0456693:/30 min [Temporal Concept]
   806   C1442458:30 min [Temporal Concept]
   760   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "continuing for 30 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0549178:Continuing [Idea or Concept]

Phrase: "simulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0284447:simulating [Biomedical or Dental Material]

Phrase: "second-phase insulin release."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1963578:Release [Therapeutic or Preventive Procedure]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.39: A third group received the same amount of insulin again over the entire duration of the study as a constant infusion, simulating both a first-phase and second-phase release. 

Phrase: "A third group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "the same amount of insulin again"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "over the entire duration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449238:Duration [Temporal Concept]
   861   C2926735:Duration [Pharmacologic Substance]

Phrase: "of the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "as a constant infusion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0574032:Infusion [Therapeutic or Preventive Procedure]
   861   C1827465:Infusion [Functional Concept]

Phrase: "simulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0284447:simulating [Biomedical or Dental Material]

Phrase: "both a first-phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "and"

Phrase: "second-phase release."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.40: Postprandial glucose tolerance significantly improved in all individuals, even those who received only first-phase insulin. 

Phrase: "Postprandial glucose tolerance significantly"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0178665:Glucose tolerance [Physiologic Function]
   812   C0013220:Tolerance [Finding]
   812   C0020963:Tolerance [Pathologic Function]
   812   C0220929:tolerance [Mental Process]
   812   C0231197:Tolerance [Physiologic Function]
   812   C1704410:Tolerance [Qualitative Concept]
   756 E C0680282:toleration [Social Behavior]
   741 E C0231198:Tolerant [Functional Concept]

Phrase: "improved in all individuals,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0184511:Improved [Qualitative Concept]
   770   C0332272:Improved [Qualitative Concept]
   770   C1561611:Improved [Intellectual Product]
   737   C0027361:Individual [Population Group]
   737   C0237401:Individual [Human]

Phrase: "even"

Phrase: "those who"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "only first-phase insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.41: Previous experiments in our laboratory (27) have looked at first- and second-phase insulin secretion in countering the action of glucagon on glucose turnover in the presence of fourfold-elevated glucagon. 

Phrase: "Previous experiments in our laboratory"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0681814:Experiments [Research Activity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "(27"

Phrase: ")"

Phrase: "have"

Phrase: "looked at first-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205435:First [Quantitative Concept]
   790   C1279901:First [Qualitative Concept]
   756   C0233426:look [Organism Attribute]

Phrase: "and"

Phrase: "second-phase insulin secretion in countering"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1256369:insulin secretion [Cell Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "the action of glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441472:Action [Functional Concept]
   770   C3266814:Action [Activity]

Phrase: "on glucose turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0031227:turnover [Quantitative Concept]
   861   C0243127:turnover [Functional Concept]
   861   C0443331:Turnover [Health Care Activity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of fourfold-elevated glucagon."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   827   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.42: Theses studies revealed that simulated first-phase insulin was more effective than second-phase in countering the glucagon effect. 

Phrase: "Theses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039828:Theses [Intellectual Product]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that simulated first-phase insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "more effective than second-phase in countering"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280519:effective [Qualitative Concept]
   748   C1704419:Effective [Qualitative Concept]

Phrase: "the glucagon effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.43: The present study had two aims. 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "had"

Phrase: "two aims."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C1947946:Aims [Idea or Concept]
   861   C3540473:AIMS [Intellectual Product]
   827 E C2948600:Aim [Pharmacologic Substance]
   827 E C3540471:AIM [Gene or Genome]
   827 E C3540472:AIM [Functional Concept]
Processing 00000000.tx.44: The first was to examine the ability of first-phase insulin release to modify net hepatic glucose uptake under conditions mimicking oral glucose loading in an insulinopenic state and to assess its potential prolonged effect on glucose uptake by nonhepatic tissues. 

Phrase: "The first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the ability of first-phase insulin release to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0085732:Ability [Organism Attribute]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "net hepatic glucose uptake under conditions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1159527:glucose uptake [Cell Function]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]

Phrase: "mimicking"

Phrase: "oral glucose loading in an insulinopenic state"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1708715:Loading [Activity]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "its potential prolonged effect on glucose uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1158774:glucose effect [Genetic Function]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "by nonhepatic tissues."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.45: The second aim was to determine whether a pulse of an insulin analog (hexyl-insulin monoconjugate 2, HIM2, Nobex), created to facilitate the absorption of orally delivered insulin, would have the same ability to modify postprandial hepatic glucose metabolism as Humulin given at the same rate. 

Phrase: "The second aim"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1947946:Aim [Idea or Concept]
   861   C2948600:Aim [Pharmacologic Substance]
   861   C3540471:AIM [Gene or Genome]
   861   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "a pulse of an insulin analog"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0232117:PULSE [Clinical Attribute]
   753   C0391850:Pulse [Physiologic Function]
   753   C1947910:Pulse [Phenomenon or Process]

Phrase: "(hexyl-insulin monoconjugate 2,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "HIM2,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "Nobex"

Phrase: ")"

Phrase: ","

Phrase: "created"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706214:Created [Activity]
   966 E C3244320:create [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "facilitate"

Phrase: "the absorption of orally delivered insulin,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0000854:Absorption [Natural Phenomenon or Process]
   753   C0220777:absorption [Functional Concept]
   753   C2347023:Absorption [Phenomenon or Process]
   753   C2347080:Absorption [Phenomenon or Process]
   753   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   753   C2825050:Absorption [Phenomenon or Process]

Phrase: "would"

Phrase: "have"

Phrase: "the same ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "postprandial hepatic glucose metabolism as Humulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0596620:glucose metabolism [Molecular Function]
   783   C1373178:Hepatic Metabolism [Organ or Tissue Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]

Phrase: "given at the same rate."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0445247:Same [Qualitative Concept]
   760   C0871208:Rate [Activity]
   760   C1442162:GIVEN [Conceptual Entity]
   760   C1521828:Rate [Quantitative Concept]
   760   C1550718:given [Idea or Concept]
   760   C3244317:given [Intellectual Product]
   726 E C1947971:Give [Functional Concept]
Processing 00000000.tx.46: In this way, the pharmacokinetics and pharmacodynamics of the molecules could be compared in the absence of the variability caused by gut absorption of HIM2.  

Phrase: "In this way,"

Phrase: "the pharmacokinetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031327:Pharmacokinetics [Physiologic Function]
  1000   C0031328:pharmacokinetics [Functional Concept]

Phrase: "and"

Phrase: "pharmacodynamics of the molecules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243145:pharmacodynamics [Functional Concept]
   770   C0851347:Pharmacodynamics [Biologic Function]

Phrase: "could"

Phrase: "be"

Phrase: "compared in the absence of the variability"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C1707455:Compared [Activity]
   748   C2827666:Variability [Conceptual Entity]

Phrase: "caused by gut absorption of HIM2."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   818   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   742   C0000854:Absorption [Natural Phenomenon or Process]
   742   C0017189:Gut [Body System]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0220777:absorption [Functional Concept]
   742   C0699819:Gut [Body Part, Organ, or Organ Component]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C2347023:Absorption [Phenomenon or Process]
   742   C2347080:Absorption [Phenomenon or Process]
   742   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   742   C2825050:Absorption [Phenomenon or Process]
   708   C0015127:cause [Functional Concept]
   708   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.47: RESEARCH DESIGN AND METHODS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  Animals and surgical procedures. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0086912:methods research [Research Activity]
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "surgical procedures."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0543467:Surgical procedures [Health Care Activity]
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.48: Studies were carried out on conscious 42-h-fasted mongrel dogs with a mean weight of 23.1  0.4 kg. 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out on conscious 42-h-fasted mongrel dogs"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   744   C0012984:Dogs [Mammal]
   744   C0033727:H+ [Element, Ion, or Isotope]
   744   C0234421:Conscious [Mental Process]
   744   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0439787:Out [Spatial Concept]
   744   C0441932:H+ [Classification]
   744   C0564385:/h [Quantitative Concept]
   744   C0849355:Out [Qualitative Concept]
   744   C1269316:Mongrel [Mammal]
   744   C1280551:Dogs [Mammal]
   711   C0015663:Fast [Finding]
   711   C0456962:Fast [Qualitative Concept]

Phrase: "with a mean weight"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0005910:weight [Organism Attribute]
   861   C0043100:Weight [Quantitative Concept]
   861   C0444504:Mean [Quantitative Concept]
   861   C1305866:weight [Diagnostic Procedure]
   861   C1705104:Weight [Idea or Concept]
   861   C2347634:Mean [Quantitative Concept]
   861   C2348143:Mean [Quantitative Concept]

Phrase: "of 23.1  0.4 kg."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0022718:KG [Geographic Area]
   804   C0439209:kg [Quantitative Concept]
Processing 00000000.tx.49: A fast of this duration was chosen because it results in liver glycogen levels that are at a stable minimum (20 mg/g liver) (12). 

Phrase: "A fast of this duration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015663:Fast [Finding]
   760   C0456962:Fast [Qualitative Concept]

Phrase: "was"

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: "because"

Phrase: "it"

Phrase: "results in liver glycogen levels"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   806   C0023902:Liver Glycogen [Biologically Active Substance,Carbohydrate]
   760   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0441889:Levels [Qualitative Concept]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C1274040:Result [Functional Concept]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C1546471:Result [Idea or Concept]
   760   C2346688:LIVER [Food]
   760   C2825142:Result [Finding]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
   704 E C0205054:Hepatic [Body Location or Region]

Phrase: "that"

Phrase: "are at a stable minimum"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205360:Stable [Qualitative Concept]
   760   C1524031:Minimum [Qualitative Concept]
   760   C1547311:Stable [Intellectual Product]
   760   C1551058:Are [Quantitative Concept]
   760   C1552614:minimum [Idea or Concept]
   760   C2826545:MINIMUM [Quantitative Concept]

Phrase: "(20 mg/g liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0023884:Liver [Body Part, Organ, or Organ Component]
   812   C0736268:LIVER [Body Part, Organ, or Organ Component]
   812   C1278929:Liver [Body Part, Organ, or Organ Component]
   812   C2346688:LIVER [Food]
   756 E C0205054:Hepatic [Body Location or Region]

Phrase: ")"

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.50: Approximately 16 days before study, each dog underwent a laparotomy under general anesthesia (15 mg/kg pentothal sodium presurgery and 1% isoflurane inhalation anesthetic during surgery), and silicone rubber catheters were inserted for sampling in the hepatic vein, the portal vein, and a femoral artery, as described in detail elsewhere (22). 

Phrase: "Approximately 16 days before study,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   781   C2826182:Study Day [Temporal Concept]
   760   C0439228:days [Temporal Concept]
   726 E C0332173:/day [Temporal Concept]
   726 E C0439505:/day [Temporal Concept]

Phrase: "each dog"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012984:Dog [Mammal]
  1000   C1280551:Dog [Mammal]

Phrase: "underwent"

Phrase: "a laparotomy under general anesthesia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0023038:Laparotomy [Therapeutic or Preventive Procedure]

Phrase: "(15 mg/kg pentothal sodium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0936073:Thiopental Sodium [Organic Chemical,Pharmacologic Substance]
   804   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   804   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "presurgery"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441943:pre surgery [Temporal Concept]

Phrase: "and"

Phrase: "1% isoflurane inhalation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0004048:Inhalation [Organism Function]
   827   C0205535:Inhalation [Functional Concept]
   827   C1705211:Inhalation [Quantitative Concept]

Phrase: "anesthetic during surgery"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0002932:Anaesthetic [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "silicone rubber catheters"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0085590:Catheters [Medical Device]
   793 E C1704454:Catheter [Medical Device]
   734   C0037110:Silicone Rubber [Biomedical or Dental Material,Organic Chemical]

Phrase: "were"

Phrase: "inserted for sampling"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0441587:Inserted [Health Care Activity]
   790   C0441621:Sampling [Diagnostic Procedure]
   790   C0870078:Sampling [Idea or Concept]
   756 E C1743766:Insert [Medical Device]
   756 E C1883719:Insert [Functional Concept]

Phrase: "in the hepatic vein,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0019155:Hepatic vein [Body Part, Organ, or Organ Component]
  1000   C1269559:Hepatic vein [Body Part, Organ, or Organ Component]
   861   C0042449:Vein [Body Part, Organ, or Organ Component]
   861   C0205054:Hepatic [Body Location or Region]
   861   C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "the portal vein,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032718:Portal Vein [Body Part, Organ, or Organ Component]
  1000   C0226735:Portal vein [Body Part, Organ, or Organ Component]
  1000   C1281393:Portal vein [Body Part, Organ, or Organ Component]
  1000   C1305775:Portal vein [Body Part, Organ, or Organ Component]
   861   C0042449:Vein [Body Part, Organ, or Organ Component]
   861   C0205054:Portal [Body Location or Region]
   861   C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "a femoral artery,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0015801:Femoral Artery [Body Part, Organ, or Organ Component]
  1000   C1280173:Femoral artery [Body Part, Organ, or Organ Component]
   861   C0003842:Artery [Body Part, Organ, or Organ Component]
   861   C0015811:Femoral [Body Part, Organ, or Organ Component]
   861   C0226004:artery [Body System]
   789 E C0221464:Arterial [Spatial Concept]

Phrase: "as"

Phrase: "described in detail elsewhere"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1522508:Detail [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C1561567:detail [Functional Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.51: Catheters for hormone infusion were also placed in a splenic and a jejunal vein. 

Phrase: "Catheters for hormone infusion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C0492262:CATHETER, INFUSION [Medical Device]
   770   C0085590:Catheters [Medical Device]
   737 E C1704454:Catheter [Medical Device]

Phrase: "were"

Phrase: "also"

Phrase: "placed in a splenic"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0037993:Splenic [Body Part, Organ, or Organ Component]
   737   C0442504:Place [Spatial Concept]
   737   C1704765:Place [Functional Concept]
   737   C1882509:Place [Activity]
   737   C3496241:place [Disease or Syndrome]

Phrase: "and"

Phrase: "a jejunal vein."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0734583:Jejunal vein [Body Part, Organ, or Organ Component]
   861   C0022378:Jejunal [Body Part, Organ, or Organ Component]
   861   C0042449:Vein [Body Part, Organ, or Organ Component]
   861   C1278960:Vein [Body Part, Organ, or Organ Component]
   789 E C1278922:Jejunum [Body Part, Organ, or Organ Component]
Processing 00000000.tx.52: A duodenal catheter was inserted for glucose infusion (19). 

Phrase: "A duodenal catheter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085590:Catheter [Medical Device]
   861   C1704454:Catheter [Medical Device]

Phrase: "was"

Phrase: "inserted for glucose infusion"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0441587:Inserted [Health Care Activity]
   770   C0574032:Infusion [Therapeutic or Preventive Procedure]
   770   C1827465:Infusion [Functional Concept]
   737 E C1743766:Insert [Medical Device]
   737 E C1883719:Insert [Functional Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.53: Transonic flow probes (Transonic Systems, Ithaca, NY) were placed around the portal vein and the hepatic artery. 

Phrase: "Transonic flow probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0182400:Probes [Medical Device]
   793 E C1704681:Probe [Gene or Genome]
   793 E C2347609:Probe [Chemical Viewed Functionally]
   793 E C3536729:Probe [Manufactured Object]

Phrase: "(Transonic Systems,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "Ithaca,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "placed around the portal vein"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0032718:Portal Vein [Body Part, Organ, or Organ Component]
   806   C0226735:Portal vein [Body Part, Organ, or Organ Component]
   806   C1281393:Portal vein [Body Part, Organ, or Organ Component]
   806   C1305775:Portal vein [Body Part, Organ, or Organ Component]
   760   C0042449:Vein [Body Part, Organ, or Organ Component]
   760   C0205054:Portal [Body Location or Region]
   760   C1278960:Vein [Body Part, Organ, or Organ Component]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "and"

Phrase: "the hepatic artery."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0019145:Hepatic artery [Body Part, Organ, or Organ Component]
   861   C0003842:Artery [Body Part, Organ, or Organ Component]
   861   C0205054:Hepatic [Body Location or Region]
   861   C0226004:artery [Body System]
   789 E C0221464:Arterial [Spatial Concept]
Processing 00000000.tx.54: The catheters were filled with saline containing heparin (1,000 U/ml; Abbott Laboratories, North Chicago, IL), their free ends were knotted, and they, along with the free ends of the transonic leads, were placed in two separate subcutaneous pockets. 

Phrase: "The catheters"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085590:Catheters [Medical Device]
   966 E C1704454:Catheter [Medical Device]

Phrase: "were"

Phrase: "filled with saline containing heparin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0036082:Saline [Substance]
   760   C0332256:Containing [Functional Concept]
   760   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C1708059:Filled [Activity]
   760   C2700400:Containing [Activity]

Phrase: "(1,000 U/ml"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C2736788:1 U/mL [Quantitative Concept]
   861   C0439340:U/ml [Quantitative Concept]
   861   C1880521:U/mL [Quantitative Concept]
   861   C2945590:U/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "; Abbott Laboratories,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1546858:Abbott Laboratories [Health Care Related Organization]
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "North Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008044:Chicago [Geographic Area]

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "their free ends"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0444930:ends [Spatial Concept]
   827 E C2746065:End [Temporal Concept]
   789 E C0205088:Terminal [Temporal Concept]
   789 E C1705314:Terminal [Manufactured Object]
   789 E C1705315:Terminal [Spatial Concept]

Phrase: "were"

Phrase: "knotted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0560032:knotted [Quantitative Concept]
  1000   C1881337:KNOTTED [Event]

Phrase: ","

Phrase: "and"

Phrase: "they,"

Phrase: "along with the free ends"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0444930:ends [Spatial Concept]
   827 E C2746065:End [Temporal Concept]
   789 E C0205088:Terminal [Temporal Concept]
   789 E C1705314:Terminal [Manufactured Object]
   789 E C1705315:Terminal [Spatial Concept]

Phrase: "of the transonic"

Phrase: "leads"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C0181586:leads [Medical Device]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "were"

Phrase: "placed in two separate subcutaneous pockets."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205448:Two [Quantitative Concept]
   753   C0443299:Separate [Spatial Concept]
   753   C0443315:subcutaneous [Spatial Concept]
   719   C0442504:Place [Spatial Concept]
   719   C1704765:Place [Functional Concept]
   719   C1882509:Place [Activity]
   719   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.55: Diet, housing, protocol approval, criteria for study, and preparation for study were as previously described (19). 

Phrase: "Diet,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0012155:Diet [Food]
  1000   C1442959:Diet [Organism Function]
  1000   C1519433:DIET [Therapeutic or Preventive Procedure]
  1000   C2983588:DIET [Food]
   928 E C2699635:DIETARY [Functional Concept]

Phrase: "housing"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0020056:Housing [Manufactured Object]
  1000   C1704678:Housing [Medical Device]
   966 E C0442519:house [Conceptual Entity]
   966 E C2003847:House [Manufactured Object]

Phrase: ","

Phrase: "protocol approval,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205540:Approval [Qualitative Concept]
   861   C2346845:Approval [Intellectual Product]

Phrase: "criteria for study,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0243161:criteria [Intellectual Product]

Phrase: "and"

Phrase: "preparation for study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0455052:Preparation [Health Care Activity]
   790   C1521827:Preparation [Functional Concept]

Phrase: "were"

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.56: This protocol was approved by Institutional Animal Care and Use Committee at Vanderbilt University, Nashville, TN. 

Phrase: "This protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442711:Protocol [Intellectual Product]
  1000   C1507394:Protocol [Intellectual Product]
  1000   C1522729:Protocol [Intellectual Product]
  1000   C2348563:Protocol [Intellectual Product]

Phrase: "was"

Phrase: "approved by Institutional Animal Care"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0178478:animal care [Occupation or Discipline]
   797   C0868975:Institutional care [Health Care Activity]
   760   C0003062:Animal [Animal]
   760   C0205540:Approved [Qualitative Concept]
   760   C1947933:Care [Activity]

Phrase: "and"

Phrase: "Use Committee at Vanderbilt University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2699414:Committee [Group]

Phrase: "Nashville,"

Phrase: "TN."
Processing 00000000.tx.57: Experimental design. 

Phrase: "Experimental design."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015320:Experimental Design [Research Activity]
  1000   C0035171:Experimental Design [Research Activity]
   861   C1517586:Experimental [Qualitative Concept]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]
Processing 00000000.tx.58: Each experiment consisted of a 100-min equilibration period (140 to 40 min), a 40-min basal period (40 to 0 min), and a 270-min experimental period (0270 min). 

Phrase: "Each experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "consisted of a 100-min equilibration period"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439531:/period [Temporal Concept]
   748   C0702093:/min [Temporal Concept]
   748   C1948053:Period [Temporal Concept]
   714   C0332529:CONSIST [Qualitative Concept]

Phrase: "(140 to 40 min),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439509:/40 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "a 40-min basal period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0439531:/period [Temporal Concept]
   812   C1948053:Period [Temporal Concept]
   741 E C0332182:Periodic [Temporal Concept]
   741 E C1706381:PERIODIC [Intellectual Product]
   712 E C0031084:Periodicities [Temporal Concept]

Phrase: "(40 to 0 min),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439509:/40 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "a 270-min experimental period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0439531:/period [Temporal Concept]
   812   C1948053:Period [Temporal Concept]
   741 E C0332182:Periodic [Temporal Concept]
   741 E C1706381:PERIODIC [Intellectual Product]
   712 E C0031084:Periodicities [Temporal Concept]

Phrase: "(0270 min)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.59: In all experiments, a constant infusion of indocyanine green (ICG) dye (0.076 mg/min) was initiated at 140 min. 

Phrase: "In all experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "a constant infusion of indocyanine green (ICG) dye"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0574032:Infusion [Therapeutic or Preventive Procedure]
   748   C1827465:Infusion [Functional Concept]

Phrase: "(0.076 mg/min)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439420:mg/min [Quantitative Concept]
   812   C0702093:/min [Temporal Concept]

Phrase: "was"

Phrase: "initiated at 140 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0702093:/min [Temporal Concept]
   737   C1548602:Initiate [Idea or Concept]
   737   C1704686:Initiate [Functional Concept]
Processing 00000000.tx.60: At 0 min, a constant infusion of somatostatin (SRIF; 0.5 gkg1min1) was begun to suppress endogenous insulin and glucagon secretion, and glucagon (0.55 ngkg1min1) and human insulin (0.25 mUkg1min1) were replaced intraportally to maintain basal levels in each protocol. 

Phrase: "At 0 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "a constant infusion of somatostatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0574032:Infusion [Therapeutic or Preventive Procedure]
   760   C1827465:Infusion [Functional Concept]

Phrase: "(SRIF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037659:SRIF [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "; 0.5 gkg1min1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0444499:0/5 [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "begun"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "endogenous insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucagon secretion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2610739:glucagon secretion [Cell Function]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(0.55 ngkg1min1"

Phrase: ")"

Phrase: "and"

Phrase: "human insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(0.25 mUkg1min1"

Phrase: ")"

Phrase: "were"

Phrase: "replaced"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0559956:Replaced [Functional Concept]
  1000   C1299987:replaced [Functional Concept]
   966 E C1554078:Replace [Idea or Concept]

Phrase: "intraportally to"

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "basal levels in each protocol."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.61: The rate of SRIF infusion was lower than that used in past studies so that the inhibitory effect of the peptide on gastric emptying seen with higher SRIF doses could be eliminated. 

Phrase: "The rate of SRIF infusion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C2964135:Infusion Rate [Temporal Concept]
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "lower than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "used in past studies"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   802   C0869040:Use studies [Research Activity]
   770   C0947630:studies [Laboratory Procedure]
   770   C1273517:used [Finding]
   770   C1444637:Past [Temporal Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C1947944:Use [Intellectual Product]
   737 E C2603343:Study [Research Activity]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "the inhibitory effect of the peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on gastric emptying"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0017127:Gastric Emptying [Organ or Tissue Function]
   861   C0038351:Gastric [Body Part, Organ, or Organ Component]
   861   C1704242:Gastric [Qualitative Concept]
   861   C1996907:Emptying [Activity]
   827 E C1880497:Empty [Qualitative Concept]
   789 E C0333668:Depleted [Functional Concept]
   768 E C1550032:Unload [Idea or Concept]

Phrase: "seen with higher SRIF doses"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   764   C0444956:High dose [Quantitative Concept]
   760   C0037659:SRIF [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0178602:Doses [Quantitative Concept]
   760   C0205397:Seen [Qualitative Concept]
   726 E C0042789:see [Organism Function]
   726   C0205250:High [Qualitative Concept]
   726 E C0869039:Dose [Quantitative Concept]
   726 E C1114758:Dose # [Clinical Attribute]
   726   C1299351:High [Qualitative Concept]
   726 E C1428722:DOS [Gene or Genome]
   726 E C1947903:See [Activity]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "could"

Phrase: "be"

Phrase: "eliminated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]
Processing 00000000.tx.62: This rate of SRIF infusion did not affect gastric motility, as indicated by the fact that 98% of the intraduodenal glucose that was infused was absorbed, and yet both the insulin and glucagon levels were successfully clamped. 

Phrase: "This rate of SRIF infusion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C2964135:Infusion Rate [Temporal Concept]
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "gastric motility,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0232572:Gastric motility [Organ or Tissue Function]
   861   C0007608:Motility [Cell Function]
   861   C0038351:Gastric [Body Part, Organ, or Organ Component]
   861   C0678835:Motility [Laboratory or Test Result]
   861   C1510470:Motility [Organism Function]
   861   C1704242:Gastric [Qualitative Concept]
   789 E C1979933:Motile [Finding]

Phrase: "as"

Phrase: "indicated by the fact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1444656:Indicated [Finding]

Phrase: "that 98% of the intraduodenal glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "that"

Phrase: "was"

Phrase: "infused"

Phrase: "was"

Phrase: "absorbed"

Phrase: ","

Phrase: "and"

Phrase: "yet"

Phrase: "both the insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucagon levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C0337437:Glucagon level [Laboratory Procedure]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "successfully"

Phrase: "clamped."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0175721:Clamp [Medical Device]
   966   C1705942:Clamp [Manufactured Object]
   966   C1883710:Clamp [Functional Concept]
Processing 00000000.tx.63: Thus a somatostatin rate of 0.5 gkg1min1 was adequate to clamp the pancreatic hormones while not impeding glucose absorption. 

Phrase: "Thus"

Phrase: "a somatostatin rate of 0.5 gkg1min1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "adequate to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205410:Adequate [Qualitative Concept]
   861   C0205411:Adequate [Qualitative Concept]

Phrase: "clamp"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175721:Clamp [Medical Device]
  1000   C1705942:Clamp [Manufactured Object]
  1000   C1883710:Clamp [Functional Concept]

Phrase: "the pancreatic hormones"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030292:Pancreatic Hormones [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormones [Hormone]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   777 E C0458083:Hormonal [Qualitative Concept]

Phrase: "while"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "impeding"

Phrase: "glucose absorption."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0000854:Absorption [Natural Phenomenon or Process]
   861   C0220777:absorption [Functional Concept]
   861   C2347023:Absorption [Phenomenon or Process]
   861   C2347080:Absorption [Phenomenon or Process]
   861   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   861   C2825050:Absorption [Phenomenon or Process]
Processing 00000000.tx.64: In the first group, insulin was infused into the portal vein at a basal rate of 0.25 mUkg1min1 throughout the study (BI, n = 6). 

Phrase: "In the first group,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "infused into the portal vein"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0032718:Portal Vein [Body Part, Organ, or Organ Component]
   806   C0226735:Portal vein [Body Part, Organ, or Organ Component]
   806   C1281393:Portal vein [Body Part, Organ, or Organ Component]
   806   C1305775:Portal vein [Body Part, Organ, or Organ Component]
   760   C0042449:Vein [Body Part, Organ, or Organ Component]
   760   C0205054:Portal [Body Location or Region]
   760   C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "at a basal rate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1648294:Basal rate [Clinical Attribute]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "of 0.25 mUkg1min1"

Phrase: "throughout the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "(BI,"

Phrase: "n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.65: In the second group, a bolus of human insulin was given into the portal vein from 0 to 5 min at an infusion rate of 10 mUkg1min1 to mimic first-phase insulin release postprandially (HI, n = 6) followed by basal insulin infusion as above. 

Phrase: "In the second group,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   964   C0680398:secondary group [Population Group]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "a bolus of human insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511237:Bolus [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "given into the portal vein"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C0032718:Portal Vein [Body Part, Organ, or Organ Component]
   806   C0226735:Portal vein [Body Part, Organ, or Organ Component]
   806   C1281393:Portal vein [Body Part, Organ, or Organ Component]
   806   C1305775:Portal vein [Body Part, Organ, or Organ Component]
   760   C0042449:Vein [Body Part, Organ, or Organ Component]
   760   C0205054:Portal [Body Location or Region]
   760   C1278960:Vein [Body Part, Organ, or Organ Component]
   760   C1442162:GIVEN [Conceptual Entity]
   760   C1550718:given [Idea or Concept]
   760   C3244317:given [Intellectual Product]
   726 E C1947971:Give [Functional Concept]

Phrase: "from 0"

Phrase: "to 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at an infusion rate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2964135:Infusion Rate [Temporal Concept]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "of 10 mUkg1min1 to"

Phrase: "mimic"

Phrase: "first-phase insulin release postprandially"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0030685:Release [Health Care Activity]
   804   C0391871:Release [Functional Concept]
   804   C0439180:% release [Quantitative Concept]
   804   C0680255:release [Health Care Activity]
   804   C1283071:Release [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1963578:Release [Therapeutic or Preventive Procedure]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "followed by basal insulin infusion"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0199782:insulin infusion [Therapeutic or Preventive Procedure]
   806   C0332283:Followed by [Temporal Concept]
           followed
   806   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205112:Basal [Spatial Concept]
   760   C0574032:Infusion [Therapeutic or Preventive Procedure]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1827465:Infusion [Functional Concept]
   726 E C1719822:Follow [Intellectual Product]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "as above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.66: In the third group, HIM2 (an orally active, modified insulin created by Nobex, Research Triangle Park, NC) was infused into the portal vein at 10 mUkg1min1 (HIM2, n = 6) over 5 min as a bolus followed by a basal infusion of human insulin as above. 

Phrase: "In the third group,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "HIM2"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "an orally active, modified insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "created by Nobex,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C1707531:Created By [Qualitative Concept]
   790   C1706214:Created [Activity]
   756 E C3244320:create [Functional Concept]

Phrase: "Research Triangle Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0562547:Park [Manufactured Object]
   827   C3160718:PARK [Disease or Syndrome]

Phrase: "NC)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027964:NC [Geographic Area]
  1000   C0028407:NC [Geographic Area]
  1000   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "infused into the portal vein"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0032718:Portal Vein [Body Part, Organ, or Organ Component]
   806   C0226735:Portal vein [Body Part, Organ, or Organ Component]
   806   C1281393:Portal vein [Body Part, Organ, or Organ Component]
   806   C1305775:Portal vein [Body Part, Organ, or Organ Component]
   760   C0042449:Vein [Body Part, Organ, or Organ Component]
   760   C0205054:Portal [Body Location or Region]
   760   C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "at 10 mUkg1min1"

Phrase: "(HIM2,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "over 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "as a bolus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511237:Bolus [Therapeutic or Preventive Procedure]

Phrase: "followed by a basal infusion of human insulin"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   793   C0199782:Infusion of insulin [Therapeutic or Preventive Procedure]
           insulin infusion
   770   C0332283:Followed by [Temporal Concept]
           followed
   770   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   767   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0086418:Human [Human]
   744   C0205112:Basal [Spatial Concept]
   744   C0574032:Infusion [Therapeutic or Preventive Procedure]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1827465:Infusion [Functional Concept]
   711 E C1719822:Follow [Intellectual Product]

Phrase: "as above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.67: Glucose (50% dextrose) was infused peripherally at 5 mgkg1min1 from 5 to 10 min and then at 10 mgkg1min1 from 10 to 15 min to prevent hypoglycemia from occurring. 

Phrase: "Glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(50% dextrose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0985453:50% dextrose [Clinical Drug]
   861   C0017725:Dextrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "infused"

Phrase: "peripherally at 5 mgkg1min1"

Phrase: "from 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "to 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "then at 10 mgkg1min1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883708:Then [Temporal Concept]

Phrase: "from 10"

Phrase: "to 15 min to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "hypoglycemia from occurring."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0020615:Hypoglycaemia [Disease or Syndrome]
   718 E C0020616:Hypoglycaemic [Pharmacologic Substance]
Processing 00000000.tx.68: At 15 min, the duodenal glucose (20% dextrose) infusion was started and continued at 5 mgkg1min1 for the duration of the experiment. 

Phrase: "At 15 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "the duodenal glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(20% dextrose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Dextrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0574032:Infusion [Therapeutic or Preventive Procedure]
  1000   C1827465:Infusion [Functional Concept]

Phrase: "was"

Phrase: "started"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1272689:Started [Qualitative Concept]
   966 E C0439659:Start [Temporal Concept]

Phrase: "and"

Phrase: "continued at 5 mgkg1min1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0549178:Continued [Idea or Concept]

Phrase: "for the duration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449238:Duration [Temporal Concept]
  1000   C2926735:Duration [Pharmacologic Substance]

Phrase: "of the experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.69: The purpose of the 15-min delay in starting the duodenal glucose infusion was to simulate insulin dosing before a meal. 

Phrase: "The purpose of the 15-min delay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1285529:Purpose [Functional Concept]

Phrase: "in starting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Start [Temporal Concept]

Phrase: "the duodenal glucose infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0574032:Infusion [Therapeutic or Preventive Procedure]
   827   C1827465:Infusion [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "simulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0284447:simulate [Biomedical or Dental Material]

Phrase: "insulin dosing before a meal."
Processing 00000000.tx.70: Femoral artery, portal vein, and hepatic vein blood samples were taken every 20 min during the basal period (40 to 0 min) and every 30 min after t = 30 min. 

Phrase: "Femoral artery,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0015801:Femoral Artery [Body Part, Organ, or Organ Component]
  1000   C1280173:Femoral artery [Body Part, Organ, or Organ Component]
   861   C0003842:Artery [Body Part, Organ, or Organ Component]
   861   C0015811:Femoral [Body Part, Organ, or Organ Component]
   861   C0226004:artery [Body System]
   789 E C0221464:Arterial [Spatial Concept]

Phrase: "portal vein,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032718:Portal Vein [Body Part, Organ, or Organ Component]
  1000   C0226735:Portal vein [Body Part, Organ, or Organ Component]
  1000   C1281393:Portal vein [Body Part, Organ, or Organ Component]
  1000   C1305775:Portal vein [Body Part, Organ, or Organ Component]
   861   C0042449:Vein [Body Part, Organ, or Organ Component]
   861   C0205054:Portal [Body Location or Region]
   861   C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "hepatic vein blood samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0178913:blood samples [Body Substance]
   858   C0586999:Vein sample [Tissue]
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "every 20 min during the basal period"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0702093:/min [Temporal Concept]

Phrase: "(40 to 0 min)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439509:/40 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "every 30 min after t = 30 min."
Processing 00000000.tx.71: The arterial and portal vein samples were taken simultaneously, and hepatic vein samples were collected 30 s later to compensate for transit time of glucose through the liver. 

Phrase: "The arterial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003842:Arterial [Body Part, Organ, or Organ Component]
  1000   C0221464:Arterial [Spatial Concept]

Phrase: "and"

Phrase: "portal vein samples"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0586999:Vein sample [Tissue]
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]
   734   C0032718:Portal Vein [Body Part, Organ, or Organ Component]
   734   C0226735:Portal vein [Body Part, Organ, or Organ Component]
   734   C1281393:Portal vein [Body Part, Organ, or Organ Component]
   734   C1305775:Portal vein [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "simultaneously,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521115:simultaneously [Temporal Concept]

Phrase: "and"

Phrase: "hepatic vein samples"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0586999:Vein sample [Tissue]
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]
   734   C0019155:Hepatic vein [Body Part, Organ, or Organ Component]
   734   C1269559:Hepatic vein [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "30 s later to"

Phrase: "compensate for transit time of glucose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0040223:Time [Temporal Concept]
   753   C0205432:compensate [Qualitative Concept]
   753   C1301827:transit [Functional Concept]
   753   C3541383:Time [Temporal Concept]

Phrase: "through the liver."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.72: The total volume of blood withdrawn did not exceed 20% of the animal's blood volume, and 2 volumes of normal saline were infused for each volume of blood withdrawn. 

Phrase: "The total volume of blood"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0365302:Volume of Blood [Clinical Attribute]
   835   C0429890:Total blood volume [Finding]
   806   C0449468:Total Volume [Quantitative Concept]
           *Volume
   797   C0005850:Blood Volume [Organism Attribute]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C1690016:% volume [Qualitative Concept]
   760   C1705102:Volume [Intellectual Product]
   760   C2700258:Volume [Laboratory Procedure]

Phrase: "withdrawn"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0424092:Withdrawn [Finding]
  1000   C2349954:Withdrawn [Activity]
  1000   C2825032:Withdrawn [Mental or Behavioral Dysfunction]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exceed"

Phrase: "20% of the animal's blood volume,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0365302:Volume of Blood [Clinical Attribute]
   790   C0005850:Blood Volume [Organism Attribute]
   753   C0003062:Animal [Animal]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0229664:Blood [Body Substance]
   753   C0449468:*Volume [Quantitative Concept]
   753   C1690016:% volume [Qualitative Concept]
   753   C1705102:Volume [Intellectual Product]
   753   C2700258:Volume [Laboratory Procedure]

Phrase: "and"

Phrase: "2 volumes of normal saline"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   781   C0332506:Normal volume [Quantitative Concept]
   781   C0808397:Volume 2 [Quantitative Concept]
   760   C0449468:volumes [Quantitative Concept]
   726 E C1690016:% volume [Qualitative Concept]
   726 E C1705102:Volume [Intellectual Product]
   726 E C2700258:Volume [Laboratory Procedure]

Phrase: "were"

Phrase: "infused for each volume of blood"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0365302:Volume of Blood [Clinical Attribute]
   783   C0005850:Blood Volume [Organism Attribute]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0229664:Blood [Body Substance]
   753   C0449468:*Volume [Quantitative Concept]
   753   C1690016:% volume [Qualitative Concept]
   753   C1705102:Volume [Intellectual Product]
   753   C2700258:Volume [Laboratory Procedure]

Phrase: "withdrawn."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0424092:Withdrawn [Finding]
  1000   C2349954:Withdrawn [Activity]
  1000   C2825032:Withdrawn [Mental or Behavioral Dysfunction]
Processing 00000000.tx.73: After completion of each experiment, the animal was killed with an overdose of pentobarbital, and a tissue sample from three of the seven liver lobes and from muscle was rapidly frozen with clamps kept in liquid nitrogen. 

Phrase: "After completion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205197:Completion [Qualitative Concept]
  1000   C1554962:completion [Qualitative Concept]

Phrase: "of each experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "the animal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animal [Animal]

Phrase: "was"

Phrase: "killed with an overdose of pentobarbital,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0029944:Overdose [Injury or Poisoning]
   753   C0030883:Pentobarbital [Organic Chemical,Pharmacologic Substance]
   753   C0162388:killed [Social Behavior]
   753   C1546941:Overdose [Idea or Concept]
   719 E C0681205:Kill [Idea or Concept]
   719 E C1550555:kill [Functional Concept]

Phrase: "and"

Phrase: "a tissue sample from three of the seven liver lobes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   777   C0586688:Liver tissue sample [Tissue]
   760   C1292533:Tissue Sample [Tissue]
   739   C0370003:Sample [Substance]
   739   C2347026:Sample [Conceptual Entity]

Phrase: "and from muscle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0026845:Muscle [Tissue]
   790   C1515981:And [Idea or Concept]
   718 E C0442025:Muscular [Spatial Concept]

Phrase: "was"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "frozen with clamps"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0016701:Frozen [Natural Phenomenon or Process]
   790   C0175721:clamps [Medical Device]
   790   C0677542:Frozen [Functional Concept]
   756 E C1705942:Clamp [Manufactured Object]
   756 E C1883710:Clamp [Functional Concept]

Phrase: "kept in liquid nitrogen."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
   833   C1550121:Liquid nitrogen [Intellectual Product]
   770   C0028158:Nitrogen [Element, Ion, or Isotope]
   770   C0302908:Liquid [Substance]
   770   C1304698:Liquid [Finding]
   770   C1546699:Liquid NOS [Intellectual Product]
   770   C1550581:nitrogen [Human-caused Phenomenon or Process]
   770   C1561501:Liquid NOS [Substance]
   737   C0333118:Keep [Functional Concept]
Processing 00000000.tx.74: The tissue was stored at 70C for later analysis of glycogen. 

Phrase: "The tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "stored at 70C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]

Phrase: "for later analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "of glycogen."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
Processing 00000000.tx.75: Processing and analysis of samples. 

Phrase: "Processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "analysis of samples."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   841   C1303103:Sample analysis [Laboratory Procedure]
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]
Processing 00000000.tx.76: The collection and immediate processing of blood samples have been described previously (9). 

Phrase: "The collection"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1516698:Collection [Functional Concept]
  1000   C1704814:Collection [Idea or Concept]
   928 E C1516695:Collected [Idea or Concept]

Phrase: "and"

Phrase: "immediate processing of blood samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709694:Processing [Activity]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.77: Four to eight 10-l aliquots of plasma from each sample were immediately analyzed for glucose via the glucose oxidase technique using a glucose analyzer (Beckman Instruments, Fullerton, CA). 

Phrase: "Four to eight 10-l aliquots of plasma"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0032105:Plasma [Body Substance]
   744   C0205450:Four [Quantitative Concept]
   744   C0205454:Eight [Quantitative Concept]
   744   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   711   C1510844:Aliquot [Quantitative Concept]

Phrase: "from each sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "analyzed for glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0936012:Analyzed [Research Activity]

Phrase: "via the glucose oxidase technique"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0449851:Technique [Functional Concept]
   743 E C0025664:techniques [Intellectual Product]
   734   C0017735:GLUCOSE OXIDASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a glucose analyzer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0472226:glucose analyzer [Medical Device]
   861   C0179038:Analyzer [Medical Device]
   861   C1706246:Analyzer [Manufactured Object]

Phrase: "(Beckman Instruments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:instruments [Medical Device]

Phrase: "Fullerton,"

Phrase: "CA)."
Processing 00000000.tx.78: Plasma insulin and glucagon concentrations were determined by RIA, as previously described (13). 

Phrase: "Plasma insulin"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0857690:plasma insulin [Laboratory Procedure]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0032105:Plasma [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucagon concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "determined by RIA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0034580:RIA [Laboratory Procedure]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.79: A comparison of standard curves was performed using Humulin and HIM2. 

Phrase: "A comparison of standard curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Humulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020171:humulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C0020172:Humulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C3538423:Humulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "HIM2."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.80: The two curves were similar but not identical, having slightly different ED50 values. 

Phrase: "The two curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205134:Curve [Spatial Concept]

Phrase: "were"

Phrase: "similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "but"

Phrase: "not identical,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205280:Identical [Qualitative Concept]

Phrase: "having"

Phrase: "slightly different ED50 values."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0042295:Values [Qualitative Concept]
   779 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.81: When human insulin standards were used, the assay slightly underestimated (5%) HIM2 values at the high end of the standard curve (150 U/ml) and slightly overestimated (20%) them at the lower end of the curve (10 U/ml). 

Phrase: "When"

Phrase: "human insulin standards"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0038137:standards [Intellectual Product]
   827   C0175675:Standards [Qualitative Concept]
   793 E C1442989:Standard [Qualitative Concept]
   793 E C2828392:Standard [Intellectual Product]
   734   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "the assay slightly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "underestimated"

Phrase: "(5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "HIM2 values at the high end of the standard curve"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   735   C0042295:Values [Qualitative Concept]
   702 E C1522609:Value [Quantitative Concept]

Phrase: "(150 U/ml)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0439340:U/ml [Quantitative Concept]
   901   C1880521:U/mL [Quantitative Concept]
   901   C2945590:U/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "overestimated"

Phrase: "(20%"

Phrase: ")"

Phrase: "them at the lower end of the curve"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0205134:Curve [Spatial Concept]
   744   C0441994:Lower [Spatial Concept]
   744   C0444930:End [Spatial Concept]
   744   C1548802:Lower [Body Location or Region]
   744   C2003888:Lower [Activity]
   744   C2746065:End [Temporal Concept]

Phrase: "(10 U/ml"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0439340:U/ml [Quantitative Concept]
   901   C1880521:U/mL [Quantitative Concept]
   901   C2945590:U/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.82: At the mid points of the curves, the values were similar. 

Phrase: "At the mid points"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0444598:Mid [Spatial Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: "of the curves,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205134:Curve [Spatial Concept]

Phrase: "the values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "similar."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.83: Samples were diluted when necessary to achieve a value near the mid point of the curve. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "when"

Phrase: "necessary to"

Phrase: "achieve"

Phrase: "a value near the mid point of the curve."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1522609:Value [Quantitative Concept]
Processing 00000000.tx.84: Free fatty acids (FFAs), cortisol, lactate, and glycerol were measured as previously described (4, 17). 

Phrase: "Free fatty acids (FFAs),"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "cortisol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020268:Cortisol [Hormone,Pharmacologic Substance,Steroid]

Phrase: "lactate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022924:lactate [Organic Chemical]
  1000   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "glycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "measured as previously"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(4,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.85: Calculations and data analysis. 

Phrase: "Calculations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1441506:Calculation [Activity]

Phrase: "and"

Phrase: "data analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0010992:Data Analysis [Occupational Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C1524024:analysis [Functional Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.86: Hepatic blood flow was measured using transonic flow probes (Transonic System, Ithaca, NY) and by the use of ICG according to the method of Leevy et al. 

Phrase: "Hepatic blood flow"
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   901   C0232338:Blood flow [Organism Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0205054:Hepatic [Body Location or Region]
   827   C0229664:Blood [Body Substance]
   827   C0806140:Flow [Natural Phenomenon or Process]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "transonic flow probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0182400:Probes [Medical Device]
   793 E C1704681:Probe [Gene or Genome]
   793 E C2347609:Probe [Chemical Viewed Functionally]
   793 E C3536729:Probe [Manufactured Object]

Phrase: "(Transonic System,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "Ithaca,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "and by the use of ICG"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0021234:Indocyanine Green [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   778   C1524063:Use of [Functional Concept]
   748   C0042153:use [Functional Concept]
   748   C0332583:Green [Qualitative Concept]
   748   C0457083:Use [Functional Concept]
   748   C1515981:And [Idea or Concept]
   748   C1947944:Use [Intellectual Product]
   723 E C0733632:Cardio-Green [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   723 E C1707127:CGS [Intellectual Product]

Phrase: "according to the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "of Leevy et al."
Processing 00000000.tx.87: (16). 

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.88: The results obtained with the Transonic flow probes and ICG were not significantly different, but the data reported here were calculated using the Transonic-determined flow because this measurement did not require an assumption regarding the distribution of the arterial and portal vein contribution to hepatic blood flow. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "obtained with the Transonic flow probes"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   753   C0182400:Probes [Medical Device]
   753   C0806140:Flow [Natural Phenomenon or Process]
   753   C1301820:Obtained [Functional Concept]
   719 E C1704681:Probe [Gene or Genome]
   719 E C1706701:Obtain [Activity]
   719 E C2347609:Probe [Chemical Viewed Functionally]
   719 E C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "ICG"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0021234:Indocyanine Green [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   944 E C0733632:Cardio-Green [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   944 E C1707127:CGS [Intellectual Product]
   861   C0332583:Green [Qualitative Concept]

Phrase: "were"

Phrase: "not significantly different,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705242:Different [Qualitative Concept]
   755 E C1705241:*Difference [Quantitative Concept]
   727 E C0443199:Differential [Qualitative Concept]

Phrase: "but"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "were"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Transonic-determined flow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "because"

Phrase: "this measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:Measurement [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "an assumption"

Phrase: "regarding"

Phrase: "the distribution of the arterial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "portal vein contribution to hepatic blood flow."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880177:Contribution [Activity]
Processing 00000000.tx.89: The hepatic substrate load, net hepatic balance, net fractional hepatic extraction, and hepatic sinusoidal insulin and glucagon concentrations were calculated as described previously, using direct calculations for glucose balance (24). 

Phrase: "The hepatic substrate load,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1550025:Load [Idea or Concept]
   827   C1704782:Load [Manufactured Object]
   827   C1708715:Load [Activity]

Phrase: "net hepatic balance,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0014653:Balance [Organism Function]
   827   C0205415:Balance [Functional Concept]
   827   C0560184:Balance [Finding]

Phrase: "net fractional hepatic extraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0185115:Extraction [Therapeutic or Preventive Procedure]
   812   C0684295:extraction [Laboratory Procedure]

Phrase: "and"

Phrase: "hepatic sinusoidal insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucagon concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "direct calculations for glucose balance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1441506:Calculation [Activity]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.90: Nonhepatic glucose uptake was calculated by adding the net hepatic glucose balance to the average net gut balance and subtracting for any change in the glucose mass between the two time points in question. 

Phrase: "Nonhepatic glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1159527:glucose uptake [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "calculated by adding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]
   756   C1883712:Add [Functional Concept]

Phrase: "the net hepatic glucose balance to the average net gut balance"

Phrase: "and"

Phrase: "subtracting for any change"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1719767:Subtract [Intellectual Product]
   737   C2348589:Subtract [Phenomenon or Process]

Phrase: "in the glucose mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "between the two time"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   958   C1948050:Two Times [Quantitative Concept]
   861   C0040223:Time [Temporal Concept]
   861   C0205448:Two [Quantitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "points in question."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1522634:Question [Intellectual Product]
   790   C1552961:Point [Quantitative Concept]
   790   C2347617:point [Quantitative Concept]
Processing 00000000.tx.91: Nonhepatic glucose clearance was calculated by dividing the nonhepatic glucose uptake by the average arterial blood glucose concentration between the two time points in question. 

Phrase: "Nonhepatic glucose clearance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3272933:Glucose Clearance [Laboratory Procedure]
   827   C0449297:Clearance [Qualitative Concept]
   827   C1382187:Clearance [Clinical Attribute]
   827   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "calculated by dividing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332849:dividing [Functional Concept]
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]

Phrase: "the nonhepatic glucose uptake by the average arterial blood glucose concentration"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   756   C1159527:glucose uptake [Cell Function]
   754   C0005802:glucose blood [Carbohydrate]
   754   C0427743:Glucose concentration [Laboratory Procedure]
   754   C1287281:Glucose concentration [Laboratory or Test Result]
   738   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   738   C0243144:Uptake [Physiologic Function]
   738   C0347980:% uptake [Quantitative Concept]

Phrase: "between the two time"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   958   C1948050:Two Times [Quantitative Concept]
   861   C0040223:Time [Temporal Concept]
   861   C0205448:Two [Quantitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "points in question."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1522634:Question [Intellectual Product]
   790   C1552961:Point [Quantitative Concept]
   790   C2347617:point [Quantitative Concept]
Processing 00000000.tx.92: Glucose absorption was calculated by taking the difference between the net gut glucose output during the experimental period and the average basal net gut glucose uptake adjusted for the increase in the arterial plasma glucose level. 

Phrase: "Glucose absorption"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0000854:Absorption [Natural Phenomenon or Process]
   861   C0220777:absorption [Functional Concept]
   861   C2347023:Absorption [Phenomenon or Process]
   861   C2347080:Absorption [Phenomenon or Process]
   861   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   861   C2825050:Absorption [Phenomenon or Process]

Phrase: "was"

Phrase: "calculated by taking"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]

Phrase: "the difference between the net gut glucose output"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "during the experimental period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "and"

Phrase: "the average basal net gut glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1159527:glucose uptake [Cell Function]
   799   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   799   C0243144:Uptake [Physiologic Function]
   799   C0347980:% uptake [Quantitative Concept]

Phrase: "adjusted for the increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442805:Increase [Functional Concept]
   770   C0456081:Adjusted [Functional Concept]

Phrase: "in the arterial plasma glucose level."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   923   C0455280:plasma glucose level [Laboratory or Test Result]
           plasma glucose
   861   C0202042:Plasma glucose [Laboratory Procedure]
   861   C0337438:glucose level [Laboratory Procedure]
   861   C0428548:Glucose level [Laboratory or Test Result]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0032105:Plasma [Body Substance]
   812   C0441889:Level [Qualitative Concept]
   812   C0456079:Level [Classification]
   812   C1547707:Level [Geographic Area]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.93: The latter was calculated as the arterial plasma glucose concentration during the last hour of the study divided by the average basal arterial plasma glucose concentration multiplied by the basal gut glucose uptake rate multiplied by a correction factor of 0.8 as previously determined (21). 

Phrase: "The latter"

Phrase: "was"

Phrase: "calculated as the arterial plasma glucose concentration"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   814   C2584434:Plasma glucose concentration [Finding]
   778   C0202042:Plasma glucose [Laboratory Procedure]
   778   C0427743:Glucose concentration [Laboratory Procedure]
   778   C0455280:plasma glucose [Laboratory or Test Result]
   778   C1287281:Glucose concentration [Laboratory or Test Result]
   774   C0683150:concentration plasma [Quantitative Concept]
   748   C0003842:Arterial [Body Part, Organ, or Organ Component]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0032105:Plasma [Body Substance]
   748   C0086045:Concentration [Mental Process]
   748   C0221464:Arterial [Spatial Concept]
   748   C0444686:Calculated [Functional Concept]
   748   C1441506:Calculated [Activity]
   748   C1443182:Calculated [Laboratory Procedure]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "during the last hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439227:Hour [Temporal Concept]
   861   C0564385:/hour [Quantitative Concept]

Phrase: "of the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "divided by the average basal arterial plasma glucose concentration"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   790   C2584434:Plasma glucose concentration [Finding]
   764   C0202042:Plasma glucose [Laboratory Procedure]
   764   C0427743:Glucose concentration [Laboratory Procedure]
   764   C0455280:plasma glucose [Laboratory or Test Result]
   764   C1287281:Glucose concentration [Laboratory or Test Result]
   762   C0683150:concentration plasma [Quantitative Concept]
   762   C2827768:Average Concentration [Quantitative Concept]
   742   C0003842:Arterial [Body Part, Organ, or Organ Component]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0032105:Plasma [Body Substance]
   742   C0086045:Concentration [Mental Process]
   742   C0205112:Basal [Spatial Concept]
   742   C0221464:Arterial [Spatial Concept]
   742   C0332849:Divided [Functional Concept]
   742   C1446561:Concentration [Quantitative Concept]
   742   C1510992:Average [Quantitative Concept]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   742   C2825518:AVERAGE [Quantitative Concept]

Phrase: "multiplied by the basal gut glucose uptake rate"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C1159527:glucose uptake [Cell Function]
   767   C1648294:Basal rate [Clinical Attribute]
   744   C0017189:Gut [Body System]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0205112:Basal [Spatial Concept]
   744   C0243144:Uptake [Physiologic Function]
   744   C0347980:% uptake [Quantitative Concept]
   744   C0699819:Gut [Body Part, Organ, or Organ Component]
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]
   711   C1719797:Multiply [Functional Concept]
   711   C2911648:Multiply [Quantitative Concept]

Phrase: "multiplied by a correction factor of 0.8"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C0960756:factor A [Organic Chemical]
   744   C1521761:Factor [Functional Concept]
   744   C1705565:CORRECTION [Intellectual Product]
   744   C1947976:Correction [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]
   711   C1719797:Multiply [Functional Concept]
   711   C2911648:Multiply [Quantitative Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "determined"

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.94: For all glucose balance calculations, glucose concentrations were converted from plasma to blood values by using previously determined correction factors (CF, the mean of the ratio of the blood value to the plasma concentration for each period and for each blood vessel). 

Phrase: "For all glucose balance calculations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1441506:Calculation [Activity]

Phrase: "glucose concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427743:Glucose concentration [Laboratory Procedure]
   983   C1287281:Glucose concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "converted from plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032105:Plasma [Body Substance]
   790   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "to blood values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "previously determined correction factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "(CF,"

Phrase: "the mean of the ratio of the blood value"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0444504:Mean [Quantitative Concept]
   742   C2347634:Mean [Quantitative Concept]
   742   C2348143:Mean [Quantitative Concept]

Phrase: "to the plasma concentration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0683150:plasma concentration [Quantitative Concept]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "for each period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0439531:/period [Temporal Concept]
  1000   C1948053:Period [Temporal Concept]
   928 E C0332182:Periodic [Temporal Concept]
   928 E C1706381:PERIODIC [Intellectual Product]
   900 E C0031084:Periodicities [Temporal Concept]

Phrase: "and for each blood vessel"
Meta Candidates (Total=14; Excluded=8; Pruned=0; Remaining=6)
   806   C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
           Vessel
   806   C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   806   C1511228:VESSEL, BLOOD [Tissue]
           Vessel
   760   C1515981:And [Idea or Concept]
   751 E C1558950:VASCULAR [Finding]
   751 E C1801960:Vascular [Qualitative Concept]
   723 E C0005767:Blood [Tissue]
   723 E C0005768:blood [Body Substance]
   723 E C0229664:Blood [Body Substance]
   723 E C0392895:Bloods [Population Group]
   704 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
   700 E C0333275:Bloody [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.95: Mean CFs during basal and experimental periods were 0.74 and 0.74 for the artery, 0.74 and 0.73 for the portal vein, and 0.73 and 0.73 for the hepatic vein, respectively (14, 23). 

Phrase: "Mean CFs during basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015674:CFS [Disease or Syndrome]

Phrase: "and"

Phrase: "experimental periods"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]

Phrase: "were"

Phrase: "0.74"

Phrase: "and"

Phrase: "0.74 for the artery,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0003842:Artery [Body Part, Organ, or Organ Component]
   760   C0226004:artery [Body System]

Phrase: "0.74"

Phrase: "and"

Phrase: "0.73 for the portal vein,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0032718:Portal Vein [Body Part, Organ, or Organ Component]
   790   C0226735:Portal vein [Body Part, Organ, or Organ Component]
   790   C1281393:Portal vein [Body Part, Organ, or Organ Component]
   790   C1305775:Portal vein [Body Part, Organ, or Organ Component]
   753   C0042449:Vein [Body Part, Organ, or Organ Component]
   753   C0205054:Portal [Body Location or Region]
   753   C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "0.73"

Phrase: "and"

Phrase: "0.73 for the hepatic vein,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0019155:Hepatic vein [Body Part, Organ, or Organ Component]
   790   C1269559:Hepatic vein [Body Part, Organ, or Organ Component]
   753   C0042449:Vein [Body Part, Organ, or Organ Component]
   753   C0205054:Hepatic [Body Location or Region]
   753   C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "respectively"

Phrase: "(14,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.96: In this report, these corrected blood glucose concentrations were used for the calculation of net hepatic glucose balance, because the use of whole blood glucose ensures accurate hepatic balance measurements regardless of the characteristics of glucose entry into the erythrocyte. 

Phrase: "In this report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "these corrected blood glucose concentrations"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   906   C2585282:Blood glucose concentration [Finding]
   875   C0427728:blood concentrations [Laboratory or Test Result]
   875   C0699870:blood concentrations [Quantitative Concept]
   875   C1313904:blood concentrations [Laboratory Procedure]
   844   C0427743:Glucose concentration [Laboratory Procedure]
   844   C1287281:Glucose concentration [Laboratory or Test Result]
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "used for the calculation of net hepatic glucose balance,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   745   C1524063:Use of [Functional Concept]
   742   C0014653:Balance [Organism Function]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0205054:Hepatic [Body Location or Region]
   742   C0205415:Balance [Functional Concept]
   742   C0560184:Balance [Finding]
   742   C1273517:used [Finding]
   742   C1441506:Calculation [Activity]
   708 E C0042153:use [Functional Concept]
   708 E C0457083:Use [Functional Concept]
   708 E C1947944:Use [Intellectual Product]

Phrase: "because"

Phrase: "the use of whole blood glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "ensures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "accurate hepatic balance measurements regardless of the characteristics of glucose entry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0337438:glucose measurements [Laboratory Procedure]
   738   C0242485:measurements [Functional Concept]

Phrase: "into the erythrocyte."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014792:Erythrocyte [Cell]
Processing 00000000.tx.97: Statistical analysis. 

Phrase: "Statistical analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.98: All data are presented as means  SE. 

Phrase: "All data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as means  SE."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0449450:Presented [Idea or Concept]
   770   C1704970:Means [Conceptual Entity]
   737 E C0150312:Present [Quantitative Concept]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.99: Time course data were analyzed with repeated-measures analysis of variance. 

Phrase: "Time course data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0449247:Time course [Temporal Concept]

Phrase: "were"

Phrase: "analyzed with repeated-"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205341:Repeated [Functional Concept]
   790   C0936012:Analyzed [Research Activity]
   718 E C1547730:Repeat [Temporal Concept]
   718 E C1705914:Repeat [Conceptual Entity]

Phrase: "measures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]
  1000   C1879489:Measures [Functional Concept]

Phrase: "analysis of variance."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]
Processing 00000000.tx.100: Independent t-tests were used for any comparisons of mean data. 

Phrase: "Independent t-tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022885:Tests [Laboratory Procedure]
   827   C0392366:Tests [Intellectual Product]
   793 E C0039593:Test [Functional Concept]

Phrase: "were"

Phrase: "used for any comparisons of mean data."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   757   C1524063:Use of [Functional Concept]
   748   C0444504:Mean [Quantitative Concept]
   748   C1273517:used [Finding]
   748   C1511726:Data [Idea or Concept]
   748   C2347634:Mean [Quantitative Concept]
   748   C2348143:Mean [Quantitative Concept]
   748   C3245479:data [Medical Device]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714   C1707455:Comparison [Activity]
   714 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.101: Statistical significance was accepted at P < 0.05.  

Phrase: "Statistical significance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "accepted at P < 0.05."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1272684:Accepted [Qualitative Concept]
   760   C1548435:Accepted [Idea or Concept]
   726 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.102: RESULTS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  Plasma glucagon and insulin concentrations. 

Phrase: "RESULTS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Plasma glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.103: Arterial and liver sinusoidal plasma glucagon levels were basal throughout the study in all three groups (Table 1). 

Phrase: "Arterial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003842:Arterial [Body Part, Organ, or Organ Component]
  1000   C0221464:Arterial [Spatial Concept]

Phrase: "and"

Phrase: "liver sinusoidal plasma glucagon levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   873   C1278023:Plasma glucagon level [Laboratory Procedure]
   823   C0337437:Glucagon level [Laboratory Procedure]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "basal throughout the study"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205112:Basal [Spatial Concept]

Phrase: "in all three groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.104: The arterial and liver sinusoidal plasma insulin levels in the BI group remained basal (6  1 and 18  2 U/ml, respectively) throughout the experiment (Fig. 1). 

Phrase: "The arterial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003842:Arterial [Body Part, Organ, or Organ Component]
  1000   C0221464:Arterial [Spatial Concept]

Phrase: "and"

Phrase: "liver sinusoidal plasma insulin levels in the BI group"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   764   C0202098:insulin levels [Laboratory Procedure]
   764   C0428405:insulin levels [Laboratory or Test Result]
   764   C0857690:plasma insulin [Laboratory Procedure]
   756   C1276042:Plasma insulin level [Laboratory Procedure]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0032105:Plasma [Body Substance]
   742   C0441889:Levels [Qualitative Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "remained"

Phrase: "basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "(6  1"

Phrase: "and"

Phrase: "18  2 U/ml,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439340:U/ml [Quantitative Concept]
   861   C1880521:U/mL [Quantitative Concept]
   861   C2945590:U/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: "throughout the experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.105: The arterial plasma insulin level in the HI group rose rapidly and peaked at 52  15 U/ml, whereas the liver sinusoidal insulin level peaked at 171  66 U/ml; 

Phrase: "The arterial plasma insulin level in the HI group"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C1276042:Plasma insulin level [Laboratory Procedure]
   764   C0202098:Insulin level [Laboratory Procedure]
   764   C0428405:insulin level [Laboratory or Test Result]
   764   C0857690:plasma insulin [Laboratory Procedure]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0032105:Plasma [Body Substance]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1547707:Level [Geographic Area]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "rose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035853:Rose [Plant]
  1000   C0995005:ROSE [Pharmacologic Substance]

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "and"

Phrase: "peaked at 52  15 U/ml,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0439340:U/ml [Quantitative Concept]
   790   C1880521:U/mL [Quantitative Concept]
   790   C2945590:U/mL [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C0444505:peaked [Quantitative Concept]

Phrase: "whereas"

Phrase: "the liver sinusoidal insulin level"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0202098:Insulin level [Laboratory Procedure]
   861   C0428405:insulin level [Laboratory or Test Result]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0441889:Level [Qualitative Concept]
   812   C0456079:Level [Classification]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1547707:Level [Geographic Area]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C2946261:Level [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "peaked at 171  66 U/ml"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0439340:U/ml [Quantitative Concept]
   790   C1880521:U/mL [Quantitative Concept]
   790   C2945590:U/mL [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C0444505:peaked [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.106: these levels returned to baseline by 30 min. 

Phrase: "these levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "returned to baseline"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   866   C0332156:Return to [Qualitative Concept]
           Return
   790   C0168634:baseline [Biomedical or Dental Material]
   790   C1442488:Baseline [Quantitative Concept]

Phrase: "by 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.107: The arterial and liver sinusoidal plasma insulin levels in the HIM2 group peaked at 164  44 and 427  185 U/ml, respectively. 

Phrase: "The arterial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003842:Arterial [Body Part, Organ, or Organ Component]
  1000   C0221464:Arterial [Spatial Concept]

Phrase: "and"

Phrase: "liver sinusoidal plasma insulin levels in the HIM2 group"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   782   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   753   C0202098:insulin levels [Laboratory Procedure]
   753   C0428405:insulin levels [Laboratory or Test Result]
   753   C0857690:plasma insulin [Laboratory Procedure]
   737   C1276042:Plasma insulin level [Laboratory Procedure]
   736   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   736   C0032105:Plasma [Body Substance]
   736   C0441889:Levels [Qualitative Concept]
   736   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   736   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   736   C1579433:Insulin [Pharmacologic Substance]
   734   C0456948:Level 2 [Intellectual Product]
   703 E C0456079:Level [Classification]
   703 E C1547707:Level [Geographic Area]
   703 E C2946261:Level [Pharmacologic Substance]

Phrase: "peaked at 164  44"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0444505:peaked [Quantitative Concept]

Phrase: "and"

Phrase: "427  185 U/ml,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439340:U/ml [Quantitative Concept]
   861   C1880521:U/mL [Quantitative Concept]
   861   C2945590:U/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "respectively."
Processing 00000000.tx.108: These values did not return to baseline until 1 h. 

Phrase: "These values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "return to baseline"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C0332156:Return to [Qualitative Concept]
           Return
   790   C0168634:baseline [Biomedical or Dental Material]
   790   C1442488:Baseline [Quantitative Concept]

Phrase: "until 1 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.109: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.110: Arterial and liver sinusoidal glucagon levels and percentages of glucose load extracted by the liver during basal and experimental periods in BI, HI, and HIM2 groups in conscious 42-h fasted dogs  View larger version (31K): [in this window] [in a new window]  Fig. 

Phrase: "Arterial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003842:Arterial [Body Part, Organ, or Organ Component]
  1000   C0221464:Arterial [Spatial Concept]

Phrase: "and"

Phrase: "liver sinusoidal glucagon levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   844   C0337437:Glucagon level [Laboratory Procedure]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "percentages of glucose load"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0439165:Percentage [Quantitative Concept]
   737   C1549488:Percentage [Idea or Concept]
   737   C1561533:Percentage [Idea or Concept]

Phrase: "extracted by the liver"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   802   C0023899:Liver Extract [Organic Chemical,Pharmacologic Substance]
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "during basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "experimental periods in BI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0439531:/period [Temporal Concept]
   737   C1948053:Period [Temporal Concept]

Phrase: "HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "and"

Phrase: "HIM2 groups in conscious 42-h fasted dogs"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   754   C0441842:Group H [Intellectual Product]
   754   C0441865:Group 2 [Intellectual Product]
   754   C1959638:H group [Clinical Attribute]
   738   C0441833:Group [Idea or Concept]
   738   C0687744:group [Population Group]
   738   C1257890:Group [Population Group]
   738   C1552516:Group [Health Care Related Organization]
   738   C1552839:groups [Idea or Concept]
   738   C1705428:Group [Conceptual Entity]
   738   C1705429:Group [Population Group]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.111: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.112: Arterial plasma insulin (top) and liver sinusoidal plasma insulin (bottom) in 42-h-fasted conscious dogs maintained on a pancreatic clamp. 

Phrase: "Arterial plasma insulin"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0857690:plasma insulin [Laboratory Procedure]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "and"

Phrase: "liver sinusoidal plasma insulin"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0857690:plasma insulin [Laboratory Procedure]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0032105:Plasma [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "in 42-h-fasted conscious dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0012984:Dogs [Mammal]
   804   C1280551:Dogs [Mammal]

Phrase: "maintained on a pancreatic clamp."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0175721:Clamp [Medical Device]
   760   C1314677:Maintained [Functional Concept]
   760   C1705942:Clamp [Manufactured Object]
   760   C1883710:Clamp [Functional Concept]
   726 E C0024501:Maintain [Activity]
Processing 00000000.tx.113: During the experimental period, insulin was kept basal (BI) or Humulin spike (HI), and hexyl-insulin monoconjugate 2 (HIM2) spikes (HIM2) were created on the background of basal insulin (n = 6/group). 

Phrase: "During the experimental period,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "kept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0333118:Keep [Functional Concept]

Phrase: "basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "(BI)"

Phrase: "or"

Phrase: "Humulin spike"

Phrase: "(HI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "hexyl-insulin monoconjugate 2"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(HIM2"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "spikes"

Phrase: "(HIM2"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "were"

Phrase: "created on the background of basal insulin"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205112:Basal [Spatial Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1706214:Created [Activity]
   748   C1706907:Background [Conceptual Entity]
   714 E C3244320:create [Functional Concept]

Phrase: "(n = 6/group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: ")."
Processing 00000000.tx.114: SRIF, somatostatin; 

Phrase: "SRIF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037659:SRIF [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "somatostatin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037659:Somatostatin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1881011:Somatostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   916 E C0373723:somatostatins [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.115: GGN, glucagon. 

Phrase: "GGN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425840:GGN [Gene or Genome]

Phrase: "glucagon."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.116: Data are means  SE. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means  SE."
Processing 00000000.tx.117: *P < 0.05 from BI; 

Phrase: "*P < 0.05 from BI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.118: P < 0.05 from HI.  

Phrase: "P < 0.05 from HI."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0018619:HI [Geographic Area]
   760   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1412082:HI [Gene or Genome]
   760   C1412316:HI [Gene or Genome]
   760   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.119: Net gut balance, glucose absorption, and arterial glucose level. 

Phrase: "Net gut balance,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0014653:Balance [Organism Function]
   827   C0205415:Balance [Functional Concept]
   827   C0560184:Balance [Finding]

Phrase: "glucose absorption,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0000854:Absorption [Natural Phenomenon or Process]
   861   C0220777:absorption [Functional Concept]
   861   C2347023:Absorption [Phenomenon or Process]
   861   C2347080:Absorption [Phenomenon or Process]
   861   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   861   C2825050:Absorption [Phenomenon or Process]

Phrase: "and"

Phrase: "arterial glucose level."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0337438:glucose level [Laboratory Procedure]
   901   C0428548:Glucose level [Laboratory or Test Result]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.120: Net gut glucose uptake was similar in all three groups during the control period and averaged 0.50  0.05 mgkg1min1. 

Phrase: "Net gut glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "similar in all three groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "during the control period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "and"

Phrase: "averaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: "0.50  0.05 mgkg1min1."
Processing 00000000.tx.121: The switch from net gut glucose uptake to net glucose output occurred 10 min after the initiation of the intraduodenal glucose infusion in all three groups. 

Phrase: "The switch from net gut glucose uptake"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707719:Switch [Manufactured Object]

Phrase: "to net glucose output"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0599782:glucose output [Organ or Tissue Function]
   827   C1709366:Output [Conceptual Entity]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "10 min after the initiation of the intraduodenal glucose infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456692:/10 min [Temporal Concept]
   739   C0702093:/min [Temporal Concept]

Phrase: "in all three groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
Processing 00000000.tx.122: Net gut glucose output averaged 3.7  0.4 mgkg1min1 over the study period (Fig. 2). 

Phrase: "Net gut glucose output"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0599782:glucose output [Organ or Tissue Function]
   812   C1709366:Output [Conceptual Entity]

Phrase: "averaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: "3.7  0.4 mgkg1min1 over the study period"

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.123: View larger version (24K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.124: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.125: Net gut glucose balance (top) and arterial plasma glucose levels (bottom) in 42-h-fasted conscious dogs maintained on a pancreatic clamp during basal and experimental periods in BI, HI, and HIM2 groups (n = 6/group). 

Phrase: "Net gut glucose balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0014653:Balance [Organism Function]
   812   C0205415:Balance [Functional Concept]
   812   C0560184:Balance [Finding]

Phrase: "(top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "and"

Phrase: "arterial plasma glucose levels"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   890   C0455280:plasma glucose level [Laboratory or Test Result]
           plasma glucose
   861   C0202042:Plasma glucose [Laboratory Procedure]
   861   C0428548:glucose levels [Laboratory or Test Result]
   827 E C0337438:glucose level [Laboratory Procedure]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0032105:Plasma [Body Substance]
   812   C0441889:Levels [Qualitative Concept]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "in 42-h-fasted conscious dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0012984:Dogs [Mammal]
   804   C1280551:Dogs [Mammal]

Phrase: "maintained on a pancreatic clamp"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0175721:Clamp [Medical Device]
   760   C1314677:Maintained [Functional Concept]
   760   C1705942:Clamp [Manufactured Object]
   760   C1883710:Clamp [Functional Concept]
   726 E C0024501:Maintain [Activity]

Phrase: "during basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "experimental periods in BI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0439531:/period [Temporal Concept]
   737   C1948053:Period [Temporal Concept]

Phrase: "HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "and"

Phrase: "HIM2 groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1552839:groups [Idea or Concept]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
   771   C1175776:hexyl-insulin monoconjugate 2 [Hormone]

Phrase: "(n = 6/group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: ")."
Processing 00000000.tx.126: Data are means  SE. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means  SE."
Processing 00000000.tx.127: *P < 0.05 from BI; 

Phrase: "*P < 0.05 from BI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.128: P < 0.05 from HI.  

Phrase: "P < 0.05 from HI."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0018619:HI [Geographic Area]
   760   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1412082:HI [Gene or Genome]
   760   C1412316:HI [Gene or Genome]
   760   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.129: Glucose absorption occurred at a steady state (4.9  0.8 mgkg1min1) in the BI group and caused the plasma glucose level to rise to a plateau of 265  20 mg/dl (Fig. 2) during the last hour of the study. 

Phrase: "Glucose absorption"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0000854:Absorption [Natural Phenomenon or Process]
   861   C0220777:absorption [Functional Concept]
   861   C2347023:Absorption [Phenomenon or Process]
   861   C2347080:Absorption [Phenomenon or Process]
   861   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   861   C2825050:Absorption [Phenomenon or Process]

Phrase: "occurred at a steady state"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0678587:steady state [Natural Phenomenon or Process]
   760   C0205361:Steady [Qualitative Concept]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C1709305:Occurred [Activity]
   760   C3148680:State [Geographic Area]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: "(4.9  0.8 mgkg1min1"

Phrase: ")"

Phrase: "in the BI group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "the plasma glucose level to"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   923   C0455280:plasma glucose level [Laboratory or Test Result]
           plasma glucose
   861   C0202042:Plasma glucose [Laboratory Procedure]
   861   C0337438:glucose level [Laboratory Procedure]
   861   C0428548:Glucose level [Laboratory or Test Result]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0032105:Plasma [Body Substance]
   812   C0441889:Level [Qualitative Concept]
   812   C0456079:Level [Classification]
   812   C1547707:Level [Geographic Area]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C2946261:Level [Pharmacologic Substance]

Phrase: "rise to a plateau of 265  20 mg/dl (Fig. 2"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   756   C0439269:mg dl [Quantitative Concept]
           mg%
   754   C2247415:DL 2 [Molecular Function]
   754   C2346927:Mg+2 [Element, Ion, or Isotope,Pharmacologic Substance]
           Mg++
   754 E C3463848:dl mg [Quantitative Concept]
   738   C0349966:Fig [Food]
   738   C1337208:FIG [Food]
   738   C1960952:mg % [Quantitative Concept]
   738   C2964353:Plateau [Quantitative Concept]
   738   C3642216:/dL [Quantitative Concept]

Phrase: ")"

Phrase: "during the last hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439227:Hour [Temporal Concept]
   861   C0564385:/hour [Quantitative Concept]

Phrase: "of the study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.130: At steady state, glucose absorption accounted for 98% of the infused glucose; 

Phrase: "At steady state,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0678587:steady state [Natural Phenomenon or Process]
   861   C0205361:Steady [Qualitative Concept]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "glucose absorption"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0000854:Absorption [Natural Phenomenon or Process]
   861   C0220777:absorption [Functional Concept]
   861   C2347023:Absorption [Phenomenon or Process]
   861   C2347080:Absorption [Phenomenon or Process]
   861   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   861   C2825050:Absorption [Phenomenon or Process]

Phrase: "accounted for 98% of the infused glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   714   C1551359:account [Idea or Concept]
   714   C2741673:Account # [Clinical Attribute]
   714   C2981730:Account [Classification]

Phrase: ";"
Processing 00000000.tx.131: the remaining 2% was presumed to be metabolized by the gut. 

Phrase: "the remaining 2%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1527428:Remaining [Qualitative Concept]

Phrase: "was"

Phrase: "presumed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "metabolized by the gut."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017189:Gut [Body System]
   770   C0699819:Gut [Body Part, Organ, or Organ Component]
   770   C1524026:Metabolized [Cell Function]
Processing 00000000.tx.132: In the HI group, glucose absorption was similar (4.8  0.5 mgkg1min1) to that seen in the BI group. 

Phrase: "In the HI group,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "glucose absorption"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0000854:Absorption [Natural Phenomenon or Process]
   861   C0220777:absorption [Functional Concept]
   861   C2347023:Absorption [Phenomenon or Process]
   861   C2347080:Absorption [Phenomenon or Process]
   861   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   861   C2825050:Absorption [Phenomenon or Process]

Phrase: "was"

Phrase: "similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "(4.8  0.5 mgkg1min1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0450367:4 5 [Quantitative Concept]

Phrase: ")"

Phrase: "to that"

Phrase: "seen in the BI group."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0205397:Seen [Qualitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]
Processing 00000000.tx.133: In this case, however, the arterial plasma glucose rose less, reaching only 214  15 mg/dl by the last hour of the study. 

Phrase: "In this case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "however,"

Phrase: "the arterial plasma glucose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0202042:Plasma glucose [Laboratory Procedure]
   901   C0455280:plasma glucose [Laboratory or Test Result]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "rose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035853:Rose [Plant]
  1000   C0995005:ROSE [Pharmacologic Substance]

Phrase: "less,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "reaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reaching [Organism Function]

Phrase: "only 214  15 mg/dl by the last hour of the study."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0439269:mg dl [Quantitative Concept]
   751 E C3463848:dl mg [Quantitative Concept]
   736   C3642216:/dL [Quantitative Concept]
Processing 00000000.tx.134: Glucose absorption in the group given the pulse of the insulin analog (HIM2) was identical to that in the other two groups (4.9  0.5 mgkg1min1), but the glycemic profile was markedly different. 

Phrase: "Glucose absorption in the group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0000854:Absorption [Natural Phenomenon or Process]
   760   C0220777:absorption [Functional Concept]
   760   C2347023:Absorption [Phenomenon or Process]
   760   C2347080:Absorption [Phenomenon or Process]
   760   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   760   C2825050:Absorption [Phenomenon or Process]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the pulse of the insulin analog"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0232117:PULSE [Clinical Attribute]
   753   C0391850:Pulse [Physiologic Function]
   753   C1947910:Pulse [Phenomenon or Process]

Phrase: "(HIM2"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "identical to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "in the"

Phrase: "other two groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "(4.9  0.5 mgkg1min1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0450367:4 5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "the glycemic profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: "was"

Phrase: "markedly different."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.135: The rise in arterial plasma glucose occurred more slowly, eventually reaching a plateau of only 193  14 mg/dl during the last hour of the study. 

Phrase: "The rise in arterial plasma glucose"

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "more slowly,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0439834:Slowly [Qualitative Concept]

Phrase: "eventually"

Phrase: "reaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reaching [Organism Function]

Phrase: "a plateau of only 193  14 mg/dl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2964353:Plateau [Quantitative Concept]

Phrase: "during the last hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439227:Hour [Temporal Concept]
   861   C0564385:/hour [Quantitative Concept]

Phrase: "of the study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.136: Despite very similar glucose absorption rates, the glycemic profiles in the three groups were markedly different, indicating that the insulin spike augmented disposition of the absorbed glucose and resulted in glycemic improvement even 4.5 h later. 

Phrase: "Despite very similar glucose absorption rates,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0000854:Absorption [Natural Phenomenon or Process]
   804   C0220777:absorption [Functional Concept]
   804   C2347023:Absorption [Phenomenon or Process]
   804   C2347080:Absorption [Phenomenon or Process]
   804   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   804   C2825050:Absorption [Phenomenon or Process]
   771   C0871208:Rate [Activity]
   771   C1521828:Rate [Quantitative Concept]

Phrase: "the glycemic profiles in the three groups"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1979963:Profile [Laboratory Procedure]
   714   C2003903:Profile [Functional Concept]

Phrase: "were"

Phrase: "markedly different,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the insulin spike augmented disposition of the absorbed glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0743223:Disposition [Idea or Concept]
   742   C1705555:Disposition [Idea or Concept]

Phrase: "and"

Phrase: "resulted in glycemic improvement even 4.5 h later."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0033727:H+ [Element, Ion, or Isotope]
   742   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441932:H+ [Classification]
   742   C0564385:/h [Quantitative Concept]
   742   C2986411:Improvement [Conceptual Entity]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]
Processing 00000000.tx.137: Hepatic glucose load, net hepatic glucose balance, and hepatic fractional glucose extraction. 

Phrase: "Hepatic glucose load,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1550025:Load [Idea or Concept]
   827   C1704782:Load [Manufactured Object]
   827   C1708715:Load [Activity]

Phrase: "net hepatic glucose balance,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0014653:Balance [Organism Function]
   812   C0205415:Balance [Functional Concept]
   812   C0560184:Balance [Finding]

Phrase: "and"

Phrase: "hepatic fractional glucose extraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0185115:Extraction [Therapeutic or Preventive Procedure]
   812   C0684295:extraction [Laboratory Procedure]
Processing 00000000.tx.138: Average hepatic blood flows were similar among the three groups. 

Phrase: "Average hepatic blood flows"
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   861   C0232338:blood flows [Organism Function]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0205054:Hepatic [Body Location or Region]
   812   C0229664:Blood [Body Substance]
   812   C0806140:flows [Natural Phenomenon or Process]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "were"

Phrase: "similar among the three groups."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.139: In the BI group, the total blood flow was 33  3 mlkg1min1, whereas in the HI and HIM2 groups it was 36  3 and 31  4 mlkg1min1, respectively. 

Phrase: "In the BI group,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "the total blood flow"
Meta Candidates (Total=14; Excluded=7; Pruned=0; Remaining=7)
   901   C0232338:Blood flow [Organism Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0229664:Blood [Body Substance]
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]
   827   C0806140:Flow [Natural Phenomenon or Process]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "33  3 mlkg1min1,"

Phrase: "whereas in the HI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0018619:HI [Geographic Area]
   770   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   770   C1412082:HI [Gene or Genome]
   770   C1412316:HI [Gene or Genome]

Phrase: "and"

Phrase: "HIM2 groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1552839:groups [Idea or Concept]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
   771   C1175776:hexyl-insulin monoconjugate 2 [Hormone]

Phrase: "it"

Phrase: "was"

Phrase: "36  3"

Phrase: "and"

Phrase: "31  4 mlkg1min1,"

Phrase: "respectively."
Processing 00000000.tx.140: At the end of the experiment, the hepatic glucose loads were 70  5, 60  1, and 50  7 mgkg1min1 in the BI, HI, and HIM2 groups, respectively (P < 0.05 in BI vs. HIM2; Fig. 3). 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "the hepatic glucose loads"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1550025:Load [Idea or Concept]
   793   C1704782:Load [Manufactured Object]
   793   C1708715:Load [Activity]

Phrase: "were"

Phrase: "70  5,"

Phrase: "60  1,"

Phrase: "and"

Phrase: "50  7 mgkg1min1 in the BI,"

Phrase: "HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "and"

Phrase: "HIM2 groups,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1552839:groups [Idea or Concept]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
   771   C1175776:hexyl-insulin monoconjugate 2 [Hormone]

Phrase: "respectively"

Phrase: "(P < 0.05 in BI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]

Phrase: "vs. HIM2"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "; Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.141: View larger version (32K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(32K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.142: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.143: Net hepatic glucose balance (top) and hepatic glucose load (bottom) in 42-h-fasted conscious dogs maintained on a pancreatic clamp during basal and experimental periods in BI, HI, and HIM2 groups (n = 6/group). 

Phrase: "Net hepatic glucose balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0014653:Balance [Organism Function]
   812   C0205415:Balance [Functional Concept]
   812   C0560184:Balance [Finding]

Phrase: "(top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "and"

Phrase: "hepatic glucose load"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1550025:Load [Idea or Concept]
   827   C1704782:Load [Manufactured Object]
   827   C1708715:Load [Activity]

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "in 42-h-fasted conscious dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0012984:Dogs [Mammal]
   804   C1280551:Dogs [Mammal]

Phrase: "maintained on a pancreatic clamp"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0175721:Clamp [Medical Device]
   760   C1314677:Maintained [Functional Concept]
   760   C1705942:Clamp [Manufactured Object]
   760   C1883710:Clamp [Functional Concept]
   726 E C0024501:Maintain [Activity]

Phrase: "during basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "experimental periods in BI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0439531:/period [Temporal Concept]
   737   C1948053:Period [Temporal Concept]

Phrase: "HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "and"

Phrase: "HIM2 groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1552839:groups [Idea or Concept]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
   771   C1175776:hexyl-insulin monoconjugate 2 [Hormone]

Phrase: "(n = 6/group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: ")."
Processing 00000000.tx.144: Data are means  SE. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means  SE."
Processing 00000000.tx.145: *P < 0.05 from BI; 

Phrase: "*P < 0.05 from BI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.146: P < 0.05 from HI.  

Phrase: "P < 0.05 from HI."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0018619:HI [Geographic Area]
   760   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1412082:HI [Gene or Genome]
   760   C1412316:HI [Gene or Genome]
   760   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.147: During the basal period net hepatic glucose output was similar in all three groups (1.7  0.1 mgkg1min1). 

Phrase: "During the basal period net hepatic glucose output"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0599782:glucose output [Organ or Tissue Function]
   799   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   799   C0205054:Hepatic [Body Location or Region]
   799   C1709366:Output [Conceptual Entity]

Phrase: "was"

Phrase: "similar in all three groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "(1.7  0.1 mgkg1min1"

Phrase: ")."
Processing 00000000.tx.148: In the BI group, it did not decrease significantly until 90 min after the initiation of glucose absorption. 

Phrase: "In the BI group,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "it"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "significantly until 90 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439083:>90 [Quantitative Concept]
   770   C0439087:<90 [Quantitative Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "after the initiation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0589507:Initiation [Mental Process]
  1000   C1158830:Initiation [Genetic Function]
  1000   C1704686:Initiation [Functional Concept]

Phrase: "of glucose absorption."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0000854:Absorption [Natural Phenomenon or Process]
   861   C0220777:absorption [Functional Concept]
   861   C2347023:Absorption [Phenomenon or Process]
   861   C2347080:Absorption [Phenomenon or Process]
   861   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   861   C2825050:Absorption [Phenomenon or Process]
Processing 00000000.tx.149: By the last hour of the study, however, net hepatic glucose uptake occurred at the rate of 2.7  0.7 mgkg1min1. 

Phrase: "By the last hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439227:Hour [Temporal Concept]
   861   C0564385:/hour [Quantitative Concept]

Phrase: "of the study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "however,"

Phrase: "net hepatic glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "occurred at the rate of 2.7  0.7 mgkg1min1."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   739   C0871208:Rate [Activity]
   739   C1521828:Rate [Quantitative Concept]
   739   C1709305:Occurred [Activity]
   706 E C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.150: Net hepatic glucose output declined more rapidly in the HI group, ceasing by 60 min. 

Phrase: "Net hepatic glucose output"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0599782:glucose output [Organ or Tissue Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0205054:Hepatic [Body Location or Region]
   812   C1709366:Output [Conceptual Entity]

Phrase: "declined"

Phrase: "more rapidly in the HI group,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0018619:HI [Geographic Area]
   753   C0205172:More [Functional Concept]
   753   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1412082:HI [Gene or Genome]
   753   C1412316:HI [Gene or Genome]
   753   C1552516:Group [Health Care Related Organization]
   753   C1637379:Rapidly [Qualitative Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]

Phrase: "ceasing by 60 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   737   C1947925:Cease [Activity]
Processing 00000000.tx.151: It declined most rapidly in the HIM2 group, in which it ceased at 30 min. 

Phrase: "It"

Phrase: "declined"

Phrase: "most rapidly in the HIM2 group,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   818   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   762   C0441865:Group 2 [Intellectual Product]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0205393:Most [Quantitative Concept]
   742   C0441833:Group [Idea or Concept]
   742   C0687744:group [Population Group]
   742   C1257890:Group [Population Group]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1552516:Group [Health Care Related Organization]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1637379:Rapidly [Qualitative Concept]
   742   C1705428:Group [Conceptual Entity]
   742   C1705429:Group [Population Group]

Phrase: "in which"

Phrase: "it"

Phrase: "ceased at 30 min."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   737   C1947925:Cease [Activity]
Processing 00000000.tx.152: By the last hour of the study, net hepatic glucose uptake was 2.7  0.6 and 2.0  0.3 mgkg1min1 in the HI and HIM2 groups, respectively (Fig. 3). 

Phrase: "By the last hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439227:Hour [Temporal Concept]
   861   C0564385:/hour [Quantitative Concept]

Phrase: "of the study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "net hepatic glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "2.7  0.6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0740116:+2 [Quantitative Concept]
   812   C2827735:2+ [Quantitative Concept]
   812   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "2.0  0.3 mgkg1min1 in the HI"

Phrase: "and"

Phrase: "HIM2 groups,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1552839:groups [Idea or Concept]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
   771   C1175776:hexyl-insulin monoconjugate 2 [Hormone]

Phrase: "respectively"

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.153: At that time, the fractional extraction of glucose by the liver was 35% in all three groups (Table 1). 

Phrase: "At"

Phrase: "that time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "the fractional extraction of glucose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C2986830:Extraction Fraction [Quantitative Concept]
   760   C0185115:Extraction [Therapeutic or Preventive Procedure]
   760   C0684295:extraction [Laboratory Procedure]

Phrase: "by the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "was"

Phrase: "35% in all three groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205449:Three [Quantitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.154: Nonesterified fatty acids and glycerol. 

Phrase: "Nonesterified fatty acids"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0015688:Nonesterified Fatty Acids [Lipid]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "glycerol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.155: In the BI group, glycerol levels and net hepatic glycerol uptake fell slightly and eventually plateaued (Fig. 4). 

Phrase: "In the BI group,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "glycerol levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "net hepatic glycerol uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "fell"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0085639:Fall [Finding]
   966   C0238715:Fall [Temporal Concept]

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "and"

Phrase: "eventually"

Phrase: "plateaued"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2964353:Plateau [Quantitative Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.156: In the HI group, the glycerol levels and net hepatic glycerol uptake fell rapidly in the first 15 min, then rose slightly, and then drifted down. 

Phrase: "In the HI group,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "the glycerol levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "net hepatic glycerol uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "fell"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0085639:Fall [Finding]
   966   C0238715:Fall [Temporal Concept]

Phrase: "rapidly in the first 15 min,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205435:First [Quantitative Concept]
   753   C0702093:/min [Temporal Concept]
   753   C1279901:First [Qualitative Concept]
   753   C1637379:Rapidly [Qualitative Concept]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "rose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035853:Rose [Plant]
  1000   C0995005:ROSE [Pharmacologic Substance]

Phrase: "slightly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "drifted down."
Processing 00000000.tx.157: In the HIM2 group, the glycerol levels and the net hepatic glycerol uptake fell rapidly over the first 30 min, reached a minimum at 60 min, and then drifted up slightly. 

Phrase: "In the HIM2 group,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
   771   C1175776:hexyl-insulin monoconjugate 2 [Hormone]

Phrase: "the glycerol levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "the net hepatic glycerol uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "fell"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0085639:Fall [Finding]
   966   C0238715:Fall [Temporal Concept]

Phrase: "rapidly over the first 30 min,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0456693:/30 min [Temporal Concept]
   790   C1442458:30 min [Temporal Concept]
   753   C0205435:First [Quantitative Concept]
   753   C0702093:/min [Temporal Concept]
   753   C1279901:First [Qualitative Concept]
   753   C1637379:Rapidly [Qualitative Concept]

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "a minimum at 60 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1524031:Minimum [Qualitative Concept]
   760   C1552614:minimum [Idea or Concept]
   760   C2826545:MINIMUM [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "drifted up slightly."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0750482:Slightly [Idea or Concept]
Processing 00000000.tx.158: By the end of the experiment, there were no significant differences in glycerol levels or net hepatic glycerol uptake among the three groups. 

Phrase: "By the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "there"

Phrase: "were"

Phrase: "no significant differences in glycerol levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "or"

Phrase: "net hepatic glycerol uptake among the three groups."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0243144:Uptake [Physiologic Function]
   744   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.159: In general, the plasma nonesterified fatty acid (NEFA) levels (Fig. 5) and net hepatic NEFA uptakes paralleled the changes in glycerol. 

Phrase: "In general,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]

Phrase: "the plasma nonesterified fatty acid (NEFA) levels"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   884   C0015688:Non-esterified fatty acid [Lipid]
   851   C1281901:Fatty acid level [Laboratory Procedure]
   840   C0015684:Fatty acid [Lipid]
   804   C0001128:Acid [Chemical]
   804   C0032105:Plasma [Body Substance]
   804   C0202406:Acid [Laboratory Procedure]
   804   C0441889:Levels [Qualitative Concept]
   804   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "net hepatic NEFA uptakes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0243144:uptakes [Physiologic Function]
   766 E C0347980:% uptake [Quantitative Concept]

Phrase: "paralleled"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C2348042:Parallel [Qualitative Concept]
   966   C2826345:PARALLEL [Research Activity]

Phrase: "the changes in glycerol."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   816   C0025320:The change [Physiologic Function]
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.160: View larger version (31K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.161: 4. 

Phrase: "4."
Processing 00000000.tx.162: Arterial blood glycerol levels (top) and net hepatic glycerol uptake (bottom) in 42-h-fasted conscious dogs maintained on a pancreatic clamp during basal and experimental periods in BI, HI, and HIM2 groups (n = 6/group). 

Phrase: "Arterial blood glycerol levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "(top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "and"

Phrase: "net hepatic glycerol uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "in 42-h-fasted conscious dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0012984:Dogs [Mammal]
   804   C1280551:Dogs [Mammal]

Phrase: "maintained on a pancreatic clamp"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0175721:Clamp [Medical Device]
   760   C1314677:Maintained [Functional Concept]
   760   C1705942:Clamp [Manufactured Object]
   760   C1883710:Clamp [Functional Concept]
   726 E C0024501:Maintain [Activity]

Phrase: "during basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "experimental periods in BI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0439531:/period [Temporal Concept]
   737   C1948053:Period [Temporal Concept]

Phrase: "HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "and"

Phrase: "HIM2 groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1552839:groups [Idea or Concept]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
   771   C1175776:hexyl-insulin monoconjugate 2 [Hormone]

Phrase: "(n = 6/group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: ")."
Processing 00000000.tx.163: Data are means  SE. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means  SE."
Processing 00000000.tx.164: *P < 0.05 from BI; 

Phrase: "*P < 0.05 from BI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.165: P < 0.05 from HI.  

Phrase: "P < 0.05 from HI."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0018619:HI [Geographic Area]
   760   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1412082:HI [Gene or Genome]
   760   C1412316:HI [Gene or Genome]
   760   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.166: View larger version (32K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(32K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.167: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.168: Arterial plasma nonesterified fatty acid (NEFA) levels (top) and net hepatic NEFA uptake (bottom) in 42-h-fasted conscious dogs maintained on a pancreatic clamp during basal and experimental periods in BI, HI, and HIM2 groups (n = 6/group). 

Phrase: "Arterial plasma nonesterified fatty acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0015688:Non-esterified fatty acid [Lipid]
   840   C0015684:Fatty acid [Lipid]
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]

Phrase: "(NEFA) levels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0015688:Non-esterified fatty acid [Lipid]
   890   C1281901:Fatty acid level [Laboratory Procedure]
   861   C0015684:Fatty acid [Lipid]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "(top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "and"

Phrase: "net hepatic NEFA uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0243144:Uptake [Physiologic Function]
   799   C0347980:% uptake [Quantitative Concept]

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "in 42-h-fasted conscious dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0012984:Dogs [Mammal]
   804   C1280551:Dogs [Mammal]

Phrase: "maintained on a pancreatic clamp"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0175721:Clamp [Medical Device]
   760   C1314677:Maintained [Functional Concept]
   760   C1705942:Clamp [Manufactured Object]
   760   C1883710:Clamp [Functional Concept]
   726 E C0024501:Maintain [Activity]

Phrase: "during basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "experimental periods in BI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0439531:/period [Temporal Concept]
   737   C1948053:Period [Temporal Concept]

Phrase: "HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "and"

Phrase: "HIM2 groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1552839:groups [Idea or Concept]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
   771   C1175776:hexyl-insulin monoconjugate 2 [Hormone]

Phrase: "(n = 6/group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: ")."
Processing 00000000.tx.169: Data are means  SE. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means  SE."
Processing 00000000.tx.170: *P < 0.05 from BI; 

Phrase: "*P < 0.05 from BI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.171: P < 0.05 from HI.  

Phrase: "P < 0.05 from HI."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0018619:HI [Geographic Area]
   760   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1412082:HI [Gene or Genome]
   760   C1412316:HI [Gene or Genome]
   760   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.172: Lactate levels and hepatic balance. 

Phrase: "Lactate levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0428445:lactate levels [Laboratory Procedure]
  1000   C1304767:lactate levels [Laboratory or Test Result]
   861   C0022924:lactate [Organic Chemical]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "hepatic balance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0014653:Balance [Organism Function]
   861   C0205415:Balance [Functional Concept]
   861   C0560184:Balance [Finding]
Processing 00000000.tx.173: The liver exhibited net lactate uptake in the basal periods in all three groups, and hyperglycemia resulted in a switch to net hepatic lactate output (Fig. 6). 

Phrase: "The liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "net lactate uptake in the basal periods"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243144:Uptake [Physiologic Function]
   748   C0347980:% uptake [Quantitative Concept]

Phrase: "in all three groups,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "resulted in a switch"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1707719:Switch [Manufactured Object]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "to net hepatic lactate output"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1709366:Output [Conceptual Entity]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.174: At the end of the experiment, net hepatic lactate output was 11.2  4.4, 8.8  1.4, and 5.4  3.2 molkg1min1 in the BI, HI, and HIM2 groups, respectively. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "net hepatic lactate output"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1709366:Output [Conceptual Entity]

Phrase: "was"

Phrase: "11.2  4.4,"

Phrase: "8.8  1.4,"

Phrase: "and"

Phrase: "5.4  3.2 molkg1min1 in the BI,"

Phrase: "HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "and"

Phrase: "HIM2 groups,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1552839:groups [Idea or Concept]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
   771   C1175776:hexyl-insulin monoconjugate 2 [Hormone]

Phrase: "respectively."
Processing 00000000.tx.175: The arterial blood lactate levels steadily rose in all three groups due to the switch in net hepatic lactate balance and reached an average value of 1,500 mol/l by the end of the experiment. 

Phrase: "The arterial blood lactate levels steadily"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   921   C1273449:Arterial blood lactate level [Laboratory Procedure]
   840   C0428445:lactate levels [Laboratory Procedure]
   840   C1304767:lactate levels [Laboratory or Test Result]
   804   C0022924:lactate [Organic Chemical]
   804   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "rose in all three groups"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0035853:Rose [Plant]
   760   C0205449:Three [Quantitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C0995005:ROSE [Pharmacologic Substance]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "due to the switch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707719:Switch [Manufactured Object]

Phrase: "in net hepatic lactate balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0014653:Balance [Organism Function]
   812   C0205415:Balance [Functional Concept]
   812   C0560184:Balance [Finding]

Phrase: "and"

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "an average value of 1,500 mol/l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1522609:Value [Quantitative Concept]

Phrase: "by the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.176: View larger version (34K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.177: 6. 

Phrase: "6."
Processing 00000000.tx.178: Arterial blood lactate levels (top) and net hepatic lactate balance (bottom) in 42-h-fasted conscious dogs maintained on a pancreatic clamp during basal and experimental periods in BI, HI, and HIM2 groups (n = 6/group). 

Phrase: "Arterial blood lactate levels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   983   C1273449:Arterial blood lactate level [Laboratory Procedure]
   861   C0428445:lactate levels [Laboratory Procedure]
   861   C1304767:lactate levels [Laboratory or Test Result]
   812   C0022924:lactate [Organic Chemical]
   812   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "(top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "and"

Phrase: "net hepatic lactate balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0014653:Balance [Organism Function]
   812   C0205415:Balance [Functional Concept]
   812   C0560184:Balance [Finding]

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "in 42-h-fasted conscious dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0012984:Dogs [Mammal]
   804   C1280551:Dogs [Mammal]

Phrase: "maintained on a pancreatic clamp"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0175721:Clamp [Medical Device]
   760   C1314677:Maintained [Functional Concept]
   760   C1705942:Clamp [Manufactured Object]
   760   C1883710:Clamp [Functional Concept]
   726 E C0024501:Maintain [Activity]

Phrase: "during basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "experimental periods in BI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0439531:/period [Temporal Concept]
   737   C1948053:Period [Temporal Concept]

Phrase: "HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "and"

Phrase: "HIM2 groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1552839:groups [Idea or Concept]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
   771   C1175776:hexyl-insulin monoconjugate 2 [Hormone]

Phrase: "(n = 6/group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: ")."
Processing 00000000.tx.179: Data are means  SE. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means  SE."
Processing 00000000.tx.180: *P < 0.05 from BI; 

Phrase: "*P < 0.05 from BI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.181: P < 0.05 from HI.  

Phrase: "P < 0.05 from HI."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0018619:HI [Geographic Area]
   760   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1412082:HI [Gene or Genome]
   760   C1412316:HI [Gene or Genome]
   760   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.182: Nonhepatic glucose uptake and nonhepatic glucose clearance. 

Phrase: "Nonhepatic glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1159527:glucose uptake [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "nonhepatic glucose clearance."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3272933:Glucose Clearance [Laboratory Procedure]
   827   C0449297:Clearance [Qualitative Concept]
   827   C1382187:Clearance [Clinical Attribute]
   827   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.183: By the end of the experiment, the HIM2 pulse was associated with a significantly greater nonhepatic glucose clearance (1.61  0.29 mlkg1min1) than basal insulin (BI = 0.62  0.11 mlkg1min1) or the Humulin pulse (HI = 0.76  0.26 mlkg1min1; Fig. 7). 

Phrase: "By the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "the HIM2 pulse"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0232117:PULSE [Clinical Attribute]
   804   C0391850:Pulse [Physiologic Function]
   804   C1947910:Pulse [Phenomenon or Process]
   771   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   721 E C0034107:Pulses [Health Care Activity]

Phrase: "was"

Phrase: "associated with a significantly greater nonhepatic glucose clearance"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C3272933:Glucose Clearance [Laboratory Procedure]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0443228:greater [Quantitative Concept]
   744   C0449297:Clearance [Qualitative Concept]
   744   C1382187:Clearance [Clinical Attribute]
   744   C1704243:Greater [Quantitative Concept]
   744   C2825073:Clearance [Natural Phenomenon or Process]
   711 E C0549177:Great [Quantitative Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(1.61  0.29 mlkg1min1"

Phrase: ")"

Phrase: "than basal insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(BI = 0.62  0.11 mlkg1min1"

Phrase: ")"

Phrase: "or"

Phrase: "the Humulin pulse"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0232117:PULSE [Clinical Attribute]
   861   C0391850:Pulse [Physiologic Function]
   861   C1947910:Pulse [Phenomenon or Process]
   777 E C0034107:Pulses [Health Care Activity]

Phrase: "(HI = 0.76  0.26 mlkg1min1"

Phrase: "; Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.184: These differences in nonhepatic glucose clearances are also reflected in the nonhepatic glucose uptake values (Table 2). 

Phrase: "These differences in nonhepatic glucose clearances"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "are"

Phrase: "also"

Phrase: "reflected in the nonhepatic glucose uptake values"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C1159527:glucose uptake [Cell Function]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0042295:Values [Qualitative Concept]
   748   C0243144:Uptake [Physiologic Function]
   748   C0347980:% uptake [Quantitative Concept]
   748   C0558058:reflected [Mental Process]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.185: View larger version (12K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.186: 7. 

Phrase: "7."
Processing 00000000.tx.187: Nonhepatic glucose clearance in 42-h-fasted conscious dogs maintained on a pancreatic clamp during basal and experimental periods in BI, HI, and HIM2 groups (n = 6/group). 

Phrase: "Nonhepatic glucose clearance in 42-h-fasted conscious dogs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C3272933:Glucose Clearance [Laboratory Procedure]
   742   C0449297:Clearance [Qualitative Concept]
   742   C1382187:Clearance [Clinical Attribute]
   742   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "maintained on a pancreatic clamp"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0175721:Clamp [Medical Device]
   760   C1314677:Maintained [Functional Concept]
   760   C1705942:Clamp [Manufactured Object]
   760   C1883710:Clamp [Functional Concept]
   726 E C0024501:Maintain [Activity]

Phrase: "during basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "experimental periods in BI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0439531:/period [Temporal Concept]
   737   C1948053:Period [Temporal Concept]

Phrase: "HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "and"

Phrase: "HIM2 groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1552839:groups [Idea or Concept]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
   771   C1175776:hexyl-insulin monoconjugate 2 [Hormone]

Phrase: "(n = 6/group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: ")."
Processing 00000000.tx.188: Data are means  SE. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means  SE."
Processing 00000000.tx.189: *P < 0.05 from BI; 

Phrase: "*P < 0.05 from BI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.190: P < 0.05 from HI.  

Phrase: "P < 0.05 from HI."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0018619:HI [Geographic Area]
   760   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1412082:HI [Gene or Genome]
   760   C1412316:HI [Gene or Genome]
   760   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.191: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.192: Nonhepatic glucose uptake during basal and experimental periods in BI, HI, and HIM2 groups in conscious 42-h-fasted dogs   DISCUSSION TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  These data indicate that simulation of first-phase insulin release during an intraduodenal glucose infusion, given on the background of a pancreatic clamp, resulted in a significant improvement of the glycemic profile for as long as 4 h. 

Phrase: "Nonhepatic glucose uptake during basal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1159527:glucose uptake [Cell Function]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "experimental periods in BI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0439531:/period [Temporal Concept]
   737   C1948053:Period [Temporal Concept]

Phrase: "HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "and"

Phrase: "HIM2 groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1552839:groups [Idea or Concept]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
   771   C1175776:hexyl-insulin monoconjugate 2 [Hormone]

Phrase: "in conscious 42-h-fasted dogs   DISCUSSION TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0035171:Research Design [Research Activity]
   790   C0035168:research [Research Activity]
   790   C0242481:Research [Research Activity]
   790   C1707689:Design [Activity]
   790   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that simulation of first-phase insulin release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0679083:Simulation [Research Activity]

Phrase: "during an intraduodenal glucose infusion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0574032:Infusion [Therapeutic or Preventive Procedure]
   827   C1827465:Infusion [Functional Concept]

Phrase: "given on the background of a pancreatic clamp,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   744   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   744   C0175721:Clamp [Medical Device]
   744   C1442162:GIVEN [Conceptual Entity]
   744   C1550718:given [Idea or Concept]
   744   C1705942:Clamp [Manufactured Object]
   744   C1706907:Background [Conceptual Entity]
   744   C1883710:Clamp [Functional Concept]
   744   C3244317:given [Intellectual Product]
   711 E C1947971:Give [Functional Concept]

Phrase: "resulted in a significant improvement of the glycemic profile"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0237881:significant [Quantitative Concept]
   742   C0750502:Significant [Idea or Concept]
   742   C1546944:Significant [Qualitative Concept]
   742   C1979963:Profile [Laboratory Procedure]
   742   C2003903:Profile [Functional Concept]
   742   C2986411:Improvement [Conceptual Entity]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "for"

Phrase: "as long"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205166:Long [Qualitative Concept]
  1000   C1706317:Long [Qualitative Concept]

Phrase: "as 4 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.193: We also showed that a modified insulin (HIM2) molecule improved glycemia even more than Humulin, probably as a result of its modified pharmokinetics. 

Phrase: "We also"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "a modified insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(HIM2"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:Molecule [Substance]
   928 E C1521991:Molecular [Qualitative Concept]

Phrase: "improved"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0184511:Improved [Qualitative Concept]
  1000   C0332272:Improved [Qualitative Concept]
  1000   C1561611:Improved [Intellectual Product]

Phrase: "glycemia even more than Humulin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005802:glycemia [Carbohydrate]
   760   C0020171:humulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0020172:Humulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C3538423:Humulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "probably as a result of its modified pharmokinetics."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0392747:Modified [Functional Concept]
   744   C0750492:Probably [Idea or Concept]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]
Processing 00000000.tx.194: It would appear that a pulse of insulin improves postprandial glycemia by two different mechanisms. 

Phrase: "It"

Phrase: "would"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that"

Phrase: "a pulse of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0232117:PULSE [Clinical Attribute]
   770   C0391850:Pulse [Physiologic Function]
   770   C1947910:Pulse [Phenomenon or Process]

Phrase: "improves"

Phrase: "postprandial glycemia by two different mechanisms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0005802:glycemia [Carbohydrate]
Processing 00000000.tx.195: The early blunting of the glycemic rise is mediated by a quick increase in net hepatic glucose uptake, whereas the later improvement is associated with an increase in nonhepatic glucose clearance. 

Phrase: "The early blunting of the glycemic rise"

Phrase: "is"

Phrase: "mediated by a quick increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0439831:quick [Qualitative Concept]
   760   C0442805:Increase [Functional Concept]

Phrase: "in net hepatic glucose uptake,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "whereas"

Phrase: "the later improvement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986411:Improvement [Conceptual Entity]

Phrase: "is"

Phrase: "associated with an increase"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0442805:Increase [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in nonhepatic glucose clearance."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3272933:Glucose Clearance [Laboratory Procedure]
   827   C0449297:Clearance [Qualitative Concept]
   827   C1382187:Clearance [Clinical Attribute]
   827   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.196: After the 5-min pulse of human insulin, arterial plasma insulin levels rose rapidly and remained elevated for 30 min. 

Phrase: "After the 5-min pulse"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0232117:PULSE [Clinical Attribute]
   827   C0391850:Pulse [Physiologic Function]
   827   C1947910:Pulse [Phenomenon or Process]
   743 E C0034107:Pulses [Health Care Activity]

Phrase: "of human insulin,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "arterial plasma insulin levels"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   890   C1276042:Plasma insulin level [Laboratory Procedure]
   861   C0202098:insulin levels [Laboratory Procedure]
   861   C0428405:insulin levels [Laboratory or Test Result]
   861   C0857690:plasma insulin [Laboratory Procedure]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0032105:Plasma [Body Substance]
   812   C0441889:Levels [Qualitative Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "rose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035853:Rose [Plant]
  1000   C0995005:ROSE [Pharmacologic Substance]

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "and"

Phrase: "remained"

Phrase: "elevated for 30 min."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0205250:Elevated [Qualitative Concept]
   770   C0702093:/min [Temporal Concept]
   770   C3163633:Elevated [Qualitative Concept]
Processing 00000000.tx.197: Administration of HIM2 caused an elevation in plasma insulin levels that lasted almost 60 min. 

Phrase: "Administration of HIM2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C0199782:Administration of insulin [Therapeutic or Preventive Procedure]
           administration insulin
   753   C0001554:Administration [Occupational Activity]
   753   C1533734:Administration [Therapeutic or Preventive Procedure]
   716   C1175776:hexyl-insulin monoconjugate 2 [Hormone]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "an elevation in plasma insulin levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439775:Elevation [Therapeutic or Preventive Procedure]
   753   C0702240:Elevation [Spatial Concept]

Phrase: "that"

Phrase: "lasted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1517741:Last [Qualitative Concept]

Phrase: "almost 60 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]
Processing 00000000.tx.198: Despite infusion of the same amount of insulin in both groups, the HIM2 spike created a significantly higher arterial plasma insulin level than did the human insulin spike. 

Phrase: "Despite infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0574032:Infusion [Therapeutic or Preventive Procedure]
  1000   C1827465:Infusion [Functional Concept]

Phrase: "of the same amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:Amount [Quantitative Concept]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in both groups,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "the HIM2 spike"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1175776:hexyl-insulin monoconjugate 2 [Hormone]

Phrase: "created"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706214:Created [Activity]
   966 E C3244320:create [Functional Concept]

Phrase: "a significantly higher arterial plasma insulin level than"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   800   C1276042:Plasma insulin level [Laboratory Procedure]
   770   C0202098:Insulin level [Laboratory Procedure]
   770   C0428405:insulin level [Laboratory or Test Result]
   770   C0857690:plasma insulin [Laboratory Procedure]
   750   C0020459:high insulin [Disease or Syndrome]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0032105:Plasma [Body Substance]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1547707:Level [Geographic Area]
   744   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "did"

Phrase: "the human insulin spike."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.199: The area under the curve (AUC) for HIM2 was almost three times greater than that seen in the HI group. 

Phrase: "The area under the curve (AUC)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C0376690:Area under the curve [Quantitative Concept]
           Area Under Curve
   760   C0017446:Area [Geographic Area]
   760   C0205146:Area [Spatial Concept]

Phrase: "for HIM2"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "almost three times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "greater than that"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0439093:Greater Than [Quantitative Concept]
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]

Phrase: "seen in the HI group."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   760   C0018619:HI [Geographic Area]
   760   C0205397:Seen [Qualitative Concept]
   760   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1412082:HI [Gene or Genome]
   760   C1412316:HI [Gene or Genome]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]
Processing 00000000.tx.200: These data suggest that clearance of the insulin analog was significantly reduced relative to that of Humulin. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that clearance of the insulin analog"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0449297:Clearance [Qualitative Concept]
   753   C1382187:Clearance [Clinical Attribute]
   753   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "relative to that of Humulin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.201: HIM2 clearance was undoubtedly altered as a result of the structural modification of the molecule. 

Phrase: "HIM2 clearance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0449297:Clearance [Qualitative Concept]
   804   C1382187:Clearance [Clinical Attribute]
   804   C2825073:Clearance [Natural Phenomenon or Process]
   771   C1175776:hexyl-insulin monoconjugate 2 [Hormone]

Phrase: "was"

Phrase: "undoubtedly"

Phrase: "altered as a result of the structural modification of the molecule."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   756   C0581602:Structural modification [Therapeutic or Preventive Procedure]
   738   C0392747:Altered [Functional Concept]
           Modification
   738   C0567416:Molecule [Substance]
   738   C0678594:Structural [Spatial Concept]
   738   C1274040:Result [Functional Concept]
   738   C1546471:Result [Idea or Concept]
   738   C1554963:modification [Qualitative Concept]
   738   C2825142:Result [Finding]
Processing 00000000.tx.202: Its structure is composed of a single ampiphilic oligomer of low molecular weight covalently linked to a free amino group on the Lys-B29 residue of recombinant human insulin via an amide bond. 

Phrase: "Its structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "is"

Phrase: "composed of a single ampiphilic oligomer of low molecular weight covalently"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   756   C0026385:Molecular Weight [Quantitative Concept]
   754   C0041667:Low weight [Finding]
   738   C0005910:weight [Organism Attribute]
   738   C0037179:Single [Population Group]
   738   C0043100:Weight [Quantitative Concept]
   738   C0087136:single [Finding]
   738   C0205171:Single [Quantitative Concept]
   738   C0205251:low [Qualitative Concept]
   738   C1299352:Low [Qualitative Concept]
   738   C1305866:weight [Diagnostic Procedure]
   738   C1521991:Molecular [Qualitative Concept]
   738   C1550472:low [Idea or Concept]
   738   C1705104:Weight [Idea or Concept]
   718   C0872367:single molecule [Substance]

Phrase: "linked to a free amino group"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0596072:amino group [Inorganic Chemical]
   783   C0441835:Group A [Classification]
   753   C0332296:free [Functional Concept]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "on the Lys-B29 residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   755 E C1609982:Residual [Qualitative Concept]

Phrase: "of recombinant human insulin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   913   C1533581:Recombinant Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
           Insulin
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0086418:Human [Human]
   827   C1514798:recombinant [Organism]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "via an amide bond."
Processing 00000000.tx.203: It is readily absorbed due to its amphiphilic nature and has enhanced resistance to degradation by enzymes, such as insulin protease, (8), which is unable to reach its sites of action due to steric interference (28). 

Phrase: "It"

Phrase: "is"

Phrase: "readily"

Phrase: "absorbed due to its amphiphilic nature"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0349590:Nature [Idea or Concept]
   753   C1262865:Nature [Functional Concept]
   753   C3146286:Due [Idea or Concept]

Phrase: "and"

Phrase: "has"

Phrase: "enhanced resistance to degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0332325:Resistant to [Functional Concept]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]

Phrase: "by enzymes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "such as insulin protease,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021669:Insulin Protease [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]

Phrase: "(8"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "its sites of action"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   819   C0581718:action sites [Intellectual Product]
   816   C2945843:Site of [Qualitative Concept]
   770   C0205145:Sites [Spatial Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "due to steric interference"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0521102:Interference [Qualitative Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.204: It is clear that the biological activity of HIM2 insulin was reduced relative to Humulin, because the threefold increase in the AUC for plasma insulin improved glucose kinetics only slightly. 

Phrase: "It"

Phrase: "is"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that"

Phrase: "the biological activity of HIM2 insulin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   762   C1145751:insulin activity [Molecular Function]
   742   C0005532:Biological [Biomedical Occupation or Discipline]
   742   C0205177:Activity [Functional Concept]
   742   C0205460:biological [Qualitative Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "relative to Humulin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "because"

Phrase: "the threefold increase in the AUC"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0376690:Area under the curve [Quantitative Concept]
           Area Under Curve
   742   C0017446:Area [Geographic Area]
   742   C0205134:Curve [Spatial Concept]
   742   C0205146:Area [Spatial Concept]
   742   C0442805:Increase [Functional Concept]

Phrase: "for plasma insulin"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0857690:plasma insulin [Laboratory Procedure]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0032105:Plasma [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "improved"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0184511:Improved [Qualitative Concept]
  1000   C0332272:Improved [Qualitative Concept]
  1000   C1561611:Improved [Intellectual Product]

Phrase: "glucose kinetics only slightly."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0022702:Kinetics [Natural Phenomenon or Process]
   812   C0205171:Only [Quantitative Concept]
   812   C0220865:kinetics [Functional Concept]
   812   C0750482:Slightly [Idea or Concept]
   812   C1720467:Only [Intellectual Product]
   812   C2825046:Kinetics [Occupation or Discipline]
Processing 00000000.tx.205: The fact that HIM2 brought about a slight improvement in glycemia, relative to Humulin, suggests that the decrease in its biological action was not exactly proportional to its altered clearance. 

Phrase: "The fact"

Phrase: "that HIM2"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "brought about a slight improvement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0332302:brought [Functional Concept]
   760   C2937276:Slight [Qualitative Concept]
   760   C2945599:Slight [Qualitative Concept]
   760   C2986411:Improvement [Conceptual Entity]

Phrase: "in glycemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005802:glycemia [Carbohydrate]

Phrase: "relative to Humulin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the decrease in its biological action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "not exactly proportional to its altered clearance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205351:Proportional [Qualitative Concept]
Processing 00000000.tx.206: Clearly any improvements in glycemia seen in response to the pulse of insulin cannot be due to the difference in glucose delivery, since all three groups received glucose intraduodenally at the same rate. 

Phrase: "Clearly"

Phrase: "any improvements in glycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2986411:Improvement [Conceptual Entity]

Phrase: "seen in response"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0205397:Seen [Qualitative Concept]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "to the pulse"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0232117:PULSE [Clinical Attribute]
  1000   C0391850:Pulse [Physiologic Function]
  1000   C1947910:Pulse [Phenomenon or Process]
   916 E C0034107:Pulses [Health Care Activity]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "cannot"

Phrase: "be due to the difference"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0678226:Due to [Functional Concept]
           due
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]
   760   C2987476:Be [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]

Phrase: "in glucose delivery,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011209:Delivery [Therapeutic or Preventive Procedure]
   861   C0559563:delivery [Finding]
   861   C1705822:Delivery [Activity]

Phrase: "since"

Phrase: "all three groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "glucose intraduodenally at the same rate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.207: Furthermore, the calculated glucose absorption rate was identical in all three groups. 

Phrase: "Furthermore,"

Phrase: "the calculated glucose absorption rate"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   812   C0000854:Absorption [Natural Phenomenon or Process]
   812   C0220777:absorption [Functional Concept]
   812   C0871208:Rate [Activity]
   812   C1521828:Rate [Quantitative Concept]
   812   C2347023:Absorption [Phenomenon or Process]
   812   C2347080:Absorption [Phenomenon or Process]
   812   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   812   C2825050:Absorption [Phenomenon or Process]

Phrase: "was"

Phrase: "identical in all three groups."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.208: Therefore, the difference in the arterial plasma glucose levels must be attributed to changes in glucose utilization. 

Phrase: "Therefore,"

Phrase: "the difference in the arterial plasma glucose levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "must"

Phrase: "be"

Phrase: "attributed to changes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756   C0449234:Attribute [Idea or Concept]
   756   C1704772:Attribute [Conceptual Entity]
   756 E C1705241:Change [Quantitative Concept]
   756   C1882133:Attribute [Qualitative Concept]

Phrase: "in glucose utilization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042153:utilization [Functional Concept]
Processing 00000000.tx.209: In the early part of the response (15120 min), the liver ceased glucose production and began to take up glucose most rapidly in the HIM2 group. 

Phrase: "In the early part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449719:Part [Spatial Concept]
   861   C1709471:Part [Quantitative Concept]

Phrase: "of the response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "(15120 min),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "ceased"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947925:Cease [Activity]

Phrase: "glucose production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "began"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]

Phrase: "to take up glucose most rapidly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   799   C1515187:Take [Health Care Activity]
   799   C1637379:Rapidly [Qualitative Concept]
   799   C1883351:To [Qualitative Concept]

Phrase: "in the HIM2 group."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
   771   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
Processing 00000000.tx.210: There are three major factors that control net hepatic glucose uptake: the glucose load to the liver, the insulin level, and the portal signal (i.e., generated when the plasma glucose concentration in the portal vein is higher than the arterial plasma glucose concentration). 

Phrase: "There"

Phrase: "are"

Phrase: "three major factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "net hepatic glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: ":"

Phrase: "the glucose load to the liver,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1550025:Load [Idea or Concept]
   753   C1704782:Load [Manufactured Object]
   753   C1708715:Load [Activity]

Phrase: "the insulin level,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0202098:Insulin level [Laboratory Procedure]
  1000   C0428405:insulin level [Laboratory or Test Result]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1547707:Level [Geographic Area]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C2946261:Level [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the portal signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "(i.e.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "when"

Phrase: "the plasma glucose concentration in the portal vein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C2584434:Plasma glucose concentration [Finding]
   770   C0427743:Glucose concentration [Laboratory Procedure]
   770   C1287281:Glucose concentration [Laboratory or Test Result]
   767   C0683150:concentration plasma [Quantitative Concept]
   744   C0086045:Concentration [Mental Process]
   744   C1446561:Concentration [Quantitative Concept]

Phrase: "is"

Phrase: "higher than the arterial plasma glucose concentration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0860803:glucose high [Finding]
   714   C0205250:High [Qualitative Concept]
   714   C1299351:High [Qualitative Concept]
   714   C2700149:HIGH [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.211: In these experiments, the portal signal was the same in all three groups; 

Phrase: "In these experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "the portal signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "the same in all three groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0445247:Same [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.212: thus the differences in net hepatic glucose uptake must be related to the glucose load and/or the insulin concentration (23). 

Phrase: "thus"

Phrase: "the differences in net hepatic glucose uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "must"

Phrase: "be"

Phrase: "related to the glucose load"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C1550025:Load [Idea or Concept]
   760   C1704782:Load [Manufactured Object]
   760   C1708715:Load [Activity]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "and/or"

Phrase: "the insulin concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.213: The increased hepatic response in the Humulin group must have been attributable to the increase in insulin, because the hepatic glucose loads over the first 2 h in the BI and HI groups were equal. 

Phrase: "The increased hepatic response in the Humulin group"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]

Phrase: "must"

Phrase: "have"

Phrase: "been"

Phrase: "attributable to the increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596130:Attributable [Mental Process]

Phrase: "in insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "because"

Phrase: "the hepatic glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "loads over the first 2 h"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C0011744:h 2 [Element, Ion, or Isotope]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0205435:First [Quantitative Concept]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1279901:First [Qualitative Concept]
   753   C1550025:Load [Idea or Concept]
   753   C1704782:Load [Manufactured Object]
   753   C1708715:Load [Activity]

Phrase: "in the BI"

Phrase: "and"

Phrase: "HI groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "equal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205163:Equal [Qualitative Concept]
  1000   C1549782:Equal [Idea or Concept]
Processing 00000000.tx.214: In the HIM2 group, the hepatic glucose load was less than that in the BI group, but the insulin spike was much larger. 

Phrase: "In the HIM2 group,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
   771   C1175776:hexyl-insulin monoconjugate 2 [Hormone]

Phrase: "the hepatic glucose load"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1550025:Load [Idea or Concept]
   827   C1704782:Load [Manufactured Object]
   827   C1708715:Load [Activity]

Phrase: "was"

Phrase: "less than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0439092:Less Than [Intellectual Product]
           less
   790   C0547044:Less [Qualitative Concept]

Phrase: "in the BI group,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "but"

Phrase: "the insulin spike"

Phrase: "was"

Phrase: "much larger."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0443228:larger [Quantitative Concept]
   861   C0549177:Larger [Quantitative Concept]
   861   C1704243:Larger [Quantitative Concept]
Processing 00000000.tx.215: Clearly, therefore, the latter was responsible for the more rapid increase in net hepatic glucose uptake seen in this group. 

Phrase: "Clearly,"

Phrase: "therefore,"

Phrase: "the latter"

Phrase: "was"

Phrase: "responsible for the more rapid increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "in net hepatic glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "seen in this group."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0205397:Seen [Qualitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]
Processing 00000000.tx.216: At the end of the experiment, there were minimal differences between the three groups in either net hepatic glucose balance or hepatic fractional glucose extraction. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "there"

Phrase: "were"

Phrase: "minimal differences between the three groups"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "in either net hepatic glucose balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0014653:Balance [Organism Function]
   804   C0205415:Balance [Functional Concept]
   804   C0560184:Balance [Finding]

Phrase: "or"

Phrase: "hepatic fractional glucose extraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0185115:Extraction [Therapeutic or Preventive Procedure]
   812   C0684295:extraction [Laboratory Procedure]
Processing 00000000.tx.217: The rate of net hepatic glucose uptake was slightly less with HIM2 as a result of the decreased hepatic glucose load. 

Phrase: "The rate of net hepatic glucose uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "slightly less with HIM2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0750482:Slightly [Idea or Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of the decreased hepatic glucose load."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1550025:Load [Idea or Concept]
   812   C1704782:Load [Manufactured Object]
   812   C1708715:Load [Activity]
   708   C0860801:decreased glucose [Finding]
Processing 00000000.tx.218: Nevertheless, differences in net hepatic glucose uptake cannot explain the prolonged improvement that the insulin spikes had on the arterial plasma glucose level; 

Phrase: "Nevertheless,"

Phrase: "differences in net hepatic glucose uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "cannot"

Phrase: "explain"

Phrase: "the prolonged improvement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986411:Improvement [Conceptual Entity]

Phrase: "that"

Phrase: "the insulin spikes"

Phrase: "had on the arterial plasma glucose level"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   814   C0455280:plasma glucose level [Laboratory or Test Result]
           plasma glucose
   778   C0202042:Plasma glucose [Laboratory Procedure]
   778   C0337438:glucose level [Laboratory Procedure]
   778   C0428548:Glucose level [Laboratory or Test Result]
   748   C0003842:Arterial [Body Part, Organ, or Organ Component]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0032105:Plasma [Body Substance]
   748   C0062074:HAD [Therapeutic or Preventive Procedure]
   748   C0221464:Arterial [Spatial Concept]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1415458:HAD [Gene or Genome]
   748   C1547707:Level [Geographic Area]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C2946261:Level [Pharmacologic Substance]
   748   C3539897:Had [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.219: instead, it appears to be attributable to the effect of insulin on nonhepatic tissues. 

Phrase: "instead,"

Phrase: "it"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "attributable to the effect of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596130:Attributable [Mental Process]

Phrase: "on nonhepatic tissues."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.220: This is somewhat surprising, given that the plasma insulin levels returned to baseline no later than 60 min after dosing even in the HIM2 group. 

Phrase: "This"

Phrase: "is"

Phrase: "somewhat surprising,"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that"

Phrase: "the plasma insulin levels"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   966   C1276042:Plasma insulin level [Laboratory Procedure]
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   901   C0857690:plasma insulin [Laboratory Procedure]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "returned to baseline"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   866   C0332156:Return to [Qualitative Concept]
           Return
   790   C0168634:baseline [Biomedical or Dental Material]
   790   C1442488:Baseline [Quantitative Concept]

Phrase: "no later than 60 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0205087:Late [Temporal Concept]

Phrase: "after dosing even"

Phrase: "in the HIM2 group."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
   771   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
Processing 00000000.tx.221: One possible explanation for the finding, however, is that the insulin levels in the interstitial fluid may still be elevated at these latter time points, as suggested by Getty et al. 

Phrase: "One possible explanation for the finding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681841:Explanation [Intellectual Product]

Phrase: "however,"

Phrase: "is"

Phrase: "that"

Phrase: "the insulin levels in the interstitial fluid"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0202098:insulin levels [Laboratory Procedure]
   778   C0428405:insulin levels [Laboratory or Test Result]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0441889:Levels [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "still"

Phrase: "be"

Phrase: "elevated at these latter time points,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   756   C2348792:Time Point [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0205250:Elevated [Qualitative Concept]
   753   C3163633:Elevated [Qualitative Concept]
   753   C3541383:Time [Temporal Concept]
   719   C1552961:Point [Quantitative Concept]
   719   C2347617:point [Quantitative Concept]

Phrase: "as"

Phrase: "suggested by Getty et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1705535:Suggest [Idea or Concept]
Processing 00000000.tx.222: (11). 

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.223: Additionally, altered insulin kinetics in the interstitial fluid may have prolonged the effect of HIM2 on nonhepatic tissues even further. 

Phrase: "Additionally,"

Phrase: "altered insulin kinetics in the interstitial fluid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0022702:Kinetics [Natural Phenomenon or Process]
   748   C0220865:kinetics [Functional Concept]
   748   C2825046:Kinetics [Occupation or Discipline]

Phrase: "may"

Phrase: "have"

Phrase: "prolonged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439590:Prolonged [Temporal Concept]

Phrase: "the effect of HIM2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on nonhepatic tissues even further."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0040300:Tissues [Tissue]
   812   C1517331:Further [Spatial Concept]
   779 E C0205108:far [Spatial Concept]
   779 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.224: In agreement with this, nonhepatic glucose clearance in the HIM2 group was significantly greater than it was in the BI group. 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with this,"

Phrase: "nonhepatic glucose clearance in the HIM2 group"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C3272933:Glucose Clearance [Laboratory Procedure]
   739   C0449297:Clearance [Qualitative Concept]
   739   C1382187:Clearance [Clinical Attribute]
   739   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "significantly greater than it"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0439093:Greater Than [Quantitative Concept]
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "was in the BI group."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1421478:WAS [Gene or Genome]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
Processing 00000000.tx.225: Nonhepatic glucose clearance in the HI group, on the other hand, was only slightly greater than that seen in the BI group. 

Phrase: "Nonhepatic glucose clearance in the HI group,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C3272933:Glucose Clearance [Laboratory Procedure]
   748   C0449297:Clearance [Qualitative Concept]
   748   C1382187:Clearance [Clinical Attribute]
   748   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "on the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "was"

Phrase: "only slightly greater than that"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0439093:Greater Than [Quantitative Concept]
   760   C0443228:greater [Quantitative Concept]
   760   C1704243:Greater [Quantitative Concept]
   726 E C0549177:Great [Quantitative Concept]

Phrase: "seen in the BI group."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0205397:Seen [Qualitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]
Processing 00000000.tx.226: FFAs are known to alter muscle and liver glucose metabolism. 

Phrase: "FFAs"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "liver glucose metabolism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1373178:liver metabolism [Organ or Tissue Function]
   901   C0596620:glucose metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.227: There exists an inverse relation between plasma FFA concentrations and insulin sensitivity (25). 

Phrase: "There"

Phrase: "exists"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "an inverse relation between plasma FFA concentrations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0080103:Relation [Family Group]
   748   C0869014:relation [Social Behavior]

Phrase: "and"

Phrase: "insulin sensitivity"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0920563:Insulin Sensitivity [Pathologic Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.228: In normal individuals, an increase in FFAs has been shown to cause hepatic insulin resistance by interfering with the normal suppression of glycogenolysis by insulin (2). 

Phrase: "In normal individuals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "an increase in FFAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "hepatic insulin resistance by"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "interfering with the normal suppression of glycogenolysis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0205307:Normal [Qualitative Concept]
   748   C0221103:Suppression [Pathologic Function]
   748   C0301625:Suppression [Organism Function]
   748   C0439166:% normal [Quantitative Concept]
   748   C0439181:% suppression [Quantitative Concept]
   748   C0521102:interfering [Qualitative Concept]
   748   C0596624:Glycogenolysis [Molecular Function]
   748   C0728721:suppression [Mental Process]
   748   C2347086:% Normal [Quantitative Concept]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.229: Insulin resistance in skeletal muscle can also be attributed to an increase in fatty acids. 

Phrase: "Insulin resistance in skeletal muscle"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0021655:Insulin Resistance [Pathologic Function]
   806   C2700570:INSULIN RESISTANCE [Gene or Genome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "can"

Phrase: "also"

Phrase: "be"

Phrase: "attributed to an increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442805:Increase [Functional Concept]
   737   C0449234:Attribute [Idea or Concept]
   737   C1704772:Attribute [Conceptual Entity]
   737   C1882133:Attribute [Qualitative Concept]

Phrase: "in fatty acids."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.230: Type 2 diabetics who are given nicotinic acid to induce a decrease in plasma FFA levels have a decrease in gluconeogenesis with no compensatory increase in glycogenolysis; 

Phrase: "Type 2 diabetics"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0441730:Type 2 [Classification]
   827   C0241863:diabetics [Finding]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "who"

Phrase: "are"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "nicotinic acid to"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0027996:Nicotinic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   901   C0028049:nicotinic acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   901   C3536880:Nicotinic Acid [Pharmacologic Substance]
   845 E C1142562:Niacin [Laboratory Procedure]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a decrease in plasma FFA levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "have"

Phrase: "a decrease in gluconeogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "with no compensatory increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "in glycogenolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596624:Glycogenolysis [Molecular Function]

Phrase: ";"
Processing 00000000.tx.231: this leads to an overall decrease in endogenous glucose production (1). 

Phrase: "this"

Phrase: "leads to an overall decrease"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0181586:leads [Medical Device]
   760   C0282416:Overall [Intellectual Product]
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1561607:Overall [Qualitative Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in endogenous glucose production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033268:production [Occupational Activity]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.232: It has been shown (26) that hepatic glucose production can be suppressed by an increase in peripheral insulin, partly due to an inhibition of lipolysis. 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "(26"

Phrase: ")"

Phrase: "that hepatic glucose production"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0033268:production [Occupational Activity]
   827   C0205054:Hepatic [Body Location or Region]

Phrase: "can"

Phrase: "be"

Phrase: "suppressed by an increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442805:Increase [Functional Concept]
   770   C1260953:Suppressed [Functional Concept]

Phrase: "in peripheral insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "partly due to an inhibition of lipolysis."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0023796:Lipolysis [Organism Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3146286:Due [Idea or Concept]
   748   C3463820:Inhibition [Activity]
Processing 00000000.tx.233: We have shown in the dog that FFA levels control the glycolytic flux in the liver (20). 

Phrase: "We"

Phrase: "have"

Phrase: "shown in the dog"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0012984:Dog [Mammal]
   770   C1280551:Dog [Mammal]
   737   C1547282:Show [Intellectual Product]

Phrase: "that FFA levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the glycolytic flux in the liver"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348693:Flux [Natural Phenomenon or Process]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.234: A fall in FFA levels and, as a result, in the net hepatic uptake of FFA directs intrahepatic carbon into glycolysis, eventually giving rise to lactate (26). 

Phrase: "A fall in FFA levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0085639:Fall [Finding]
   760   C0238715:Fall [Temporal Concept]

Phrase: "and"

Phrase: ","

Phrase: "as"

Phrase: "a result,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "in the net hepatic uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205054:Hepatic [Body Location or Region]
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]

Phrase: "of FFA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015688:FFA [Lipid]

Phrase: "directs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "intrahepatic carbon into glycolysis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0007009:Carbon [Element, Ion, or Isotope]

Phrase: "eventually"

Phrase: "giving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "rise to lactate"

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.235: Given that the FFAs fall most dramatically in the HIM2 group and substantially in the HI group, the early differences in net hepatic glucose output might be attributable, in part, to changes in plasma FFA levels. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that"

Phrase: "the FFAs"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "fall"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085639:Fall [Finding]
  1000   C0238715:Fall [Temporal Concept]

Phrase: "most dramatically in the HIM2 group"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   818   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   762   C0441865:Group 2 [Intellectual Product]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0205393:Most [Quantitative Concept]
   742   C0441833:Group [Idea or Concept]
   742   C0687744:group [Population Group]
   742   C1257890:Group [Population Group]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1552516:Group [Health Care Related Organization]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1705428:Group [Conceptual Entity]
   742   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "substantially in the HI group,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0018619:HI [Geographic Area]
   760   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1412082:HI [Gene or Genome]
   760   C1412316:HI [Gene or Genome]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "the early differences in net hepatic glucose output"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "might"

Phrase: "be"

Phrase: "attributable,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596130:Attributable [Mental Process]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "to changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "in plasma FFA levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.236: Wajcberg et al. 

Phrase: "Wajcberg et al."
Processing 00000000.tx.237: (29) have suggested that HIM2's prolonged biological action may be attributed to a persistent suppressive effect on FFA. 

Phrase: "(29"

Phrase: ")"

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that HIM2's prolonged biological action"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0005532:Biological [Biomedical Occupation or Discipline]
   812   C0205460:biological [Qualitative Concept]
   812   C0441472:Action [Functional Concept]
   812   C3266814:Action [Activity]

Phrase: "may"

Phrase: "be"

Phrase: "attributed to a persistent suppressive effect"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205322:Persistent [Temporal Concept]
   753   C0205367:Suppressive [Functional Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
   719   C0449234:Attribute [Idea or Concept]
   719   C1704772:Attribute [Conceptual Entity]
   719   C1882133:Attribute [Qualitative Concept]

Phrase: "on FFA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015688:FFA [Lipid]
Processing 00000000.tx.238: There may be a prolongation of antilipolysis due to an enhancement of HIM2 binding to the insulin receptors in the adipocytes. 

Phrase: "There"

Phrase: "may"

Phrase: "be"

Phrase: "a prolongation of antilipolysis"

Phrase: "due to an enhancement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1627358:Enhancement [Therapeutic or Preventive Procedure]
  1000   C2349975:Enhancement [Activity]

Phrase: "of HIM2 binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C1623517:insulin binding [Molecular Function]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   771   C1175776:hexyl-insulin monoconjugate 2 [Hormone]

Phrase: "to the insulin receptors"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   966 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in the adipocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]
Processing 00000000.tx.239: Unless these early changes in FFAs had a prolonged effect on glucose uptake by muscle, it seems unlikely that they were affecting the glucose profile toward the end of the experiments, since the plasma FFA levels were similar in all three groups by then. 

Phrase: "Unless"

Phrase: "these early changes in FFAs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   757   C0152254:Fatty change [Pathologic Function]
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "had"

Phrase: "a prolonged effect on glucose uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1158774:glucose effect [Genetic Function]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "by muscle,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "it"

Phrase: "seems"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "they"

Phrase: "were"

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the glucose profile toward the end of the experiments,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1979963:Profile [Laboratory Procedure]
   742   C2003903:Profile [Functional Concept]

Phrase: "since"

Phrase: "the plasma FFA levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "similar in all three groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "by then."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]
Processing 00000000.tx.240: In summary, a brief 5-min pulse of insulin infused intraportally at a rate of 10 mUkg1min1 simulated the first-phase insulin release seen postprandially, increased plasma insulin levels for 30 min, and eliminated net hepatic glucose production by 60 min. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "a brief 5-min pulse of insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0444804:Brief pulse [Spatial Concept]
   748   C0232117:PULSE [Clinical Attribute]
   748   C0391850:Pulse [Physiologic Function]
   748   C1947910:Pulse [Phenomenon or Process]

Phrase: "infused"

Phrase: "intraportally at a rate of 10 mUkg1min1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "simulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0284447:simulated [Biomedical or Dental Material]

Phrase: "the first-phase insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1963578:Release [Therapeutic or Preventive Procedure]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "postprandially,"

Phrase: "increased plasma insulin levels for 30 min,"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   788   C1295675:Increased insulin level [Finding]
   780   C1276042:Plasma insulin level [Laboratory Procedure]
   778   C0202098:insulin levels [Laboratory Procedure]
   778   C0428405:insulin levels [Laboratory or Test Result]
   778   C0857690:plasma insulin [Laboratory Procedure]
   774   C0020459:increased insulin [Disease or Syndrome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0032105:Plasma [Body Substance]
   748   C0441889:Levels [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "eliminated net hepatic glucose production by 60 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0033268:production [Occupational Activity]
   744   C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.241: It still had a significant effect on plasma glucose levels 4.5 h later. 

Phrase: "It still"

Phrase: "had"

Phrase: "a significant effect on plasma glucose levels 4.5 h later."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C1158774:glucose effect [Genetic Function]
   738   C1280500:Effect [Qualitative Concept]
   738   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.242: HIM2 was cleared less efficiently than Humulin, resulting in higher plasma insulin levels at both the liver and the periphery. 

Phrase: "HIM2"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "cleared"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521097:cleared [Functional Concept]
   966 E C2963144:Clear [Qualitative Concept]

Phrase: "less efficiently than Humulin,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0439092:Less Than [Intellectual Product]
           less
   770   C0020171:humulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0020172:Humulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0547044:Less [Qualitative Concept]
   770   C3538423:Humulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "resulting in higher plasma insulin levels"
Meta Candidates (Total=23; Excluded=6; Pruned=0; Remaining=17)
   799   C1276042:Plasma insulin level [Laboratory Procedure]
   790   C0202098:insulin levels [Laboratory Procedure]
   790   C0332294:Resulting in [Functional Concept]
   790   C0428405:insulin levels [Laboratory or Test Result]
           Insulin level result
   790   C0857690:plasma insulin [Laboratory Procedure]
   767   C0020459:high insulin [Disease or Syndrome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0032105:Plasma [Body Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C0678226:resulting [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   719   C0205250:High [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1274040:Result [Functional Concept]
   719   C1299351:High [Qualitative Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C1547707:Level [Geographic Area]
   719   C2700149:HIGH [Intellectual Product]
   719 E C2825142:Result [Finding]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "at both"

Phrase: "the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "the periphery."
Processing 00000000.tx.243: This pulse increased plasma insulin levels for almost 60 min, eliminated net hepatic glucose production by 30 min, and continued to have a significant effect on plasma glucose levels even at the end of the experiment (4.5 h). 

Phrase: "This pulse"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0232117:PULSE [Clinical Attribute]
  1000   C0391850:Pulse [Physiologic Function]
  1000   C1947910:Pulse [Phenomenon or Process]
   916 E C0034107:Pulses [Health Care Activity]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "plasma insulin levels for almost 60 min,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   780   C1276042:Plasma insulin level [Laboratory Procedure]
   778   C0202098:insulin levels [Laboratory Procedure]
   778   C0428405:insulin levels [Laboratory or Test Result]
   778   C0857690:plasma insulin [Laboratory Procedure]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0032105:Plasma [Body Substance]
   748   C0441889:Levels [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "net hepatic glucose production by 30 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0033268:production [Occupational Activity]
   748   C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "continued"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continued [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "a significant effect on plasma glucose levels even"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1158774:glucose effect [Genetic Function]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "at the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "(4.5 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
   734   C0450367:4 5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.244: These data demonstrate the ability of a brief burst of insulin secretion to result in prolonged glycemic improvement and speak to the importance of first-phase insulin release in postprandial glucose homeostasis. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "the ability of a brief burst of insulin secretion to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0085732:Ability [Organism Attribute]

Phrase: "result in prolonged glycemic improvement"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0439590:Prolonged [Temporal Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]
   760   C2986411:Improvement [Conceptual Entity]

Phrase: "and"

Phrase: "speak to the importance of first-phase insulin release"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0030685:Release [Health Care Activity]
   742   C0205390:Phase [Temporal Concept]
   742   C0205435:First [Quantitative Concept]
   742   C0234856:Speak [Daily or Recreational Activity]
   742   C0391871:Release [Functional Concept]
   742   C0439180:% release [Quantitative Concept]
   742   C0600116:speak [Finding]
   742   C0680255:release [Health Care Activity]
   742   C1279901:First [Qualitative Concept]
   742   C1283071:Release [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1547187:Speak [Idea or Concept]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "in postprandial glucose homeostasis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1326961:glucose homeostasis [Physiologic Function]
   827   C0019868:Homeostasis [Biologic Function]
Processing 00000000.tx.245: They also point to the need to further evaluate the pharmacokinetic and pharmacodynamic properties of the HIM2 insulin analog. 

Phrase: "They also"

Phrase: "point to the need"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0027552:Need [Qualitative Concept]
   770   C0686904:need [Functional Concept]
   770   C1552961:Point [Quantitative Concept]
   770   C2347617:point [Quantitative Concept]

Phrase: "to further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the pharmacokinetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201734:PHARMACOKINETIC [Research Activity]

Phrase: "and"

Phrase: "pharmacodynamic properties of the HIM2 insulin analog."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   739   C0871161:properties [Qualitative Concept]
   739   C1292721:properties [Functional Concept]
   706 E C1882134:Property [Conceptual Entity]
   706 E C2347695:Property [Entity]
Processing 00000000.tx.246: Subsequent studies are needed to compare the biological activities of HIM2 and Humulin at selective tissues (muscle, fat, liver) within the body. 

Phrase: "Subsequent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the biological activities of HIM2"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   750   C1145751:insulin activity [Molecular Function]
   744   C0005532:Biological [Biomedical Occupation or Discipline]
   744   C0205460:biological [Qualitative Concept]
   744   C0441655:Activities [Activity]
   711 E C0205177:Activity [Functional Concept]
   711 E C0439167:% activity [Quantitative Concept]
   711 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "Humulin at selective tissues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0020171:humulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0020172:Humulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C3538423:Humulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(muscle,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "fat,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0424612:FAT [Organism Attribute]

Phrase: "liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: ")"

Phrase: "within the body."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242821:body [Human]
  1000   C0460148:Body [Anatomical Structure]
  1000   C1268086:Body [Anatomical Structure]
   916 E C1995017:Bodies [Cell Component]
Processing 00000000.tx.247: Although several studies (6, 15, 29) have shown that the HIM2 analog is effective in the human following oral delivery, our data suggest that a better understanding of its tissue-specific effects is needed in view of its decreased biological activity and clearance.  

Phrase: "Although"

Phrase: "several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "(6,"

Phrase: "15,"

Phrase: "29"

Phrase: ")"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the HIM2 analog"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   875   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0243071:Analog [Chemical Viewed Structurally]
   771   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   704 E C0679213:analogies [Idea or Concept]

Phrase: "is"

Phrase: "effective in the human"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280519:effective [Qualitative Concept]
   770   C1704419:Effective [Qualitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "oral delivery,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011209:Delivery [Therapeutic or Preventive Procedure]
   861   C0559563:delivery [Finding]
   861   C1705822:Delivery [Activity]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a better understanding of its tissue-specific effects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0162340:Understanding [Mental Process]

Phrase: "is"

Phrase: "needed in view of its decreased biological activity"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   767   C0086439:Decreased activity [Sign or Symptom]
   744   C0005532:Biological [Biomedical Occupation or Discipline]
   744   C0027552:Needed [Qualitative Concept]
   744   C0205177:Activity [Functional Concept]
   744   C0205216:Decreased [Quantitative Concept]
   744   C0205460:biological [Qualitative Concept]
   744   C0392756:Decreased [Qualitative Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0442797:decreased [Qualitative Concept]
   744   C0449911:View [Spatial Concept]
   744   C0686904:needed [Functional Concept]
   744   C1561536:*Activity [Idea or Concept]
   711 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "clearance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449297:Clearance [Qualitative Concept]
  1000   C1382187:Clearance [Clinical Attribute]
  1000   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.248: GRANTS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  This investigation was supported by a grant from the Nobex Corporation, Inc., Durham, NC, by National Institute of Diabetes and Digestive and Kidney Diseases DK-43706, and the Diabetes Research and Training Center SP-60-AM-20593.  

Phrase: "GRANTS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This investigation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1261322:Investigation [Health Care Activity]
  1000   C1552578:investigation [Idea or Concept]
   928 E C1517586:Investigational [Qualitative Concept]
   928 E C3245491:investigational [Intellectual Product]

Phrase: "was"

Phrase: "supported by a grant"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0018173:Grant [Quantitative Concept]
   770   C1521721:Supported [Conceptual Entity]
   770   C1548284:Grant [Idea or Concept]
   737 E C0183683:Support [Medical Device]

Phrase: "from the Nobex Corporation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corporation [Organization]

Phrase: "Inc.,"

Phrase: "Durham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454851:Durham [Geographic Area]

Phrase: "NC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027964:NC [Geographic Area]
  1000   C0028407:NC [Geographic Area]
  1000   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "by National Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "of Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "Digestive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012238:Digestive [Organism Function]
  1000   C0012240:Digestive [Body System]

Phrase: "and"

Phrase: "Kidney Diseases DK-43706,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   861   C0022658:Kidney Diseases [Disease or Syndrome]
   812   C0011318:DK [Geographic Area]
   812   C0012634:Diseases [Disease or Syndrome]
   812   C0022646:Kidney [Body Part, Organ, or Organ Component]
   812   C0227665:kidney [Body Part, Organ, or Organ Component]
   812   C1278978:Kidney [Body Part, Organ, or Organ Component]
   812   C1514845:KIDNEY [Tissue]
   741 E C1836721:MALS [Finding]
   741 E C3538764:MALS [Gene or Genome]
   741 E C3540595:MAL [Gene or Genome]
   719 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "and"

Phrase: "the Diabetes Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "and"

Phrase: "Training Center SP-60-AM-20593."
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   827   C0557814:Training center [Manufactured Object]
   799   C0040607:Training [Educational Activity]
   799   C0205099:Center [Spatial Concept]
   799   C0220931:Training [Educational Activity]
   799   C2673163:training [Qualitative Concept]
   766 E C0336809:Train [Manufactured Object]
   766 E C1552514:Train [Manufactured Object]
   727 E C0009647:Conditioned [Mental Process]
   727 E C0012634:condition [Disease or Syndrome]
   727 E C0348080:Condition [Qualitative Concept]
   727 E C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.249: ACKNOWLEDGMENTS  We appreciate the assistance of Jon Hastings and the Diabetes Research and Training Center Hormone Core (Wanda Snead, Angelina Penaloza, and Eric Allen) in these studies. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "appreciate"

Phrase: "the assistance of Jon Hastings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0018896:Assistance [Social Behavior]

Phrase: "and"

Phrase: "the Diabetes Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "and"

Phrase: "Training Center Hormone Core"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0444669:Core [Spatial Concept]
   812   C1167518:core [Cell Component]
   812   C1706352:Core [Medical Device]
   812   C1882467:Core [Manufactured Object]
   812   C3274653:Core [Body Substance]

Phrase: "(Wanda Snead,"

Phrase: "Angelina Penaloza,"

Phrase: "and"

Phrase: "Eric Allen"

Phrase: ")"

Phrase: "in these studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]
Processing 00000000.tx.250: We also thank Phil Williams for technical assistance. 

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Phil Williams for technical assistance."
Processing 00000000.tx.251: This work was presented in part at the 62nd annual meeting of the American Diabetes Association, San Francisco, CA, June 2002.  

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "presented in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449450:Presented [Idea or Concept]
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]
   756 E C0150312:Present [Quantitative Concept]

Phrase: "at the 62nd annual meeting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0556656:Meeting [Health Care Activity]

Phrase: "of the American Diabetes Association,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1705019:American Diabetes Association [Professional Society]
   827   C0004083:Association [Mental Process]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0439849:Association [Qualitative Concept]
   827   C0596070:American [Population Group]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "San Francisco,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036152:San Francisco [Geographic Area]
   861   C1826357:San [Gene or Genome]

Phrase: "CA,"

Phrase: "June 2002."
Processing 00000000.tx.252: FOOTNOTES  Address for reprint requests and other correspondence: C. 

Phrase: "FOOTNOTES  Address for reprint requests"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0376649:Address [Intellectual Product]
   760   C1442065:Address [Spatial Concept]

Phrase: "and"

Phrase: "other correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "C."
Processing 00000000.tx.253: DiCostanzo, 710 Medical Research Bldg. 

Phrase: "DiCostanzo,"

Phrase: "710 Medical Research Bldg."
Processing 00000000.tx.254: I, Vanderbilt Univ. 

Phrase: "I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Vanderbilt Univ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:UNIV [Manufactured Object,Organization]
Processing 00000000.tx.255: Medical School, Nashville, TN 37232-0615 (e-mail: Catherine.dicostanzo{at}vanderbilt.edu ) The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   861   C0036375:School [Manufactured Object,Organization]

Phrase: "Nashville,"

Phrase: "TN 37232-0615"

Phrase: "(e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "Catherine.dicostanzo{at}vanderbilt.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.256: The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.257: Section 1734 solely to indicate this fact.  

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.258: REFERENCES TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  Boden G, Chen X, Capulong E, and Mozzoli M. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035171:Research Design [Research Activity]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1707689:Design [Activity]
   812   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Boden G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Chen X,"

Phrase: "Capulong E,"

Phrase: "and"

Phrase: "Mozzoli M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.259: Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. 

Phrase: "Effects of free fatty acids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on gluconeogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017715:Gluconeogenesis [Molecular Function]

Phrase: "and"

Phrase: "autoregulation of glucose production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019868:Autoregulation [Biologic Function]

Phrase: "in type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.260: Diabetes 50: 810816, 2001.[Abstract/Free FullText] Boden G, Cheung P, Stein TP, Kresge K, and Mozzoli M. 

Phrase: "Diabetes 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "810816,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Boden G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Cheung P,"

Phrase: "Stein TP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541334:TP [Gene or Genome]

Phrase: "Kresge K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Mozzoli M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.261: FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. 

Phrase: "FFA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015688:FFA [Lipid]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0021655:Insulin Resistance [Pathologic Function]
   764   C2700570:INSULIN RESISTANCE [Gene or Genome]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0237834:Resistance [Mental Process]
   742   C1514892:Resistance [Physiologic Function]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.262: Am J Physiol Endocrinol Metab 283: E12E19, 2002.[Abstract/Free FullText] Bruce DG, Chisholm DJ, Storlien LH, and Kraegen EW. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 283"

Phrase: ":"

Phrase: "E12E19,"

Phrase: "2002."

Phrase: "[Abstract/Free FullText"

Phrase: "] Bruce DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Chisholm DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Storlien LH,"

Phrase: "and"

Phrase: "Kraegen EW."
Processing 00000000.tx.263: Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. 

Phrase: "Physiological importance of deficiency"

Phrase: "in early prandial insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in non-insulin-dependent diabetes."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0011860:Non-Insulin Dependent Diabetes [Disease or Syndrome]
   923   C0011854:Insulin Dependent Diabetes [Disease or Syndrome]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1518422:Non [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.264: Diabetes 37: 736744, 1988.[Abstract] Cardin S, Jackson PA, Edgerton DS, Neal DW, Coffey CS, and Cherrington AD. 

Phrase: "Diabetes 37"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "736744,"

Phrase: "1988."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Cardin S,"

Phrase: "Jackson PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Edgerton DS,"

Phrase: "Neal DW,"

Phrase: "Coffey CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "and"

Phrase: "Cherrington AD."
Processing 00000000.tx.265: Effect of vagal cooling on the counterregulatory response to hypoglycemia induced by a low dose of insulin in the conscious dog. 

Phrase: "Effect of vagal cooling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the counterregulatory response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "to hypoglycemia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0020615:Hypoglycaemia [Disease or Syndrome]
   928 E C0020616:Hypoglycaemic [Pharmacologic Substance]

Phrase: "induced by a low dose of insulin"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0445550:Low dose [Quantitative Concept]
   778   C1708745:Low-Dose [Research Activity]
   774   C0861023:insulin low [Finding]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0178602:Dose [Quantitative Concept]
   748   C0205251:low [Qualitative Concept]
   748   C0205263:Induced [Functional Concept]
   748   C0869039:Dose [Quantitative Concept]
   748   C1114758:Dose # [Clinical Attribute]
   748   C1299352:Low [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1550472:low [Idea or Concept]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "in the conscious dog."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012984:Dog [Mammal]
   861   C1280551:Dog [Mammal]
Processing 00000000.tx.266: Diabetes 50: 558564, 2001.[Abstract/Free FullText] Cherrington AD, Sindelar D, Edgerton D, Steiner K, McGuinness OP, and Edgerton DS. 

Phrase: "Diabetes 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "558564,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Cherrington AD,"

Phrase: "Sindelar D,"

Phrase: "Edgerton D,"

Phrase: "Steiner K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "McGuinness OP,"

Phrase: "and"

Phrase: "Edgerton DS."
Processing 00000000.tx.267: Physiological consequences of phasic insulin release in the normal animal. 

Phrase: "Physiological consequences of phasic insulin release"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "in the normal animal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animal [Animal]
Processing 00000000.tx.268: Diabetes 51, Suppl 1: S103S108, 2002. 

Phrase: "Diabetes 51,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "Suppl 1"

Phrase: ":"

Phrase: "S103S108,"

Phrase: "2002."
Processing 00000000.tx.269: Clement S, Dandona P, Still JG, and Kosutic G. 

Phrase: "Clement S,"

Phrase: "Dandona P,"

Phrase: "Still JG,"

Phrase: "and"

Phrase: "Kosutic G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.270: Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: results from a phase I/II clinical trial. 

Phrase: "Oral modified insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(HIM2"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with type 1 diabetes mellitus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0011854:Diabetes Mellitus, Type 1 [Disease or Syndrome]
           Type 1 diabetes
  1000   C2984334:Type I diabetes mellitus [Functional Concept]
   875   C1320657:type diabetes [Finding]
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0441729:Type 1 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: ":"

Phrase: "results from a phase I/II clinical trial."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]
Processing 00000000.tx.271: Metab Clin Exper 53: 5458, 2004.[CrossRef][ISI][Medline] Del Prato S and Tiengo A. 

Phrase: "Metab Clin Exper 53"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "5458,"

Phrase: "2004."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Del Prato S"

Phrase: "and"

Phrase: "Tiengo A."
Processing 00000000.tx.272: The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus. 

Phrase: "The importance of first-phase insulin secretion"

Phrase: ":"

Phrase: "implications for the therapy of type 2 diabetes mellitus."
Processing 00000000.tx.273: Diabetes Metab Res Rev 17: 164174, 2001.[CrossRef][ISI][Medline] Duckworth WC. 

Phrase: "Diabetes Metab Res Rev 17"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]
   804   C2347379:RES [Finding]
   804   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "164174,"

Phrase: "2001."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duckworth WC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]
Processing 00000000.tx.274: Insulin degradation: mechanisms products, and significance. 

Phrase: "Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: ":"

Phrase: "mechanisms products,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "significance."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.275: Endocr Rev 9: 319345, 1988.[Abstract] Galassetti P, Hamilton KS, Gibbons FK, Bracy DP, Lacy DB, Cherrington AD, and Wasserman DH. 

Phrase: "Endocr Rev 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "319345,"

Phrase: "1988."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Galassetti P,"

Phrase: "Hamilton KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Gibbons FK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349396:FK [Geographic Area]
   861   C1150640:FK [Molecular Function]

Phrase: "Bracy DP,"

Phrase: "Lacy DB,"

Phrase: "Cherrington AD,"

Phrase: "and"

Phrase: "Wasserman DH."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1832586:DH [Disease or Syndrome]
Processing 00000000.tx.276: Effect of fast duration on disposition of an intraduodenal glucose load in the conscious dog. 

Phrase: "Effect of fast duration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on disposition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0743223:Disposition [Idea or Concept]
  1000   C1705555:Disposition [Idea or Concept]

Phrase: "of an intraduodenal glucose load"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1550025:Load [Idea or Concept]
   827   C1704782:Load [Manufactured Object]
   827   C1708715:Load [Activity]

Phrase: "in the conscious dog."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012984:Dog [Mammal]
   861   C1280551:Dog [Mammal]
Processing 00000000.tx.277: Am J Physiol Endocrinol Metab 276: E543E552, 1999.[Abstract/Free FullText] Gerich JE. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 276"

Phrase: ":"

Phrase: "E543E552,"

Phrase: "1999."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gerich JE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]
Processing 00000000.tx.278: Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? 

Phrase: "Is"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "first-phase insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1963578:Release [Therapeutic or Preventive Procedure]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "the earliest detectable abnormality in individuals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704258:Abnormality [Finding]

Phrase: "destined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "develop"

Phrase: "type 2 diabetes?"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.279: Diabetes 51, Suppl 1: S117S121, 2002. 

Phrase: "Diabetes 51,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "Suppl 1"

Phrase: ":"

Phrase: "S117S121,"

Phrase: "2002."
Processing 00000000.tx.280: Getty L, Hamilton-Wessler M, Ader M, Dea MK, and Bergman RN. 

Phrase: "Getty L,"

Phrase: "Hamilton-Wessler M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Ader M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Dea MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "and"

Phrase: "Bergman RN."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540639:RN [Gene or Genome]
Processing 00000000.tx.281: Biphasic insulin secretion during intravenous glucose tolerance test promotes optimal interstitial insulin profile. 

Phrase: "Biphasic insulin secretion during intravenous glucose tolerance test"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   815   C0546683:Intravenous insulin tolerance test [Laboratory Procedure]
   793   C0236287:Insulin tolerance test [Laboratory Procedure]
   770   C0356369:Biphasic Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1256369:insulin secretion [Cell Function]
   767   C0202098:insulin test [Laboratory Procedure]
   767   C0598703:insulin tolerance [Pathologic Function]
   767   C1719133:Glucose/Insulin [Quantitative Concept]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "optimal interstitial insulin profile."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1979963:Profile [Laboratory Procedure]
   812   C2003903:Profile [Functional Concept]
Processing 00000000.tx.282: Diabetes 47: 19411947, 1998.[Abstract] Hendrick GK, Frizzell RT, Williams PE, and Cherrington AD. 

Phrase: "Diabetes 47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "19411947,"

Phrase: "1998."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hendrick GK,"

Phrase: "Frizzell RT,"

Phrase: "Williams PE,"

Phrase: "and"

Phrase: "Cherrington AD."
Processing 00000000.tx.283: Effect of hyperglucagonemia on hepatic glycogenolysis and gluconeogenesis after a prolonged fast. 

Phrase: "Effect of hyperglucagonemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on hepatic glycogenolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596624:Glycogenolysis [Molecular Function]

Phrase: "and"

Phrase: "gluconeogenesis after a prolonged fast."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017715:Gluconeogenesis [Molecular Function]
Processing 00000000.tx.284: Am J Physiol Endocrinol Metab 258: E841E849, 1990.[Abstract/Free FullText] Hsieh PS, Moore MC, Marshall B, Pagliassotti MJ, Shay B, Szurkus D, Neal DW, and Cherrington AD. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 258"

Phrase: ":"

Phrase: "E841E849,"

Phrase: "1990."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hsieh PS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "Moore MC,"

Phrase: "Marshall B,"

Phrase: "Pagliassotti MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Shay B,"

Phrase: "Szurkus D,"

Phrase: "Neal DW,"

Phrase: "and"

Phrase: "Cherrington AD."
Processing 00000000.tx.285: The head arterial glucose level is not the reference site for generation of the portal signal in conscious dogs. 

Phrase: "The head arterial glucose level"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0337438:glucose level [Laboratory Procedure]
   861   C0428548:Glucose level [Laboratory or Test Result]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0441889:Level [Qualitative Concept]
   812   C0456079:Level [Classification]
   812   C1547707:Level [Geographic Area]
   812   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the reference site for generation of the portal signal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C2945843:Site of [Qualitative Concept]
   742   C0205145:Site [Spatial Concept]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]

Phrase: "in conscious dogs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012984:Dogs [Mammal]
   861   C1280551:Dogs [Mammal]
Processing 00000000.tx.286: Am J Physiol Endocrinol Metab 277: E678E684, 1999.[Abstract/Free FullText] Hsieh PS, Moore MC, Neal DW, and Cherrington AD. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 277"

Phrase: ":"

Phrase: "E678E684,"

Phrase: "1999."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hsieh PS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "Moore MC,"

Phrase: "Neal DW,"

Phrase: "and"

Phrase: "Cherrington AD."
Processing 00000000.tx.287: Hepatic glucose uptake rapidly decreases after removal of the portal signal in conscious dogs. 

Phrase: "Hepatic glucose uptake rapidly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "decreases after removal of the portal signal"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0015252:Removal [Therapeutic or Preventive Procedure]
   748   C0205054:Portal [Body Location or Region]
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]
   748   C0728940:Removal [Therapeutic or Preventive Procedure]
   748   C1710082:Signal [Phenomenon or Process]

Phrase: "in conscious dogs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012984:Dogs [Mammal]
   861   C1280551:Dogs [Mammal]
Processing 00000000.tx.288: Am J Physiol Endocrinol Metab 275: E987E992, 1998.[Abstract/Free FullText] Kipnes M, Dandona P, Tripathy D, Still JG, and Kosutic G. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 275"

Phrase: ":"

Phrase: "E987E992,"

Phrase: "1998."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kipnes M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Dandona P,"

Phrase: "Tripathy D,"

Phrase: "Still JG,"

Phrase: "and"

Phrase: "Kosutic G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.289: Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes. 

Phrase: "Control of postprandial plasma glucose"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0726398:GLUCOSE CONTROL [Indicator, Reagent, or Diagnostic Aid]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "by an oral insulin product"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C3205666:Oral Product [Pharmacologic Substance]
   901   C0021641:Insulin product [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "(HIM2"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.290: Diabetes Care 26: 421426, 2003.[Abstract/Free FullText] Leevy CM, Mendenhall CL, Lesko W, and Howard MM. 

Phrase: "Diabetes Care 26"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C1947933:Care [Activity]

Phrase: ":"

Phrase: "421426,"

Phrase: "2003."

Phrase: "[Abstract/Free FullText"

Phrase: "] Leevy CM,"

Phrase: "Mendenhall CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Lesko W,"

Phrase: "and"

Phrase: "Howard MM."
Processing 00000000.tx.291: Estimation of hepatic blood flow with indocyanine green. 

Phrase: "Estimation of hepatic blood flow"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0680844:estimation [Mental Process]
   760   C0681916:Estimation [Quantitative Concept]
   760   C0750572:Estimation [Quantitative Concept]

Phrase: "with indocyanine green."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0021234:Indocyanine Green [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   944 E C0733632:Cardio-Green [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   944 E C1707127:CGS [Intellectual Product]
   861   C0332583:Green [Qualitative Concept]
Processing 00000000.tx.292: J Clin Invest 41: 11691179, 1962.[ISI][Medline] Lloyd B, Burrin J, Smythe P, Alberti KG, and Fingerhut B. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "41"

Phrase: ":"

Phrase: "11691179,"

Phrase: "1962."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lloyd B,"

Phrase: "Burrin J,"

Phrase: "Smythe P,"

Phrase: "Alberti KG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022718:KG [Geographic Area]
   861   C0439209:kg [Quantitative Concept]

Phrase: "and"

Phrase: "Fingerhut B."
Processing 00000000.tx.293: Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. 

Phrase: "Enzymic fluorometric continuous-flow assays for blood glucose,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0005507:Assay [Laboratory Procedure]
   711   C0243073:assay [Qualitative Concept]
   711   C1510438:Assay [Laboratory Procedure]

Phrase: "lactate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022924:lactate [Organic Chemical]
  1000   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "pyruvate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034354:pyruvate [Organic Chemical]
  1000   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "alanine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "3-hydroxybutyrate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0106006:3-Hydroxybutyrate [Biologically Active Substance,Organic Chemical]
  1000   C0523524:3-Hydroxybutyrate [Laboratory Procedure]
   861   C0020332:hydroxybutyrate [Biologically Active Substance,Organic Chemical]
Processing 00000000.tx.294: Clin Chem 24: 17241729, 1978.[Abstract/Free FullText] Luzi L and DeFronzo RA. 

Phrase: "Clin Chem 24"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0201682:CHEM [Laboratory Procedure]
   827   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "17241729,"

Phrase: "1978."

Phrase: "[Abstract/Free FullText"

Phrase: "] Luzi L"

Phrase: "and"

Phrase: "DeFronzo RA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]
Processing 00000000.tx.295: Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. 

Phrase: "Effect of loss of first-phase insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on hepatic glucose production"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0033268:production [Occupational Activity]
   827   C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "tissue glucose disposal in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707797:Disposal [Activity]
Processing 00000000.tx.296: Am J Physiol Endocrinol Metab 257: E241E246, 1989.[Abstract/Free FullText] Moore MC, Cherrington AD, Cline G, Pagliassotti MJ, Jones EM, Neal DW, Badet C, and Shulman GI. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 257"

Phrase: ":"

Phrase: "E241E246,"

Phrase: "1989."

Phrase: "[Abstract/Free FullText"

Phrase: "] Moore MC,"

Phrase: "Cherrington AD,"

Phrase: "Cline G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Pagliassotti MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Jones EM,"

Phrase: "Neal DW,"

Phrase: "Badet C,"

Phrase: "and"

Phrase: "Shulman GI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]
Processing 00000000.tx.297: Sources of carbon for hepatic glycogen synthesis in the conscious dog. 

Phrase: "Sources of carbon"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0449416:sources [Finding]
   756 E C1705919:Source [Idea or Concept]

Phrase: "for hepatic glycogen synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1157202:glycogen synthesis [Molecular Function]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]
   734   C0023902:Hepatic Glycogen [Biologically Active Substance,Carbohydrate]

Phrase: "in the conscious dog."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012984:Dog [Mammal]
   861   C1280551:Dog [Mammal]
Processing 00000000.tx.298: J Clin Invest 88: 578587, 1991.[ISI][Medline] Moore MC, Satake S, Lautz M, Soleimanpour SA, Neal DW, Smith M, and Cherrington AD. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "88"

Phrase: ":"

Phrase: "578587,"

Phrase: "1991."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Moore MC,"

Phrase: "Satake S,"

Phrase: "Lautz M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Soleimanpour SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Neal DW,"

Phrase: "Smith M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Cherrington AD."
Processing 00000000.tx.299: Nonesterified fatty acids and hepatic glucose metabolism in the conscious dog. 

Phrase: "Nonesterified fatty acids"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0015688:Nonesterified Fatty Acids [Lipid]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "hepatic glucose metabolism in the conscious dog."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0596620:glucose metabolism [Molecular Function]
   774   C1373178:Hepatic Metabolism [Organ or Tissue Function]
   748   C0025519:Metabolism [Organism Function]
   748   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.300: Diabetes 53: 3240, 2004.[Abstract/Free FullText] Myers SR, Biggers DW, Neal DW, and Cherrington AD. 

Phrase: "Diabetes 53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "3240,"

Phrase: "2004."

Phrase: "[Abstract/Free FullText"

Phrase: "] Myers SR,"

Phrase: "Biggers DW,"

Phrase: "Neal DW,"

Phrase: "and"

Phrase: "Cherrington AD."
Processing 00000000.tx.301: Intraportal glucose delivery enhances the effects of hepatic glucose load on net hepatic glucose uptake in vivo. 

Phrase: "Intraportal glucose delivery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0011209:Delivery [Therapeutic or Preventive Procedure]
   827   C0559563:delivery [Finding]
   827   C1705822:Delivery [Activity]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the effects of hepatic glucose load"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C1158774:glucose effect [Genetic Function]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on net hepatic glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.302: J Clin Invest 88: 158167, 1991.[ISI][Medline] Myers SR, Hendrick GK, Williams PE, Triebwasser K, Floyd B, Cherrington AD, and Adkins BA. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "88"

Phrase: ":"

Phrase: "158167,"

Phrase: "1991."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Myers SR,"

Phrase: "Hendrick GK,"

Phrase: "Williams PE,"

Phrase: "Triebwasser K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Floyd B,"

Phrase: "Cherrington AD,"

Phrase: "and"

Phrase: "Adkins BA."
Processing 00000000.tx.303: Importance of the route of intravenous glucose delivery to hepatic glucose balance in the conscious dog. 

Phrase: "Importance of the route of intravenous glucose delivery"

Phrase: "to hepatic glucose balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0014653:Balance [Organism Function]
   827   C0205415:Balance [Functional Concept]
   827   C0560184:Balance [Finding]

Phrase: "in the conscious dog."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012984:Dog [Mammal]
   861   C1280551:Dog [Mammal]
Processing 00000000.tx.304: Diabetes 39: 8795, 1990.[Abstract] Pagliassotti MJ, Holste LC, Moore MC, Neal DW, and Cherrington AD. 

Phrase: "Diabetes 39"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "8795,"

Phrase: "1990."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Pagliassotti MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Holste LC,"

Phrase: "Moore MC,"

Phrase: "Neal DW,"

Phrase: "and"

Phrase: "Cherrington AD."
Processing 00000000.tx.305: Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog. 

Phrase: "Comparison of the time courses of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "the portal signal on hepatic glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "glycogen metabolism in the conscious dog."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0599784:glycogen metabolism [Molecular Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.306: J Clin Invest 97: 8191, 1996.[Abstract/Free FullText] Satake S, Moore MC, Igawa K, Converse M, Farmer B, Neal DW, and Cherrington AD. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: ":"

Phrase: "8191,"

Phrase: "1996."

Phrase: "[Abstract/Free FullText"

Phrase: "] Satake S,"

Phrase: "Moore MC,"

Phrase: "Igawa K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Converse M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Farmer B,"

Phrase: "Neal DW,"

Phrase: "and"

Phrase: "Cherrington AD."
Processing 00000000.tx.307: Direct and indirect effects of insulin on glucose uptake and storage by the liver. 

Phrase: "Direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "indirect effects of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159527:glucose uptake [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "storage by the liver."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0337174:Storage [Spatial Concept]
   770   C1698986:Storage [Functional Concept]
   770   C1753314:storage [Cell Component]
Processing 00000000.tx.308: Diabetes 51: 16631671, 2002.[Abstract/Free FullText] Shulman GI. 

Phrase: "Diabetes 51"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "16631671,"

Phrase: "2002."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shulman GI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]
Processing 00000000.tx.309: Cellular mechanisms of insulin resistance. 

Phrase: "Cellular mechanisms of insulin resistance."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C1522618:resistance mechanism [Clinical Attribute]
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.310: J Clin Invest 106: 171176, 2000.[Free FullText] Sindelar DK, Chu CA, Rohlie M, Neal DW, Swift LL, and Cherrington AD. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "106"

Phrase: ":"

Phrase: "171176,"

Phrase: "2000."

Phrase: "[Free FullText"

Phrase: "] Sindelar DK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "Chu CA,"

Phrase: "Rohlie M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Neal DW,"

Phrase: "Swift LL,"

Phrase: "and"

Phrase: "Cherrington AD."
Processing 00000000.tx.311: The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. 

Phrase: "The role of fatty acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in"

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "the effects of peripheral insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on hepatic glucose production"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0033268:production [Occupational Activity]
   827   C0205054:Hepatic [Body Location or Region]

Phrase: "in the conscious dog."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012984:Dog [Mammal]
   861   C1280551:Dog [Mammal]
Processing 00000000.tx.312: Diabetes 46: 187196, 1997.[Abstract] Steiner KE, Mouton SM, Bowles CR, Williams PE, and Cherrington AD. 

Phrase: "Diabetes 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "187196,"

Phrase: "1997."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Steiner KE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022558:KE [Geographic Area]

Phrase: "Mouton SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Bowles CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "Williams PE,"

Phrase: "and"

Phrase: "Cherrington AD."
Processing 00000000.tx.313: The relative importance of first- and second-phase insulin secretion in countering the action of glucagon on glucose turnover in the conscious dog. 

Phrase: "The relative importance of first-"

Phrase: "and"

Phrase: "second-phase insulin secretion in countering"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1256369:insulin secretion [Cell Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "the action of glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441472:Action [Functional Concept]
   770   C3266814:Action [Activity]

Phrase: "on glucose turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0031227:turnover [Quantitative Concept]
   861   C0243127:turnover [Functional Concept]
   861   C0443331:Turnover [Health Care Activity]

Phrase: "in the conscious dog."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012984:Dog [Mammal]
   861   C1280551:Dog [Mammal]
Processing 00000000.tx.314: Diabetes 31: 964972, 1982.[ISI][Medline] Still JG. 

Phrase: "Diabetes 31"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
   861   C0450355:31 [Intellectual Product]

Phrase: ":"

Phrase: "964972,"

Phrase: "1982."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Still JG."
Processing 00000000.tx.315: Development of oral insulin: progress and current status. 

Phrase: "Development of oral insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: ":"

Phrase: "progress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1272688:progress [Functional Concept]
  1000   C1280477:Progress [Functional Concept]

Phrase: "and"

Phrase: "current status."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449438:Status [Qualitative Concept]
Processing 00000000.tx.316: Diabetes Metab Res Rev 18: S29S37, 2002.[CrossRef][ISI][Medline] Wajcberg E, Miyazaki Y, Triplitt C, Cersosimo E, and DeFronzo RA. 

Phrase: "Diabetes Metab Res Rev 18"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]
   804   C2347379:RES [Finding]
   804   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "S29S37,"

Phrase: "2002."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wajcberg E,"

Phrase: "Miyazaki Y,"

Phrase: "Triplitt C,"

Phrase: "Cersosimo E,"

Phrase: "and"

Phrase: "DeFronzo RA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]
Processing 00000000.tx.317: Dose-response effect of a single administration of oral hexyl-insulin monoconjugate 2 in healthy nondiabetic subjects. 

Phrase: "Dose-response effect of a single administration"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0178602:Dose [Quantitative Concept]
   748   C0869039:Dose [Quantitative Concept]
   748   C0871261:Response [Organism Attribute]
   748   C1114758:Dose # [Clinical Attribute]
   748   C1280500:Effect [Qualitative Concept]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2348382:Effect [Qualitative Concept]
   748   C2911692:Response [Mental Process]

Phrase: "of oral hexyl-insulin monoconjugate 2"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   937   C1175776:hexyl-insulin monoconjugate 2 [Hormone]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in healthy nondiabetic subjects."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1708335:HEALTHY SUBJECTS [Population Group]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]
Processing 00000000.tx.318: Diabetes Care 27: 286873, 2004.[Abstract/Free FullText] This Article Abstract Full Text (PDF) All Versions of this Article: 289/1/E46 most recent 00583.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by DiCostanzo, C. 

Phrase: "Diabetes Care 27"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C1947933:Care [Activity]

Phrase: ":"

Phrase: "286873,"

Phrase: "2004."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "289/1/E46 most recent 00583.2004v1"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in ISI Web"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282111:Web [Manufactured Object]

Phrase: "of Science Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1706852:Article [Intellectual Product]

Phrase: "by DiCostanzo,"

Phrase: "C."
Processing 00000000.tx.319: A. 

Phrase: "A."
Processing 00000000.tx.320: Articles by Cherrington, A. 

Phrase: "Articles by Cherrington,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "A."
Processing 00000000.tx.321: D. 

Phrase: "D."
Processing 00000000.tx.322: Articles citing this Article PubMed PubMed Citation Articles by DiCostanzo, C. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by DiCostanzo,"

Phrase: "C."
Processing 00000000.tx.323: A. 

Phrase: "A."
Processing 00000000.tx.324: Articles by Cherrington, A. 

Phrase: "Articles by Cherrington,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "A."
Processing 00000000.tx.325: D. 

Phrase: "D."
Processing 00000000.tx.326: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Visit Other APS Journals Online Copyright  2005 by the American Physiological Society.

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0039224:Table [Manufactured Object]
   742   C1706073:Table [Medical Device]
   742   C1706074:Table [Intellectual Product]

Phrase: "Visit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0545082:Visit [Behavior]
  1000   C1512346:visit [Health Care Activity]
  1000   C2826704:VISIT [Intellectual Product]

Phrase: "Other APS Journals Online Copyright  2005 by the American Physiological Society."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   738   C0009993:Copyright [Intellectual Product]
   738   C0037455:society [Organization]
   738   C0162443:journals [Intellectual Product,Manufactured Object]
   738   C0205394:Other [Qualitative Concept]
   738   C0205463:Physiological [Functional Concept]
   738   C0596070:American [Population Group]
   738   C1552856:copyright [Idea or Concept]

